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and 4 and CL6 and 7 and CL11. Error bars indicate standard deviation. *=p<0.10, **=p<0.05, 
***=p=<0.01 
5.10 Correlation between dynamic water contact angle and number of carbon atoms in 
hydrocarbon chain of silane molecule.  Results were plotted as a correlation and R
2
 value 
showed a significant correlation 
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days incubation with hMSC they were fixed and stained with Von Kossa stain for 
mineralization. (f) Shows positive mineralization staining on CL11 modification 
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modifiections;(a)untreated PLGA (b) CL3 (c) CL4, (d) CL6, (e) CL7, and (f) CL11. After 28 
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5.18 hMSC on modified PLGA scaffolds.  Scaffolds were  modified with with (a) CL3 (b) CL4, 
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mineralisation. 
5.19 hMSC on modified PLGA scaffolds.  Scaffolds were  modified with with (a) CL3 (b) CL4, 
(c) CL6, (d) CL7, (e) CL11 and (f) untreated PLGA and cultured for 28 days. After 
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Glycosaminoglycan (GAG)5.20 hMSC on modified PLGA scaffolds.  Scaffolds were  
modified with with (a) CL3 (b) CL4, (c) CL6, (d) CL7, (e) CL11 and (f) untreated PLGA and 
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cultured for 28 days. After incubation the samples were processed, sectioned and stained 
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Abstract 
Non-union fractures are defined as fractures that do not heal after 6 months of 
conventional treatment.  They usually require multiple surgical treatments, autologous bone 
grafts or treatments with growth factors or Bone morphogenetic proteins (BMPs).  There is a 
clinical need for a material which can be used to replace autologous bone transplantation in 
the treatment non-union fractures that negates the problems associated with autologous grafts.   
This thesis aims to consider and develop a coating that can be used on a readily 
available polymer biomaterial to induce a response from mesenchymal stem cells, which are 
found in abundance at fracture sites, and facilitate repair by their differentiation into 
osteogenic cells.  The use of a synthetic chemical coating rather than a growth factor or 
peptide aims to cause similar effects at a greatly reduced cost 
Plasma application techniques were used initially to screen potential terminal groups 
on a 3D system.  Amine groups were found to be osteogenic (which was confirmed by 
positive Von Kossa and Alizarin red staining), and hydroxyl groups were found to be 
chondrocytic (which was confirmed by positive Van Geison and Alcian blue staining).  The 
osteogenic effect of the amine group was investigated further, but in the form of silane 
SAMs, which were more easily definable.  The presentation of the terminal group was 
investigated using varying carbon chain length, to see if this had an effect on osteogenicity)  
This was explored using both MSC and primary osteoblast-like cell models on glass initially, 
then on PLGA films and finally a 3D PLGA system. 
  The results of this showed positive expression of osteogenic markers for the MSC 
and osteoblast-like cells when on glass and PLGA films.  There was an expression of  the 
osteogenic marker osteocalcin and a positive mineralisation stain (Von Kossa) at 7 days.  
This effect however was not transferred to a 3D platform as further optimisation will be 
required to achieve this goal-an essential progression on the way to the development of an 
injectable 3D system suitable for clinical application. 
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Chapter 1:Introduction, Literature Review and 
Hypothesis 
 
1.1 The Principles of Regenerative Medicine 
 The primary purpose of regenerative medicine is to provide strategies to replace tissue 
when injury, disease or congenital defect causes it to be missing
1
.  This is becoming more and 
more important.  Therapies that enable people to retain their healthy bodies beyond what is 
experienced today, in this changing economic climate with an aging population, will become 
more relevant. 
The natural response to injury, depending on the location, is to fill the space created 
by degraded tissue with scar/fibrous tissue.  This often has insufficient mechanical and 
functional properties to provide the full functionality of the tissue lost and can lead to severe 
complications.  The core principle of regenerative medicine is to guide the healing process 
using a range of signals to improve the quality of the repair, achieving more natural tissue 
faster, hence providing improved functionality more quickly.  This principle in its broadest 
sense can be applied to any aspect of regenerative medicine, but for the purposes of this 
thesis, the issues surrounding skeletal regeneration will be the main focus.   
1.2 Bone Fracture 
 Most uncomplicated bone fractures will heal after 3-4 months of conventional 
treatment. There is a little variation depending on the site of the fracture, but as a general rule, 
this is considered to be correct.  Clinicians will use X-rays to determine the normal 
physiological anatomy of the bone has been restored.  There are also a few physiological tests 
that are carried out to determine if a fracture has healed sufficiently and these are the absence 
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of pain with movement, and ability to bear weight.  When the normal pathway of treatment is 
not effective, the fracture is defined as being non-union
2
. 
1.3 Non Union Bone Fracture 
A non-union bone fracture is defined as a bone injury that fails to heal after six 
months - when conventional treatments have been applied, or a fracture that has shown no 
progression of healing for 3 months
2
.  There is some debate about this figure as some delayed 
unions can occur after the 6 month period has passed, particularly if there have been 
complications such as infection in the site, but as a general rule, the 6 month period is the 
guideline most clinicians use
2
.  The repercussions of non-union bone fractures for the patient 
can be impaired function and skeletal deformity.  It is expensive to treat, and often causes the 
patient to have numerous surgical procedures
3
.  The root cause of why some patients 
experience this failure to heal is not well documented, however there are some indications in 
the literature that the initial cellular response is considerably different in patients suffering 
from non-union fractures
4
. 
Webber defined two types of non-union fracture, depending on the viability of the 
fragments of bone present.  The first classification is called the hyper-vascular or 
hypertrophic non-union.  In this presentation of the non-union fracture, the bone ends are still 
biologically active and have a functioning blood supply.  A light callus forms because there is 
slight movement in the joint around the fracture site, which is not detectable until the patient 
is in surgery, but the callus prevents the fracture ends from joining.  It is a well-established 
fact that the bone ends need to be totally immobilised to fully join, and even slight motion 
can be responsible for non-union fracture.  Hyper-vascular non-union fractures have been 
defined as taking three different presentations.  The first presentation is the “elephant foot” 
morphology, which is named because the ends of the bone are covered with a highly vascular 
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callus that broadens at the fracture site.  The reason for this presentation varies, but can be 
linked to poor fixation, the join being too mobile, or due to premature loading of weight, 
which can lead to peudoarthrosis.  The second presentation contains less callus and is named, 
“horses foot” which is less hypertrophic.  This presentation is more common if the fixation of 
the bone has been slightly unstable and is more likely to spontaneously join, as the callus 
forms and stabilises the fracture.  The third presentation is oligotrophic, and contains no 
callus and is referred to as a lax non-union fracture
2
. 
The second classification is avascular non-union bone fracture.  In this class the bone 
fractures are avascular or atrophic and not able to form callus.  These are the more 
problematic fractures as they show no changes over long periods of time, and require 
sustained surgical intervention as immobilisation will not allow the bone ends to heal as they 
are no longer vital.  Avascular non-union is defined by one of four presentations.  The torsion 
wedge non-union is defined as a fragment of non-viable bone which has fused onto one of the 
viable ends.  The comminuted non-union occurs if the fragments are necrotic.  Defect non-
unions occur if a piece of the bone has been lost, during an accident, or because of infection.  
In these cases the ends can still be viable but the distance between them is too large to bridge, 
and because of this the ends become atrophic.  Lastly there are the atrophic non-unions, 
which usually start out as one of the other classifications and are the end point of the non-
union
2
. 
If left untreated the medullary canals become blocked, and the bone ends become 
joined by fibrous tissue.  Pseudoarthrosis can form, which takes either a stiff or lax form. 
Treatments for this condition vary from compression
5
 and distraction, to dissection and the 
grafting of new autologous bone
6
.  This is a long and complicated process, and there is a 
significant clinical need for a system that can be used to treat it without the need for the use 
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of autologous tissue.  One possible solution is the application of a material to support stem 
cell growth and differentiation.  Increasing and enhancing the healing process between the 
non-union ends of the bone, with an aim to regenerate functional and calcified bone in the 
void rather than fibrous tissue that can lead to pseudoarthrosis.  
 
1.4 Normal Bone Healing Pathway 
The sequence of events after a bone fracture has occurred starts with the formation of 
a haematoma. Injury incurred to the vascular system causes the clotting cascade to be 
stimulated and haematoma formation.  The haematoma contains large volumes of platelets 
and releases cellular signals.  Inflammation is initiated with an increase in localised blood 
flow and permeability of the blood vessels.  There is a migration of leukocytes to the injury 
site stimulates more cytokines to be released, recruiting mesenchymal stem cells (MSC) to 
the site of injury.  MSC proliferate and differentiate into osteoblast-like cells and there is 
increased angiogenisis.  Ossification then occurs, where the osteoblasts start to lay down a 
collagen network, which then ossifies to form a callus capable of bridging the gap between 
bone ends.  At this point the callus is named lamellar bone.  The last phase is remodelling 
which is orchestrated by osteoclasts and results in the woven bone formation, which has 
better mechanical properties than lamellar bone
7
. 
 There are four major populations of cells responsible for the regeneration of bone:  
 Osteoblasts, which have a regenerative role, and originate from MSC and are the main 
producers of the extracellular matrix that comprises bone.   
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 Osteoclasts, which are the enzyme producing cells that can dissolve collagens and are 
the key to bone remodelling, originate from the haemopoteitic stem cell fraction of 
bone marrow. 
 Osteocytes, which are differentiated osteoblasts, and have a less productive and more 
regulatory role. 
 Bone lining cells, which are osteocytes which are not embedded in the bone matrix, 
line the bone surface, remaining inactive until they are stimulated to change
8
. 
During fracture healing the role of MSC is vitally important.  They are the essential 
player in the bone regeneration process, and it has been shown that the bone morphogenetic 
proteins (BMPs) play key roles in mesenchymal stem cell recruitment in vivo
9
.  There is also 
some evidence to suggest that stromal cell derived factor -1 (SDF-1) plays a role in regulating 
the recruitment of MSC to the site where they are required
9
. 
1.5 The Formation of a Cartilaginous Callus 
 The formation of a cartilaginous callus is the result of initial stem cell differentiation, 
which later will be mineralised and remodelled.  This cartilaginous callus is the blueprint for 
the formation of bone, and provides many of the raw materials required.  The ossification of 
the callus occurs at the bone ends before it bridges into the central portion of the callus.  This 
causes the initial stabilisation phase. 
On a molecular level, it is at this point collagen I and II are produced in abundance, 
and the transforming growth factor beta (TGF- peptides are involved in endochondral 
ossification.  The BMPs are also involved in the ossification process
10
.  The vascularisation 
of the site is a necessity if the callus is to lead to full bone repair.  There is a fine balance 
required to instigate the required angiogenesis, alongside the removal of cartilaginous tissue 
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to make way for it.  Vascular endothelial growth factor (VEGF) plays a principle role in the 
angiogenesis of the fracture site. 
After angiogenesis has occurred the cartilaginous callus should be resorbed and 
replaced by a bony callus which has greater mechanical properties.  The number of cells in 
the bone fracture site increases as they are switched into a proliferative state, allowing more 
extracellular matrix to be produced.  The Wnt family of molecules is likely to be key 
facilitators in this in the differentiation of MSCs to osteoblasts, which is required for this step 
in fracture healing to occur.  Chondrocytes from the callus proliferate quickly during this 
phase of the healing process and can become hypertrophic which can lead to the extracellular 
matrix becoming calcified.  When this occurs there is a cascade of inflammatory cytokines 
including macrophage-colony stimulating factor (M-CSF), receptor activator of nulear factor 
kappa B ligand (RANKL) osteoprotegrin (OPG) and tissue necrosis factor alpha (TNFa).  
This cascade allows the recruitment of more osteoblasts and osteoclasts which promotes 
chondrocyte apoptosis.  Calcium accumulates in the mitochondria of the chondrocytes in this 
hypoxic environment.  Calcium is transported though the cytoplasm and is deposited in the 
extracellular matrix (ECM), where they can precipitate with phosphate and start the 
mineralisation process.  These initial deposits nucleate and form apatite crystals, which are 
carried to the nucleation point in microvesicles
11
, forming the hard callus.  As the calcified 
cartilage is mineralised it becomes woven bone
9
.  The growth factors that are responsible for 
this phase of osteoblastic activity have been studied extensively and it has been determined 
that there is a balance required of several growth factors including transforming growth 
factors (TGF-B1, TGF-B2 and TGF-B), vitamin D and fibroblast growth factor (FGF-2) 
which are key players in maintaining osteoblast function and establishing a mineralisation 
pathway. None of these factors in isolation can cause mineralisation from osteoblasts
12
. 
 
 
 
 Page 7 
 
 
 
The next phase is the remodelling of the woven bone so that it can become lamellar 
bone with a medullary cavity.  Again, the inflammatory cytokines interleukin 1(IL-1) and 
tumour necrosis factor alpha (TNF alpha) have a role to play in the second reabsorption 
phase.  The BMPs also have roles to play in this phase, especially bone morphogenetic 
protein 2 (BMP-2).  During this phase it is the role of osteoclasts to reabsorb the woven bone, 
and the job of the osteoblasts to extrude correctly structured lamellar bone.  This is a process 
which can take years to be fully achieved, and requires specific environmental conditions, 
creating an inductive electrical polarity, by the correct amount of pressure being loaded onto 
the micro-crystalline environment. 
 
1.6 The in vivo Osteogenic Differentiation Pathway of Mesenchymal Stem Cells 
 Bone formation is a complex morphological process that results in complete 
differentiation of MSCs, at a temporally correct point within a constantly fluxing system, and 
at the correct location. 
Multiple local and systemic factors play a role in this differentiation.  The local 
factors that instigate and maintain osteogenic differentiation of MSCs include transforming 
growth factor beta (TGF-B), core binding factor alpha-1 (CBFA-1), alkaline phosphtase 
(ALP), collagen I, osteopontin (OP), osteonectin (ON), bone sialoprotein (BSP), apoptosis 
mediating surface antigen (Fas), the interleukins (IL), and the apoptosis regulating Bd-2-
associated X protein (BAX).  These local factors however do not work in isolation and there 
are also some systemic factors that stimulate the osteogenic response, including parathyroid 
hormone, vitamin D, leptin, calcitonin, somatotropin, thyroxine, estrogens, androgens and 
glucocorticoids.  All of these factors play their part in the mesenchymal response in vivo, and 
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help to support the pathway of the MSC, to pre-osteoblast, to mature osteoblast and all the 
mineralisation phases, and ultimately to apoptosis or maturation into osteocyte morphology
13
. 
 To highlight just a few of these factors in a little more detail, the role of CBFA-1 is 
vital to the osteogenic process, and is considered a key marker of osteogenesis.  It is a 
member of the runt-related transcription factor (RUNX) family of transcription factors, and 
has demonstrated an important regulatory role where it stimulates the up-regulation of 
osteoblast genes such as osteocalcin.  It could be described as the corner pin of the osteogenic 
response and this is one reason why this marker is used so frequently as a marker of 
osteogenesis
14
,
15
.  Caution should be taken however when using CBFA-1 as a marker of the 
osteogenic differentiation of MSCs, as it is a transcription factor, and will only be present in 
the early phases of differentiation, for short periods of time, so it is not a marker that could be 
used alone, but would add weight to a panel of markers for osteogenesis. 
Osteonectin is expressed in pre-osserous cells, as well as osteoblasts and is one of the 
first indicators of osteogenic differentiation. However is is not specific to osteogenic 
differentiation as it can also be expressed by cells undergoing a chondrogenic lineage 
differentiation
16
.  Osteopontin is expressed during the mineralisation process, and is only 
present when mineralisation is occurring.  It has been shown to be present in cells found 
adjacent to mineralised matrix
16
.  Osteocalcin is a marker of bone metabolism, and has been 
used extensively as a marker of new bone formation
17
.  It could be described as a bone-
specific protein which consists of a sequence 49 amino acids
18
.  Osteocalcin is only secreted 
by osteoblasts that have been in contact with an established mineralised matrix and so is a 
very specific marker of functioning cells. 
 The TGF super-family contains all the BMPs and are involved in many 
regenerative and developmental processes, not just bone regeneration.  BMP 2 is specific to 
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bone regeneration, as is BMP 7
10
.  TGF-beta itself has been shown to increase bone 
formation in vitro, by allowing osteoblasts to expand in culture more readily, but seems to 
retard the mineralisation effect
12
. 
 
1.7 Current Therapy for Bone Loss in Non Union Fracture  
Autologous bone grafts are the gold standard for the treatment of non- union bone 
fractures.  There are many reasons why autologous bone grafts are the treatment of choice.  
The bone harvested can be classified as osteoinductive, as it contains viable MSCs and 
osteoblasts in addition to the molecules that are necessary to induce undifferentiated cells 
along an osteogenic lineage, such as BMPs and members of the TGF  super family.  It can 
also be classified as osteoconductive, because its structure (particularly if it is cancellous 
bone), will allow the in-growth of cells from the adjacent bone ends of the fracture site.  All 
the factors required to achieve a repair are present, because the bone taken from a donor site 
in the patient’s body is ideally suited for the purpose of filling a non-union fracture void19.  
The type of bone harvested does influence the success and the mechanical stability of the 
repair.  Cancellous bone, as described above has lots of properties that influence and bring 
about a good repair, but initially it has no mechanical strength, and it takes approximately 12 
months for the repair to be as mechanically sound as normal bone.  Conversely, cortical bone 
has  better mechanical properties but because of its dense structure, is less effective at 
delivering the appropriate factors to the site
19
.  But, removing bone from another area of the 
patient’s body to use in the fracture site is not always possible, depending on the size of the 
defect, can cause further complications. 
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Donor site morbidity is a serious problem, and the use of the fibula as a harvesting 
site can lead to pain, muscle weakness, nerve damage, infection, stress fractures and joint 
instability.  It is thought that up to 57.7% of patients experience some of these 
complications
20
.  Short term complications such as muscle weakness, do improve over a short 
period of time, but pain can last in excess of 12 months in some patients
20
. The quality of the 
autologous bone graft also reduces with the age of the patient
21
. 
Bone marrow aspirates are used to treat non-union fractures in some instances, where 
relatively large quantities of bone marrow are used and where stem cells are added back into 
the site.  There are several problems associated with this technique, one being that there is no 
means of keeping the cells in the intended location if no scaffold is used.  The quantity of 
bone marrow required to do this procedure could cause other complications
20
. 
Allografts are the next option for treatment after the other possibilities have been 
explored.  Allografts use de-cellularized bone from human cadavers or live donors.  They are 
less effective than autografts as the processing used to make them safe to use in other 
patients, strip them of many of the factors that make the graft osteoinductive, and mean that 
only their osteoconductive properties remain, loosing many of the osteogenic properties
20
.  
Complications from using donor tissue like this include transmission of viruses, including 
very rarely human immunodeficiency virus (HIV).  Bacterial infection is also more likely, 
with some reports suggesting that these rates are as high as 12.8%, but this is variable in the 
literature
20
,
21
. 
The use of bone morphogenetic proteins (BMPs) as a therapy greatly increases the 
healing potential of non-union fractures
22
, as an overview of the studies conducted into the 
use of BMPs states that success rate in patients who were treated for pseudoarthrosis was 
around 75%.  This still does not quite meet the 84% success rate of autologous bone, but was 
 
 
 
 Page 11 
 
 
 
seen to be a good substitute
21
,
22
.  Initially it was thought that BMP2 was completely safe for 
human use, as initial studies undertaken in 2002 showed no complications arising from its use 
for bone regeneration.  This, however, was not the case and initial studies have been 
discredited.  Later studies, when rhBMP2 was in general use in several countries, found that 
there were severe complications, including overgrowth of bone, osteoclast stimulation and 
activity leading to graft failure, local wound problems, including inflammation, neurological 
complications and carcinogenic properties
23
.  Treatment using BMP 7 seems to be showing 
some promise to date
24
. 
There are incidences where a synthetic bone regeneration system, which has 
osteoinductive, osteoconductive and osteogenic potential and is close to the gold standard of 
autologous bone, would be clinically-relevant and aid the recovery of patients with severe 
and often life-threatening injury.  The direction of the work undertaken in this thesis is 
influenced heavily by this aim. 
1.8 Synthetic Bone Grafts 
Of the synthetic bone grafts, the ceramic-based materials are the most commonly 
used.  Hydroxyapatite and -tricalcium phosphate are the most common of this subset.  There 
are a few advantages to these materials over allogeneic bone, as there is no risk of virus 
transmittance, and they have a very long shelf life.  They are osteoconductive but not 
osteoinductive when used in their unmodified states
21
.  To fully integrate they are reliant on 
bone in-growth, and need to be stable under physiological conditions to last long enough for 
this to occur.  One disadvantage of hydroxyapatite is that there is no reabsorption by 
osteoclasts, unlike allografts, which are eventually reabsorbed.  Conversely, the material will 
be in situ long enough to be integrated by the in-growth of bone if the porous structure of the 
scaffold is sufficient. 
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1.9 The Ideal Bone Biomaterial 
The ideal bone biomaterial would have all of the properties of an autologous graft.  It 
would have the capability to be osteoconductive, osteoinductive and osteogenic.  It would be 
osteoconductive to allow full integration with the host skeletal tissue, it would be 
osteoinductive to the cells that migrate into the material from the host, but ideally it would 
also be osteogenic as it could be used as a carrier or delivery system for the patient’s own 
therapeutic MSC.  The material would have mechanical properties similar to the tissue it 
intends to replace and, ideally if used in conjunction with cells, be degradable at the same rate 
as cells can mineralise the scaffold.  If this was incorporated into an easy to use injectable 
system that could bridge gaps of any shape or size it would be both clinically useful, and 
remove the requirement for autologous bone harvesting, thus improving the health of the 
patient. 
During this work, we have taken an injectable polymer system which already has 
osteoconductive properties, and mechanical strength similar to trabecular bone, and changed 
its surface chemistry to boost its osteoinductive properties, while testing its osteogenic 
potential using an in vitro MSC model. 
 
1.10 Mesenchymal Stem Cells (MSCs) 
It has already been stated that MSCs play a crucial role in the normal healing pathway 
of bone fracture injuries.  Undifferentiated stem cells migrate to the area where they are 
required and are stimulated by BMPs and regulatory cytokines to proliferate and differentiate 
into chondrocytes and osteoblasts, allowing osteogenic regeneration to occur
25
.  Much of the 
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current bone regeneration research has concentrated on using BMPs in their various forms to 
stimulate this natural healing response
26
.  Mimicking and enhancing this response should lead 
to a successful therapy.  This is one of the reasons why adult MSCs are ideal candidates for 
autologous bone regeneration. 
  There are multiple sources of MSCs within the body
27
.  Most tissues contain their 
own source of cells, but their potency and their niche varies between tissues.  It is the current 
opinion that a stem cell isolated from adipose tissue will not be capable of achieving the same 
fate as a stem cell derived from blood.  While there may be a small degree of overlap, there is 
a fundamental difference in their differentiation capability.  Bone marrow derived MSCs are 
considered to be more potent than stem cells derived from other adult tissues
25
.  There are 
two populations of stem cells found in the bone marrow, these are MSCs and hematopoietic 
stem cells.  Hematopoietic stem cells have a very specific niche where they produce blood 
cells and osteoclasts.  Hematopoietic stem cells are unlikely to be used as a cell for bone 
regeneration which is regulated by the osteoblastic lineage.  However, bone marrow derived 
MSCs are likely to be very useful for this task. 
It is currently considered that bone marrow derived mesenchymal stem cells (BM-
MSCs) are pluripotent, rather than multipotent
28
 as they can, and have been stimulated to 
differentiate into cells that derive from each of the germ layersfor example they can be 
pushed down osteogenic and chondrogenic 
29
 pathways from the mesoderm, neurons which 
originate from the ectoderm 
30
, and pancreatic cells and hepatocytes from the endoderm
31,28
. 
BM-MSCs are ideal for any osteogenic lineage induction as this cell type plays a role 
in the healing response of bone in vivo.  It is well documented that this cell type has the 
potential to be used in bone regeneration therapies, under the correct conditions
32
,
33
.  These 
cells are donor specific, ideally cells can be taken from bone marrow aspirates and cultured to 
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increase cell number until enough of the patients own cells are available to perform a 
regeneration procedure.  Another advantage is the isolation techniques are relatively simple, 
and exploit the cells inherent ability to adhere to plastic when cultured.  The bone marrow 
aspirate, usually taken from the iliac crest, is first subjected to sorting of nucleated cells from 
other material via a density gradient.  Then the nucleated cells are cultured for 24 hours in an 
appropriate media, and all non-adherent material is removed
34
. 
The lack of standardization in the initial isolation, characterisation of the cell 
population, and culture methodology can be problematic.  There is variation between 
techniques used to isolate and culture MSCs, and these subtle variations could be responsible 
for some of the conflicting results seen in some studies.  It is for this reason it is often 
unreliable to compare results obtained from different research groups, and it could explain 
some of the discrepancies seen
35
.  Therefore there is a need for standardization of isolation 
protocols, characterization of resultant cell populations and expansion techniques. 
There is patient variability in these cells and often the age and general health of the 
patient can affect how these cells proliferate in vitro.  Any work undertaken with primary 
MSCs should consider donor variation
36
.  There was considerable donor variation 
demonstrated by Zhukareva et al
36
, when MSC response to pro-inflammatory cytokines was 
measured using a panel of markers.  This study exemplifies how the patients’ cells will 
behave differently when exposed to exogenous stimuli.  This however, does not detract from 
the positive aspects of adult human MSCs, but must be considered when any research 
involving these cells is undertaken in respect of  the number of repeats necessary to validate a 
given response
36
. 
One of the most remarkable advantages of using MSCs relates to their immunological 
profile and how they can be classed as non-immunogenic.  They are essentially 
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immunologically privileged because they express major histocompatibility complex I (MHC 
I) but not major histocompatibility complex II (MHC II).  They do not express the cluster of 
differentiation antigens (CD antigens) CD40, CD80 or CD86 which stimulate an immune 
response.  These cells will evade the immune system of the host, and there is some evidence 
to suggest that the MSCs can suppress T cell proliferation
37
. 
1.11 The Identification and Profile of Mesenchymal Stem Cells 
The definition of the BM-MSC has been problematic.  The answer to that issue is not 
simple, because the defining feature of a stem cell is that it has the potential to change into 
any number of other cells, all of which will present markers the BM-MSC may also present.  
A panel of positive and negative markers is therefore the way they are defined, and should be 
defined periodically throughout the lifespan of the culture.  This brings together a profile of 
the cell that a potential BM-MSC has to meet.  Positive markers of BM-MSCs include CD73, 
CD90, CD105.  BM-MSCs should also be CD34, CD45, CD14 or CD11b, CD79 or CD19 
and HLA-DR negative.  The minimum number of cells expressing CD73, CD105 and CD90 
in a population should be 95%.  The maximum number of cells expressing the negative 
markers should be 2%
38
.  If this profile is used universally by researches it may go some way 
towards creating a standardized profile by which MSCs are defined and creating a cohesive 
methodology. 
There is also a physical requirement that needs to be met, when defining BM-MSCs, 
which is their ability to adhere to plastic in culture.  If they do not adhere to plastic they are 
not MSCs. The cells also need to have at least a multipotent differential potential.  They must 
be capable of differentiation into osteoblasts, chondrocytes and adipocytes as a minimum 
requirement, under the appropriate stimuli.  Histological stains can be used as evidence of 
this; osteoblasts can be stained by Von Kossa for calcification or Alizarin Red for 
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mineralization, chondrocytes using Alcian blue for glycos-amino-glycan (GAG) and 
adipocytes can be stained with Oil red O for lipids
38
. 
Another problem that researchers face when using BM-MSCs is that of senescence.  
Embryonic stem cells (ESC) go through many passages, and remain phenotypically correct, 
where  BM-MSCs will only passage a relatively small number of times before they lose their 
stem markers and become senescent.  This creates problems when it is necessary to achieve 
the large cell numbers required for cell therapies
39
.  Senescence is thought to occur due to 
shortening of telomere length during cell division, and as this is also a phenomenon observed 
during the natural ageing process, it also suggests that stem cells from older patients will be 
more prone to senescence
40
.  It is necessary to use MSCs before they get to the point of 
senescence.  It is important before undertaking any experiment with cultured mesenchymal 
stem cells that they are tested to express the panel of stem cell markers mentioned previously, 
as senescence halts their expression
40
.  The characterisation of MSC populations will ensure 
the cells used in any experiment or therapy are a homogeneous population most likely to 
behave in a predictable way, being more predisposed to differentiate. 
 
1.12 Differentiation of Mesenchymal Stem Cells 
The aim of differentiating MSCs is to create terminally differentiated cells that have 
applications for treating disease or injury. The ultimate goal is to be able to put MSCs into the 
body, either on a scaffold or on their own. They get their cues from the physical and chemical 
properties of the scaffold, either prior to implantation or after.  Alternatively, the scaffold can 
create a host response that cues the differentiation required.   
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There is evidence to suggest that MSCs have been differentiated into many different 
cells and tissues.  Adipogenic differentiation of MSCs would potentially be very useful for 
producing a filler material for reconstructive surgery 
41
.  Chondrogenic differentiation is 
leading to the growth of new cartilage that would represent a significant advance for the 
treatment of sports injuries 
42
.  Osteogenic differentiation could help surgeons repair non-
union bone fractures
43
 and the production of nervous tissue through neural differentiation 
would help many people who are paralysed with spinal injuries
30
.  Differentiation of MSCs 
into pancreatic islet cells may be an avenue to explore for type 1 diabetes mellitus
31
.  The 
underlying fundamental science of the cell differentiation pathways is not yet fully 
understood.  It is possible to promote differentiation in vitro using a wide range of stimuli 
using many different physical factors, exogenous growth factors supplied via culture media, 
or the interactions of cells with a surface. 
 
 
1.13 Cell Delivery Systems for Bone Regeneration 
Stem cell therapies undoubtedly have a lot of potential in regenerative medicine.  
Seeding MSCs at the area where the regeneration is required to occur, is more problematic 
than first anticipated.  A quantitative study of the delivery of MSCs into a rat model by two 
intravascular routes (the coronary artery and directly into the myocardium) demonstrated this 
particularly well.  The cells injected were labelled and it was shown that none of the cells 
injected into the coronary artery were found in the myocardial tissue, and only 15% of the 
cells injected directly into the myocardium were found to have been retained.  This example 
highlights the extent to which stem cells will migrate if introduced by the vascular system, as 
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the cells were found in the spleen, liver and lungs of the rat model
44
.  The small retention rate 
highlights the necessity of a delivery system that will retain the appropriate number of cells in 
the designated area of application. 
 As stated above, a major obstacle in the development of a stem cell-based therapy is 
the delivery of the cells to the required location.  A delivery system is needed that fulfils the 
requirements of being both conducive to MSC proliferation and differentiation but also 
degradable at a rate that allows tissue regeneration to occur, and has the correct mechanical 
properties to substitute bone whilst regeneration occurs.  There are a few studies (outlined 
below) that are working towards some of these properties.   
Some injectable hydrogels show promise for the stimulation and delivery of bioactive 
compounds to a site of injury, but struggle to match up to the mechanical properties required 
for bone replacement, particularly if the replacement has to bear weight
45
.  Injectable systems 
that would bear weight such as foamed injectable hydroxyapatite scaffolds, require exact 
timing of the injection to retain their pore structure which is vitally important for the 
osteoconductivity of the material, and the application of this in surgery would be 
impractical
46
.  Some studies have tried to combine the two techniques, using a hydrogel to 
encapsulate umbilical cord stem cells prior to incorporation into a calcium phosphate paste
47
.  
While this study has showed some positive results, there is still the question of how this 
technique could be used in a clinical setting.  Putting aside the issues regarding using 
umbilical cord stem cells and the risks of viral transmission that come into play when using 
donor cells, the encapsulation process requires specialised equipment to achieve the size of 
spheres required to maintain the mechanical strength required for bone applications.  Several 
other studies have used hydrogels in various forms
48
,
49
,
50
 but some of these studies were very 
preliminary, and will require further investigation before they would be used in a clinical 
 
 
 
 Page 19 
 
 
 
setting.  Detection of ectopic bone formation has proven to be a good model for proof of 
principle systems, in terms of observing how the materials will react in the in vivo 
environment.  Some of the calcium phosphate/hydrogel biphasic injectable systems have 
showed very promising results under these experimental conditions
51
.  But there is some way 
to go, before these systems have the correct load bearing mechanical strength for applications 
in real non-union bone fracture environments.  It seems a simple yet effective system that 
meets all the requirements is, as yet, unavailable.  Hydrogel and calcium phosphate injectable 
systems may not be appropriate bone regeneration biomaterials and novel degradable 
polymers could be good candidates for the next phase of research into injectable bone 
regeneration systems. 
1.14 Polymers as Cell Delivery Systems 
Polymers can be designed to have properties which are desirable for tissue 
engineering processes.  Elasticity, strength, and the ability to degrade at a controlled rate are 
just a few of the possibilities that make them very versatile and applicable for the generation 
of new tissues.  The molecular structure of a polymer includes repeating units, which form 
long chains that can have cross linkages.  The presence or absence of these cross linkages are 
responsible for many of the physical properties of polymers that provide their versatility for 
regenerative medicines purposes.  The poly(α-hydroxyacids) are particularly useful for the 
purposes of tissue engineering, this group includes poly(lactic acid) (PLA), poly(glycolic 
acid)(PGA), poly (lactic-co-glycolic acid) (PLGA) and poly(carpolactone) (PCL).  These 
polymers have been used extensively in the tissue engineering field 
52
,
53
.   
The physical properties of polymers are temperature dependant, and polymers can 
change state at certain temperatures.  When a polymer is in a liquid, or melt, state it has 
enough thermal energy to allow long free chains of molecules to move around randomly.  
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During this phase the polymer is elastic and flexible.  When cooled a polymer passes through 
its glass transition temperature (Tg), which varies between polymers and occurs when the 
long free chain molecules cease to move and the polymer will then become hard and stiff, 
like glass.  This explains why some polymers are flexible or stiff, the temperature the 
individual polymer is used at, whether below or above its Tg value, determines its physical 
properties.  In applications for regenerative medicine the temperature that the polymer will be 
used at is 37 
o
C.  Therefore the physical properties of the polymer must be appropriate for its 
intended end use at 37 
o
C, if it is required to be flexible, for example, in the case of a blood 
vessel, the polymer must be in its melt phase.  If the purpose it bone regeneration, it is more 
likely that the polymer must be more rigid, and should be used below its Tg value
54
.  
Although 37 
o
C is the temperature at which the polymer will function, it should also be stated 
that initially the material will cause an inflammatory response, which will increase the 
localised temperature to a small degree and it must be capable of withstanding some 
temperature tolerance without changing its structural integrity
55
. 
The aliphatic polyesters PGA and poly-L-lactide (PLLA), are used heavily in tissue 
engineering and regenerative medicine applications.  The copolymer of these two polymers 
(PLGA) has shown to be particularly versatile in this area of research because its degradation 
products are glycolic acid and lactic acid, which are easily metabolised
56
.  PLGA is seen to be 
biocompatible, as it has been used with many different cell types, including MSC
52
.  PLGA in 
its bulk form has got some limitations due to its hydrophobic nature and the released 
metabolic products can cause an acidic environment
56
,
57
.  Its capacity for variable 
degradation rate however is a benefit, which has led to further work being conducted to try to 
make use of this polymer in the tissue engineering and regenerative medicine field.  
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PLGA is a good candidate for an injectable system, as it can be used in a Tg phase 
that is conducive to bone regeneration
58
.  The degradation profile of PLGA it has been 
exploited when used in conjunction with calcium phosphate scaffolds to allow the 
degradation of the osteoinductive calcium phosphate structure
59
.  This work is starting to 
show some promise as the PLGA improves the osteoconductivity of the injectable calcium 
phosphate by degrading and leaving a pourous structure behind.  This technique has been 
employed in other studies
60
, and the resulting biomaterial has been shown to have load 
bearing qualities after 8 weeks of implantation.  To make a fully degradable system is the 
ultimate goal, and using PLGA alone may be a way to execute this.  The bulk qualities of 
PLGA have many advantages.  A material that can degrade in a controllable manner has 
mechanical properties which are desirable for the purpose of bone tissue engineering and 
which can be manufactures to form spheres or particles that are injectable has many benefits 
for this application.  In its standard form, the surface properties are not as desirable as the 
bulk qualities (i.e, it controllable degradation rate).  Several studies have been conducted to 
test the effects of making the surface of PLGA more biocompatible and less hydrophobic, 
ranging from bulk coatings of gelatin
61
, to the addition of peptides and surface chemistries
62
 
in order to support cell growth
62
, proliferation and differentiation, and so create a material 
that is osteoinductive in addition to being osteoconductive
63,57
.  There are many appealing 
surface modification methods that have attempted improve the biocompatibility of PLGA, 
outlined below. 
 
 
1.15 Surface Modifications 
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 Modifying the surface of a currently available and approved material is a method of 
retaining the desirable bulk qualities of an established biomaterial while enhancing the 
surface properties.  As discussed earlier, the use of whole proteins and peptides is a stage 
along a route to discovering the factors that influence the differentiation of stem cells.  
Breaking the idea down to basic interactions, the next logical progression of the idea that 
stem cell fate can be influenced by ECM is to look at the basic chemical composition of the 
ECM and to investigate if it can be copied to some extent by the addition of synthetic 
chemicals onto a biomaterial surface.  This technique is a relatively inexpensive way of 
broadening the applications in which approved biomaterials can be used, which reverses the 
significant downside of applying very expensive and complicated to produce peptides to the 
biomaterials surface.   
In the case of stem cell interactions it is desirable to induce a differentiation response 
from the cells via interactions with applied chemical groups on the surface of the 
material
62
,
64
,
65
,
66
.   
1.16 Modifications for Cellular Interactions to Mimic the Extracellular Matrix (ECM). 
 The main aim of modifying a surface is to make it more conducive for regenerative 
medicine/tissue engineering purposes.  The ideal scenario is to mimic the extracellular 
matrix.  The extracellular matrix is the overall term for the extruded proteinacious matrix that 
is produced by cells to provide a scaffold with the architecture required for a particular tissue.  
Many different cells are responsible for the different extracellular matrix profiles of different 
tissues, for example, chondrocytes are responsible for the ECM in cartilage which is rich in 
glycos-amino-glycans (GAG) and specific to that tissue, and bone matrix is excreted by 
osteoblasts and consists of the proteins collagen I, osteocalcin, osteonectin and osteopontin to 
give just a few examples
11
.  The function of the extracellular matrix varies between tissues, 
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but it always acts as a structural material for the tissue it constitutes.  However it is not 
merely a structural protein network, the some of the effects of the ECM are much more 
subtle.  ECM also influences the cells that are recruited to its location by inducing 
undifferentiated cells such as MSC, along a particular lineage.  Cells use the signals given to 
them by the structure of the ECM to reorder their cytoskeleton and take on different 
morphologies, which ultimately leads to different phenotypes
67
.  There is currently some 
debate as to whether it is the surface topography that influences cell fate, or the surface 
chemistry
62
.  Both these factors likely influence cell-matrix interactions.  Both topography 
and surface chemistry of ECM have been taken forward as approaches to create smart 
materials that can influence cell fate, essentially mimicking the ECM, in either its physical or 
chemical properties. 
 Initial studies in this area demonstrated the concentration of specific proteins, (i.e. 
fibronectin and laminin) and their subsequent concentrations on a 3D collagen scaffold could 
influence embryonic stem cells to differentiate into specific lineages (smooth muscle and 
cardiac cells)
68
.  This bulk coating of protein however could be refined, so that specific active 
pieces of the proteins could be used to influence stem cell fate in a very targeted and accurate 
way.   
1.17 Peptide Modifications 
Peptides are the next step along this surface chemistry driven pathway, allowing 
biomaterials to mimic natural ECM, avoiding some of the risk factors of using whole proteins 
from either xenological or human sources.  This work has enabled researchers to establish the 
origins of important signals in the differentiation pathway of stem cells.  This is being 
conducted using  several novel screening methods, including the expression of peptides in a 
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bacterial model where the bacterium are transfected with a plasmid containing the coding for 
different peptides, which are then expressed in the bacteria
69
. 
 Peptides that are engineered synthetically are very useful as a research tool as they 
simulate the ECM in a controllable manner.  It is possible to distinguish the differing roles of 
the various molecules in ECM by engineering the individual peptides and testing them in 
isolation
70
.  Isolating the peptides was an important step towards determining the individual 
capacity of the peptides and the peptides which were relevant for the osteogenic lineage.  
More established RGD and BMP were determined to be very relevant for the osteogenic 
lineage.  During one study peptide amphiphiles were functionalised with RGD and DGEA 
which were seen to be osteoinductive in their properties
71
.  Both of the peptides showed an 
increase in osteoinductivity when cultured with media containing growth factors, whilst RGD 
showed a degree of phenotypic change when cultured in the absence of growth factors.  This 
demonstrated very clearly the RGD has osteoinductive qualities that may be used to 
functionalise biomaterial surfaces
71
. 
 The osteoinductive properties of the RGD peptide are difficult to deny. The only 
foreseeable problems (which are considerable) with the use of peptides on a large scale is 
cost and availability.  It is very expensive and time consuming to produce peptides, and if 
they were to be used commercially would be required in large volumes.  The expense of 
using peptides is their limiting factor, and for this reason, identifying active molecules to bind 
material surfaces is progressing as the analytical techniques have improved.  Isolating the 
chemical groups active from within the peptide, and applying them to biomaterial surfaces is 
a new strategy within the field.  This is more cost effective than using peptides, and is starting 
to yield similar results, in vitro. 
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1.18 Chemical Modification 
  There are many methods of modifying a polymer surface
72
. A polymer surface 
usually needs to be functionalised before the application of an active chemical group.  There 
are several ways to do this depending on the outcome that is required.  To achieve maximum 
functionalization, a polyfunctional agent can be grafted to the surface of the polymer.  This 
allows the more functional units to be available and effectively increases the functional units 
per given unit of surface area compared to that of using a single function molecule.  
However, there can be problems with steric hindrance when functional groups are tightly 
packed together on a surface.  One way to overcome this difficulty is to use a spacer 
molecule, which allows movement and often acts as a protective layer to keep the active 
chemical group away from hydrophobic surfaces, which can denature some bioactive 
compounds
73
.  The chain length of these spacer molecules is variable, and finding an 
optimum chain length for a particular chemical group is important and could be a reason for 
the conflicting results reported in the literature where surface modifications appear to have 
the same chemical terminal group but induce different differentiation pathways in stem 
cells
74
.
 
By using combinations of functional groups arranged in different ways it is possible 
to mimic the natural ECM in various tissues.  The chemical groups that are of particular 
interest for skeletal regeneration are -NH2, CH3, -OH and –COOH as all these groups are 
found on bone ECM. 
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1.19 Amine Groups 
Amine groups have been shown to play an active role in the immobilisation of 
proteins, because of their positive charge and  it is thought that the amine groups have the 
capacity to attract and interact with proteins on the surface of a biomaterial
75
.  However there 
have been some variable results reported in terms of the effects observed on MSCs exposed 
to these modifications, in some cases have been directly contradictory.  Amine rich surfaces 
have been reported to be osteogenic,
62
 chondrogenic
65
 and non-differentiating
75
.  Clearly the 
reaction of the cells to the terminal groups is only part of the differentiation and presentation 
of the modification is likely to also play a role.  Interestingly, there have been differences 
seen when the same chemical is deposited onto a biomaterials surface in different ways (e.g. 
APTES). APTES was deposited using a Plasma technique
76
 showed no significant increase in 
osteogenic response with a pre-osteoblastic cell line compared to a control untreated 
substrate, where-as APTES applied using a wet chemical technique caused an osteogenic 
effect from MSCs
62
.  This contradictory data merits further investigation, as it appears that 
amine groups if presented in the correct way could have powerful osteogenic properties.  It is 
essential to isolate the parameters that affect the presentation of the amine and determine 
which of the many possible modification techniques will have the most clinical relevance. 
Clearly there is need for clarification of the surface modifications at a molecular level.  
Clarification may come from varying presentation of the terminal groups to achieve an 
optimised and reproducible response from the cells. 
1.20 Methyl Groups 
 The addition of methyl groups to a surface has also shown mixed results.  There is 
evidence to show that this is due to several different factors.  The addition of methyl groups 
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to a surface has been shown in some studies to cause a chondrogenic response in MSC
65
, 
whilst others have shown that specific hydrocarbon chain lengths can maintain the MSC 
phenotype
74
.  The different results seen when the chain length is varied could offer some 
explanation for the variance in the results seen in the literature from studies where the 
presentation of the chemical group has not been considered to be a factor. 
1.21 Hydroxyl Groups 
 Hydroxyl groups have been used quite extensively in biomaterials applications and 
have been shown to induce and maintain chondrogenic in chondrogenic phenotype 
77
.  
However they have also demonstrated that they have the ability to form apatite surfaces when 
in contact with calcium rich solutions
78
, which would indicate that the surface chemistry 
would induce an osteogenic response.  So again there seems to be more factors involved in 
the differentiation of the cells than purely the terminal group, and it may be that again it is the 
presentation of the end group that is the key to its effect on cell populations. 
1.22 Carboxyl Groups 
 Carboxyl groups have also demonstrated varying results in the literature.  There is 
some evidence to suggest that carboxyl groups can cause an osteogenic response from 
mesenchymal stem cells
65
, whilst other studies show that there is a chondrogenic response
62
.  
These conflicting results require further investigation. 
 
1.23 Plasma Modification Techniques 
The use of plasma to introduce different surface chemistries to a substrate is widely 
reported. 
66
,
79
,
80
.  Plasma is considered to be the fourth state of matter and can be produced 
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when gases are excited into high energy states with either an electron source such as a hot 
filament, micro-waves or radio- waves.  When plasma is in this state ions and molecules of 
various different can be deposited onto a surface.  One advantage to this technique is that it 
can be used on 3D shapes, as it does not require a line of sight.  This is particularly useful for 
complex tissue engineering scaffolds.  An example of this which has been used clinically is 
the coating of calcium ions onto a titanium bone implant to increase bone adhesion
79
. 
Plasma deposition has several other advantages when used to coat a 3D object, which 
is likely to be a considerable advantage when applying surface chemistries to biomaterials 
suitable for bone regeneration.  It can graft surface discrete chemistries onto polymers 
without the need for prior functionalization, even when using polymers.   
The main disadvantage to using plasma coating is that there is no way to control the 
order of the deposition.  It is completely random and there is no way of controlling the 
distance between the surface chemistries.  In addition it can be very difficult to quantify the 
concentration of the groups deposited.  This is problematic as the characterisation of the 
surfaces is vitally important when it comes to transferring the optimal concentration onto 
different substrates.  Defining the concentration of a chemistry on a surface is much simpler 
if you are using a wet chemical technique, where a known concentration can be measured at 
the start of the coating reaction and at the end of the coating reaction, allowing quantification 
of the deposited chemical.  
1.24 Silane Modification Techniques 
 Surfaces can be modified using a silanisation technique.  It has successfully been 
used on an array of polymer substrates to introduce –CH3, -NH2, -OH and –COOHgroups
62
. 
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Silanisation of a polymer first requires it to be functionalised, usually via the addition 
of oxygen groups to the surface.  This is usually done using an oxygen plasma technique.  
When the oxygen groups have been attached to the surface of the polymer, a silane group can 
bond.  Silanes are remarkable molecules for several reasons.  There have a reactive silane 
body, a hydrocarbon chain and an end group.  The chain length can be varied as can the end 
group, while the silane group remains able to bind free oxygen molecules on a surface.  It is 
also a non toxic molecule that is suitable for cellular interaction. 
The most useful feature of silane molecules however is their ability to form self-
assembled monolayers (SAMs)
81
,
82
.  The formation of silane SAMs includes a step which 
involves an irreversible covalent which makes them particularly stable
81
.  They do however, 
need surface oxygen or –OH groups on the substrate with which to form hydrolytic bonds, so 
the layer can be bonded to the substrate at anchor points.  The packing density is controlled 
ultimately by the formation of a siloxane network 
81
 so there is more control of this parameter 
using silane modification compared to a plasma coating method.  This may be useful for 
determining the optimum concentration of a given surface modification.   
 
1.25 The Characterisation of Surface Modifications 
It is particularly difficult to define the specific concentration of some surface 
chemistries on a modified surface.  Most techniques used to characterise a surface 
characterise one particular parameter a modification has brought about.  No one technique 
fully characterises all of the properties of a surface so it is always necessary to use a panel of 
techniques to comprehensively characterize a surface.  
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1.26 Water Contact Angle 
Water contact angle (WCA) is generally the first technique that is performed to 
determine the likely surface energy of a modified surface, and is has the advantage of being 
relatively simple and quick to perform.  Surface energy can predict the wettability of a 
surface (hydrophilic or hydrophobic) which can be a direct predictor of its ability to interact 
with cells.  The use of WCA  is a long established
83
,
84
 indication of surface energy and a core 
test for the assessment of a biomaterial and is often the first test done to evaluate the 
suitability of a surface for further research.
85
,
86
. 
 
1.27 Scanning Electron Microscopy(SEM) 
SEM is used to examine surface topography.  An electron beam passes across a 
surface and bounces secondary electrons from the surface into a detector.  From the energy 
patterns of these secondary electrons, an image on a surface is displayed in incredible detail 
in gray-scale.  Until recently, this technique was reserved for conductive samples as any 
charge that built up on the surface as a result of the electron beam distorted the image.  
However the field has advanced sufficiently to provide instruments capable of imaging at low 
accelerating voltages, which do not require the samples to be fully conductive.  This is 
combined with sputter coating, which ionises metal to form plasma which allows a very thin 
(10-20nm) coating of metal to be deposited on the samples surface.  Thus the technique is 
suitable for the examination of polymer surfaces and macrotopographical features 
87
.  One 
drawback is that there is some loss of resolution when imaging at very high magnification.  It 
is not possible to image nanoscale surface features on polymers where it would be entirely 
possible to observe these features on a very conductive sample such as a metal. 
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1.28 AFM (Atomic Force Microscopy) 
To determine the topography of a polymeric surface at the nanoscale it generally 
requires use of an atomic force microscope (AFM).
88
,
89
,
90
.  AFM uses a canter-lever to tap 
the surface and its attenuation determines the nanotopography of the surface.  It has several 
advantages compared to SEM.  It does not have to be conducted under a vacuum so it is not 
necessary to dry samples if they are wet, and it does not require the sample to be conductive.  
However, this technique is unsuitable for large areas as it is very time consuming.  An area of 
500nm
2
 can take several minutes to scan, so the technique is useful only on a nanoscale.  
Using this technique in conjunction with SEM builds up a comprehensive picture of  the 
macro and nano topography of a surface
91
.  Some drawbacks of using this technique include 
the aberration of some surface characteristics because of the tip.  It is impossible to visualise 
overhanging features and spherical features will appear cone-like as the tip can not reach 
under them.  
 
1.29 XPS (X-ray Photoelectron Spectroscopy) 
The microscopy techniques discussed above are useful for defining the topography of 
the surfaces but do not reveal any differences in the chemical composition of the 
modification.  One way to achieve a limited amount of information about the composition is 
to use X-ray photoelectron spectroscopy (XPS).  This uses the element-specific pattern of 
photons and X-rays that are released when a surface is hit with an electron beam at a specific 
energy level
84
,
92
. This gives the specific elemental composition of the surface, but is limited 
to any element higher on the periodic table than helium.  Hydrogen and helium cannot be 
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measured using this technique because the as the diameter of the orbital is too small to 
facilitate the catch probability.  This is a well established technique and is used routinely to 
determine the chemical composition of a biomaterials surface.
93
,
94
,
95
. 
 
1.30 Specific Chemical Assays - Ninhydrin 
To determine a specific concentration of a particular terminal group, it is sometimes 
possible to use a specific chemical test such as Ninhydrin.  Ninhydrin is a molecule which 
will react with free amine groups, to give a colorimetric change.  This colour change can be 
quantified to determine changes in the amine concentration of a solution.  It is possible then, 
to measure the depletion of an amine in a coating solution to determine quantity of amine 
deposited onto a surface.   
Cellular interactions can only be accredited to surface modifications if they have been 
extensively characterised. 
 
1.31 Topography vs Chemistry 
The ability of surface topography to affect the fate of MSCs has been 
comprehensively researched in recent years.  The size of surface features seems to be a factor 
in the stimulation of MSC differentiation.  It has been shown in several publications that the 
grain size of titanium is particularly influential in the resulting stem cell neiche.  Particle sizes 
smaller than 50nm appear to retain stem cell phenotype even in the presence of exogeneous 
stimulation from additional growth factors in the media.  Conversely grain sizes larger than 
200nm showed an increase in osteogenic markers, but only when stimulated to do so by 
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osteoinductive growth factors.  In these examples it is not the chemistry of the surface that is 
responsible for this phenotypic change, as the surface chemistry is the same, it just 
differences in topography
96
.  In another study, sub-nanoscale titanium surfaces could not 
sustain or increase differentiation from mouse MSC, but nanoscale surfaces did influence this 
significantly
97
.  It appears that topography of titanium substrates in the range of 2-4nm causes 
osteogenic differentiation of human MSCs. 
 When the topographical stimulus is not sufficient to stimulate the cells to produce 
their own growth factors, topography to influence stem cell fate if the correct osteogenic 
stimulus is supplied in the media
62
. 
By increasing the stimulus, a nanotopography has been used to stimulate an 
osteogenic response from MSCs and osteo-progentitor cells, in the absence of differentiating 
media, using disordered nanolithography techniques up to 21 days
98
. 
To date there has been little research to determine what the effect of different 
chemistries on surface topography at a nano scale.  It has often been shown that the chemistry 
enriched surfaces do not show any macro-topographical changes, but it is likely that 
significant changes do occur at a nano-topographical level.  It may be that it is a combination 
of surface topography and chemistry that allows the powerful effects to be seen and it may 
here in this area of combining chemistry and topography will have the greatest results.  It is at 
this point that it is worth mentioning that most of the research done in this area is conducted 
on a film or relatively flat substrate such as glass or gold add 
62
,
82
.  Transferring the surface 
chemistries onto 3D substrates may not result in the same cell response, and this must be 
considered when taking a surface chemistry onto the 3D system. 
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1.31 2D to 3D 
Base level cell reactions are assessed using the 2D substrates to observe how cells 
react to surface chemistries in the absence of other factors that inevitably require optimisation 
when cell culture is stepped up to 3D, such as the transportation of nutrient through a porous 
scaffold, oxygen gradient and the cell seeding density required to populate the scaffold.  It is 
also important to determine if the modifications will produce a similar effect on a 3D 
substrate.  The clinical applications for these chemistries would be in 3D systems, so it is 
important to demonstrate that it is possible and apply the fundamental theories to a usable 
clinical product. 
1.32 Cell Responses in 3D Cultures 
 The 3D culture models that have been reported using osteoblasts suggest that they can 
be successfully cultured this way.  In fact there have been reports that osteoblasts require no 
further exogenous growth factors to retain their phenotype when put into a 3D culture 
environment, although the cells were grown in sheets then bunched together in a spheroid 
like configuration
99
. 
In addition, 3D culture it is a well established chondrogenic differentiation tool.  
Pellet cultures allow cells to grow within a defined oxygen gradient.  Any of the cells in the 
central portion of the cell pellet will experience a hypoxic environment which may be 
responsible for differentiation growth factors to be released. 
1.33 The Ideal Bone Regeneration System 
To summarise, an ideal bone regeneration system would be a degradable polymer, 
which could support active surface chemistries and could be used either as a carrier for the 
patients’ own stem cells, or to stimulate the influx of MSCs and osteoblasts in vivo.  The 
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material would have sufficient mechanical properties to withstand the forces inflicted upon it 
and mimic ECM to produce a response of sufficient power to allow the differentiation and 
mineralisation of the scaffold, at the same rate at which it degrades, in the absence of any 
cytotoxic degradation products.  A porous, injectable PLGA system with an osteoinductive 
surface chemistry could meet all these demands and it is the development and optimisation of 
these surface chemistries on which this research will focus. 
1.34 Hypothesis 
Hypothesis 1 
 Surface chemistry can affect the phenotypical response of mesenchymal stem cells, 
when applied to a 3D polymeric bone regeneration system. 
Hypothesis 2 
 The presentation of amine functional groups can have an effect of the cell response 
seen, when on a flat glass surface. 
Hypothesis 3 
The optimised amine modifications can be transferred to a polymeric surface, and a 
3D injectable bone regeneration system, to give a unified cellular response. 
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Chapter 2: Materials and Methods 
2.1 Methods for Chapter 3.  PLGA scaffold construction and analysis 
2.1.1 Manufacture of Materials:  The two component injectable system. 
The manufacture and plasma modification of the injectable system was conducted and 
supplied by Dr. Lloyd Hamilton, University of Nottingham.  The basis of the injectable 
scaffold is a two part system; the PLGA sphere, which was the carrier component on which 
the modifications were made, and the adhesive component which was also PLGA but 
modified to change its glass transition temperature (Tg) temperature, which facilitated its 
adhesive properties. 
2.1.2 Manufacture of PLGA sphere  
 1.2g of 85:15 PLGA (Lakeshore Biomaterials, UK) was dissolved in 6mL 
dichloromethane (Sigma, UK).  This solution was pipetted drop by drop into a stirring 
solution of poly (vinyl alcohol) (PVA) 0.3% 
w
/v mw 23,000 (Sigma, UK).  The solution was 
stirred constantly in a fume hood for 48 hours, spheres were recovered by filtration, and 
washed with distilled water and dried at room temperature under vacuum. 
2.1.3 PLGA adhesive 
The adhesive particles (component II) were manufactured by melt blending up to 15 
wt% PEG (Mw 400) and PLGA and recovered as thin films.  Polymer films were placed in 
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liquid nitrogen then ground and sieved into size fractions. The scaffold was composed of 
particles 100-300µm in diameter. 
2.1.4 Material Modification of PLGA spheres 
Plasma polymerisation was conducted on the PLGA spheres (method outlined in 
2.1.2), in a custom built enclosed T-shaped borosilicate chamber system.(Lloyd Hamilton, 
University of Nottingham). Plasma was initiated via two external copper band electrodes 
secured to the borosilicate vessel and connected to a 13.56 MHz radio frequency power 
source (Coxial Power Ltd, UK).  The power was adjusted to <1W and all substrates were 
exposed to an oxygen plasma (20W, 300mTorr) for 3 minutes.  The thickness of the 
deposition process was monitored with a quartz crystal microbalance located within the 
reactor and coated to a thickness of 100 nm.  The reactive monomers (allyl amine, hexane, 
acrylic acid and allyl alcohol) were deposited at 20W and 300mTorr. 
 
Material characterisation: 
2.1.5  Water contact angle measurement 
 The water contact angle is measured to determine the surface energy of a material, 
and when compared to other materials and controls is indicative of changes is surface energy, 
and in turn changes in surface properties and chemistry. 
Water contact angle was measured using the PLGA spheres, compressed into cakes to 
enable the measurements to be taken.  A total of 10 repeats were conducted, and the resulting 
means were analysed using ANNOVA to determine any statistical significance between the 
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values.  Water contact angle measures the surface energy, and from this its 
hydrophobicity/hydrophlicity can be measured. 
 
2.1.6 SEM of materials 
SEM was conducted to determine what macro-topographical changes had occurred on the 
modified materials. 
Dry films, glass or spheres were mounted onto aluminium SEM stubs (Agar scientific UK) 
using double sided carbon sticky tabs (Agar Scientific, UK).  The samples were coated with 
20nm of chromium using an EMTECH 575X sputter coater (Emtech, UK).  The samples 
were then observed in a LEO 1550 FESEM (Zeiss, UK) using the secondary electron detector 
at 5kV accelerating voltage.   
 
2.1.7 X-ray Photoelectron Spectroscopy (XPS)  
XPS was conducted by Dr. Lloyd Hammilton, University of Nottingham.  XPS is used to 
measure the elemental composition of a surface.  XPS analysis was conducted with a Kratos 
Axis Ultra instrument equipped with a monochromated Al Kα X-ray source (1486.6 eV) at 15 
mA emission current and 10 kV anode potential.  The instrument was operated at fixed 
transmission mode and the take- off angle of 90° for the photoelectron analyser. All scans 
were charge-corrected to C 1s at 285eV.  Data analysis was carried out with Casa XPS using 
the manufacturer’s empirical sensitivity factors to quantify the elemental composition (in 
atomic %) from the spectra.  The modified polymer spheres were fixed to a glass slide using 
double sided adhesive tape.  The XPS spectra were taken from the surface of the spheres. 
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2.1.8.  Culture of Mesenchymal stem cells (MSC) 
Primary human MSC purchased from Lonza (UK), were defrosted rapidly in a 37
o
C 
water bath.  The vial was decanted into a T25 (Falcon, SLS UK) flask containing 5mL of 
HMSC culture media with 5% foetal calf serum (both Lonza UK).  After 12 hours, the media 
was removed and replaced, to remove any traces of cryo-preservative that remained from the 
initial suspension solution.  The cells were cultured until confluent, which typically was 1-2 
days, and then passaged into a T75 culture flask (Falcon, SLS UK).  The passaging process 
was as follows; all media was aspirated from the flask containing the MSC, and discarded.  
The adherent cells were washed with Dulbecco’s PBS solution (Sigma, UK), for 1 minute 
and then aspirated off.  Three mL of 10 % trypsin solution (Sigma UK) in Dulbecco’s PBS 
(Sigma UK) were added and then incubated at 37
o
C for 3-5 minutes, carefully noting the 
moment when the MSCs start to detach from the flask.  Immediately 3mL of culture media 
containing serum was added to the flask to stop the enzymatic reaction.  The cell suspension 
was then removed from the culture flask, and placed into a 15mL centrifuge tube (Falcon, 
SLS UK).  The cell suspension was then centrifuged at 1500rpm for 5 minutes, to create a 
cell pellet.  The supernatant was removed, and the pellet re-suspended in 1mL of fresh media 
containing 5% serum.  The cells were seeded into a new T75 flask containing 10 mL of 
serum containing media.  This flask was incubated at 37
o
C with 5% CO2 until confluent, with 
5mL of old media removed and 5mL of new media added every 3-4 days.   
When confluent, the media was removed, cells were washed with PBS for 1 minute, 
trypsinised using 5mL of trypsin (following the protocol above) and the reaction was stopped 
using 5 mL of serum containing media.  The cells were pelleted (as described above) and re-
suspended in 1.2 mL of media.  0.4mL of the cell suspension was then added to each of 3 T75 
culture flasks containing 10 mL of media.  These flasks were incubated at 37
o
C with 5% CO2 
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until confluent (as above).  This process was repeated another 2 times, until passage 5 was 
reached, at which point the cells were used in the experiments outlined below. 
2.1.9.  Mesenchymal stem cell culture with 3D scaffolds. 
 MSCs were cultured in contact with modified PLGA spheres to determine the cellular 
response to the different surface chemistries.  The PLGA system used consisted of two 
components, the PLGA sphere which act as a carrier for the surface chemistries (as 
introduced in chapter 3), and a PLGA adhesive which is temperature sensitive and cures at 
37
o
C binding the spheres.  For this in vitro study the injectable system was cured into 
cylindrical scaffolds using a modified syringe.  During the development of this technology 
the mechanical properties were examined and the ratio of adhesive to spheres was optimised 
for its suitability for bone regeneration.  This optimised ratio was used in this work. 
Modified beads (component 1) were mixed with the adhesive component (component 
2) in a ratio of 1:3.  They were sterilized by exposure to UV ozone for 10 seconds, and 
shaken. This was repeated three times, to ensure even exposure of beads to sterilizing 
environment. 
A modified 1mL syringe was used to mould the scaffolds.  The calibrations on the 
barrel of the syringe were used to measure the volume of the scaffold.  The pr-mixed and 
optimised bead/adhesive mixture was packed into the syringe to a volume of 60l.  A 
previously optimised cell number of 0.5x10
6
 hMSCs was seeded onto the scaffold in a 100l 
of serum free MSC media (Lonza, UK).  The syringe mould was then incubated at 37
o 
C in 
5% CO2 for 30 minutes to cure.  The cured scaffold was then ejected from its mould into a 6 
well tissue culture plate and covered with 10 mL of basal MSC culture media with serum 
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(Lonza UK) placed on a shaker plate at 65rpm, and cultured at 37
o 
C in 5% CO2 for 7, 14 and 
28 days.  Fresh media was added every 3 days. 
2.1.10.  Sample preparation for LDH Assay 
LDH is an intracellular membrane bound marker which is released during cell lysis.  
The quantity of LDH that is released is consistent enough to aproximate the number of cells 
present using a serial dilution of cell lysates.  A serial dilution of cells was made to create a 
standard curve of cells for the assay.  Released LDH can be measured and related back to the 
standard curve of cells, to ascertain number on the scaffolds.  The following concentrations of 
cells were prepared in 1mL of serum-free basal media (Lonza, UK); 0, 1x10
5
, 2.5x10
5
, 5x10
5 
and 1.2x10
6
.  These tubes were then frozen at -80
o
C until required for assay.  Prior to assay 
samples were subjected to repeated freeze/thaw cycles to ensure complete release of LDH 
from all cells.  All experiments were repeated 4 times. 
At the 14 and 28 day time points, scaffolds were removed from their well and placed 
into a new 12 well tissue culture plate with 1 mL of serum free MSC media (Lonza, UK). As 
serum contains LDH, it should not be used with this assay.  The scaffold was crushed, and 
placed in a -80
o
C freezer.  Samples were then subjected to the same freeze/thaw cycle 
described above to ensure complete release of LDH from all adhered cells throughout the 
scaffold.  
 
2.1.11 LDH Assay  
  12mL of assay solution was added to 1 bottle of substrate mix (Promega, UK).  50l 
of each of the test samples was added to a 96 well plate (SLS, UK). Each sample was run in 
triplicate.  A standard curve was created using the positive LDH control in the kit (Promega, 
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UK).  The following dilutions of units of LDH per mL were made; 6.6x10
-4
, 3.3x10
-4
, 
1.65x10
-4
, 8.3325x10
-5
.  These dilutions were made in PBS with 1% bovine serum albumin 
(BSA) (both Sigma, UK).50 l of each of the dilutions were added to the empty wells on the 
96 well plate. 50l of standard cell solutions were added to empty wells.  50l of assay buffer 
was added to all wells.  After 30 minutes incubation in dark, 50l of stop solution were added 
to the well plate.  Each plate was measured on a plate reader at 492nm wavelength 
immediately.  4 separate repeats were conducted and data was analysed using standard 
deviations and ANNOVA to determine the variance of means and any statistical significance 
between the modifications. 
 
 
2.1.12.  Histology  
 The histological investigation of the 3D scaffolds was undertaken to examine the 
penetration of cells into the scaffold, and to ascertain if any of the cells had differentiated. 
2.1.13.  Fixation 
Samples were removed from culture at 7, 14 and 28 day time points.  They were fixed 
with a 2.5% solution of glutaraldehyde (Sigma, UK) for 48 hours, and dehydrated by 2 hour 
submersions in 70, 90 and 100% ethanol solutions.  
2.1.14.  Embedding of Samples in Glycolmethacrylate (GMA) Resin 
Samples were embedded using Technovit 8100 (TAAB, UK) glycolmethacrylate 
(GMA) based resin.  100mL of base glycomethacrylate solution was mixed with 1 sachet of 
hardener 1.  To 90mL of this solution 3mL of hardener 2 was added.  Samples were then 
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placed into moulds and covered with the embedding solution and put in a vacuum on ice for 
20 minutes.  Samples were then removed from the vacuum oven, mineral oil was placed on 
top of the embedding solution, and then they were placed at -55
o
C for 4 days, 4
o
C for 6 hours 
prior to ejection from moulds. 
2.1.15.  Sectioning 
Seven m thick sections were taken from the resin blocks using a Polycut sledge 
microtome (Leica UK).  These sections were floated in a water bath at room temperature and 
captured on a glass microscope slide pre-coated with aminopropyltriethyoxysilane (APTES) 
(Sigma UK). 
2.1.16.  Haematoxylin and Eosin stain  
 Haematoxylin and Eosin (H&E) stains the cell nucleus (blue) and cytoplasm (pink).  
This stain is useful for determining the extent of cellular infiltration throughout the scaffold. 
Sections were taken through decreasing concentrations of ethanol (100%, 90% and 
70%) for 2 minutes each then put into distilled water for 2 minutes.  Sections were then 
stained with Harris’s haematoxylin (Sigma, UK) for 5 minutes, washed in running alkali tap 
water for 5 minutes, differentiated using acid alcohol (100mL ethanol with 1mL of 1M 
hydrochloric acid (Sigma, UK)) for 2 seconds, washed with distilled water and stained with 
1% Eosin (Sigma, UK) for 3 minutes.  Sections were washed for 2 minutes in distilled water, 
followed by dehydration through increasing concentrations of ethanol (70%, 90% and 100%) 
for 2 minutes each, cleared in xylene (BDH, UK) for 2 minutes then mounted with glass 
coverslips in DPX (BDH, UK). 
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2.1.17.  Van Gieson stain 
 Van  iesons’ stain for collagen will show any of the multiple types of collagen that is 
produced by the cells in the scaffold.  It does not differentiate between the different types of 
collagen and is a generic collagen stain.  This is useful as an investigative stain to show the 
production of collagen by the differentiated stem cells, as the cells have to go down either an 
osteogenic or chondrogenic pathway to produce collagen. 
Sections were taken through decreasing concentrations of ethanol (100%, 90% and 
70%) for 2 minutes each then put into distilled water for 2 minutes.  Sections were stained for 
30 minutes with Weigerts’ haematoxilyn (Sigma UK), then washed in running alkali tap 
water for 5 minutes.  Samples were differentiated using 1% acid alcohol (100mL ethanol with 
1mL of 1M hydrochloric acid (Sigma, UK)) for 2 seconds, and washed well with distilled 
water.  Van Giesons stain (100mL of saturated picric acid solution) (Sigma, UK) was added 
to 5mL of 1% acid fuchsin solution (Sigma, UK). This solution was used to stain the sections 
for 5 minutes.  Samples were blotted with filter paper and dehydrated through increasing 
concentrations of ethanol (70%, 90% and 100%) for 2 minutes each and cleared in xylene for 
2 minutes followed by mounting with glass coverslips in DPX (BDH, UK). 
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2.1.18.  Von Kossa stain 
 Von Kossa’s stain for mineralisation is a standard test for osteogenic mineralisation.  
It only stains mineralised tissues and is a key indicator in the osteogenic differentiation 
pathway of MSCs. 
Sections were hydrated using 3 submersions in distilled water for 2 minutes each, then 
covered with 2% silver nitrate solution (Sigma UK) and placed under a UV lamp for 1 hour.  
Samples were washed with distilled water and put in a 2.5% sodium thiosulphate solution 
(Sigma UK) for 3 minutes.  Samples were washed with distilled water and counterstained 
using Harris’s haematoxylin (Sigma UK) for 5 minutes, washed in running tap water for 5 
minutes and differentiated in 1% acid alcohol for 2 seconds before being washed in distilled 
water. Samples were dehydrated through increasing concentrations of ethanol (70%, 90% and 
100%) for 2 minutes each and cleared in xylene (BDH, UK) for 2 minutes prior to mounting 
with a glass coverslip in DPX (BDH, UK). 
2.1.19.  Alcian Blue stain 
 Alcian blue stains for glycosaminoglycan (GAG).  GAG is a key marker for 
chondrogenic differentiation, there are many types of GAG, but Alcian blue is a generic stain 
for all  A ’s, which are key proteoglycans in the chondrogenic differentiation pathway.  
Sections were taken through decreasing concentrations of ethanol (100%, 90% and 
70%) for 2 minutes each then put into distilled water for 2 minutes.  Sections were stained for 
30 minutes with alcian blue solution (1g of alcian blue 8GX (Sigma UK) dissolved in 3% 
glacial acetic acid (Sigma UK)).  Samples were washed in running alkali tap water for 2 
minutes then counterstained with nuclear fast red stain (Sigma UK) for 5 minutes and washed 
for 1 minute in running alkali tap water.  Samples were then dehydrated through increasing 
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concentrations of ethanol (70%, 90% and 100%) for 2 minutes each and cleared in xylene for 
2 minutes then mounted with glass coverslips in DPX (BDH, UK). 
2.1.20.  Alizarin Red stain 
 Alizarin red is a key histological stain for mineralised tissue, and an important marker 
for osteogenesis. 
Samples were taken through decreasing concentrations of ethanol (100%, 90% and 
70%) for 2 minutes each then put into distilled water for 2 minutes.  2% aqueous solution of 
Alizarin red (Sigma, UK) adjusted to pH to 4.1-4.3 with 10% ammonium hydroxide was 
applied to the sections for 5 minutes.  Sections were blotted with filter paper.  Samples were 
dehydrated through submersion for 2 minutes in increasing concentrations of ethanol (70%, 
90% and 100%) and cleared by submersion in xylene for 2 minutes.  Sections were then 
mounted with glass coverslips in DPX (BDH, UK). 
2.1.21.  Cryo SEM examination of cellular samples 
Samples were removed from culture, washed with PBS and fixed in an aqueous 
solution of 2.5 % Glutaraldehyde (Sigma, UK) for 15 minutes.  Samples were stored at 4
o
C in 
Dulbecco’s PBS (Sigma, UK). 
Samples were prepared further immediately before examination by snap freezing in 
liquid nitrogen slush (BOC, UK) under vacuum using a Gatan Alto preparation station 
(Gatan, UK).  Samples were transferred under vacuum to a Gatan Alto 2500 (Gatan UK) cryo 
transfer system which had been cooled to -190
o
C with liquid nitrogen.  The sample was 
sublimated by increasing the temperature of the chamber to -95
o
C and held at that 
temperature for 15 minutes.  The sample was then sputter coated with platinum, to a 
thickness of 20 nm and transferred under vacuum to the Gatan cold stage, which was chilled 
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to -190
o
C with cooled nitrogen gas. The samples were examined using a LEO-1550 Field 
emission scanning electron microscope secondary electron detector at 5kV(Carl Zeiss SMT 
Ltd, UK).  
 
2.1.22.  MSCs on 3D scaffold prepared with multiple layers of modification 
Beads modified with different chemistries were assembled to determine if a different 
response was observed when the chemistries varied across the scaffold.  This aim would have 
implications in osteochondral regeneration, where a banded/zoned response would be 
necessary. 
 
 
 
Figure 2.1: Diagram of layered surface modified spheres in scaffold, red spheres 
depict amine modified surface, purple spheres depict hexane modified surface 
and gold spheres depict allyl alcohol modified spheres. 
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The individual modifications were mixed with adhesive in 1:3 ratio.  The total volume 
of the scaffolds was 120l.  The scaffold layers were prepared in the modified syringe 
(discussed earlier in this chapter) as described in the table below: 
Scaffold Number Total scaffold 120l 
1 40l Allyl amine 40l Hexane 40l Allyl alcohol 
2 60l Allyl amine 60l Allyl alcohol 
3 120l Allyl amine 
4 120l Allyl alcohol 
5 120l Hexane 
6 120l Unmodified Control 
 
  
The individual modifications were packed into the modified syringes to the specified 
volumes, and then the scaffolds were seeded with 1x10
6
 MSCs in 100l of serum free media 
(both Lonza, UK) for 60 minutes at 37
o
C.  The scaffolds were then ejected from the syringes 
into a 6 well plate, filled with MSC media with 5% serum (Lonza, UK).  The samples were 
cultured on a rocker plate for 7, 14 and 28 days, with 2 mL media added every 3 days.  The 
samples were then fixed with glutaraldehyde and processed using the histological processing 
technique described above. 
  
Table 2.1: Diagram showing quantities and layer format of modified spheres 
incorporated into scaffold 
 
 
 
 Page 57 
 
 
 
2.2.  Methods for preparation and analysis of silane modified borsilicate 
glass  
2.2.1.  Preparation and modification of borsilicate glass. 
 Glass was used as a substrate for the modifications in the initial investigation of the 
response of MSCs and and primary human osteoblast-like cells cultured with silanes. 
Glass was cleaned using a 0.5M solution of sodium hydroxide (Sigma, UK) for 30 
minutes in a ultrasonic bath, the samples were then washed in 3 changes of distilled water, 
and placed in 1M nitric acid for 30 minutes in an ultrasonic bath.  Samples were then washed 
with 3 changes of distilled water and dried in a 50
o
C oven.  Clean coverslips were then 
modified using the silanes in table 2.2 in 0.1M solutions for 30 minutes.  Samples were then 
washed with isopropyl alcohol for 5 minutes and then washed with distilled water. 
 
2.2.2.  Atomic Force Microscopy(AFM) 
 The modified coverslips (both Glass and PLGA-coated) were attached to glass 
microscope slides using double sided adhesive tape.  The samples were examined using an 
AFM microscope (operated by Mark Murphey at Liverpool John Moores University).  3 
samples of each modification were examined and 4 areas on each of the samples were 
scanned in tapping mode on 500nm scan area.  The maximum feature height was measured, 
and averaged (using Argile light software).  The results were analysed using ANOVA. 
2.2.4.  Ninhydrin on films and glass 
The concentration of the –NH2 groups on the silane modified surfaces were measured 
using a ninhydrin assay.  0.35g of ninhydrin (Fluka, UK) was dissolved in 100mL of ethanol.  
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1mL of this solution was placed on each of the samples and incubated for 5 minutes at 90
o
C.  
The solution was removed from the coverslips and diluted 1:3 with ethanol.  Light 
absorbance were measured spectroscopically at 600nm.  A standard curve of each of the 
above listed silanes concentrations was measured and plotted and the resulting equation from 
each curve was used to apply to the unknown concentrations (see appendix for standard 
curves/equations).  The coverslips were photographed showing a colour change on the 
surface of the substrate, to qualitatively asses the distribution of the NH2 groups across the 
surface. 
2.2.5 Water contact angle (WCA) measurements 
Double sided materials were used for this technique, as the WCA were measured 
using a Camtel DCA machine (Camtel LTD, UK) which takes the reading from both sides of 
the material inserted into the water.  These measurements were repeated 6 times for each 
modification.  The results were analysed using ANOVA to see if there was any significant 
difference between the surfaces. 
2.2.6.  Material modification and PBS interaction  
 Silane modified glass discs were placed into a 24 well plate, in addition to an 
untreated glass control.  The sample tests were conducted as follows: 
Concentration of minerals in 
PBS solution 
CL3 CL4 CL6 CL7 CL11 Untreated 
control 
H20 x x x x x x 
34.25mM sodium chloride, 
0.675mM potassium chloride, 
2.5mM phosphate 
x x x x x x 
68.5mM sodium chloride, 
1.35mM potassium chloride, 
5mM phosphate 
x x x x x x 
137mM sodium chloride, 
2.7mM potassium chloride, 
x x x x x x 
 
 
 
 Page 59 
 
 
 
10mM phosphate 
  
One PBS tablet (Sigma, UK) was dissolved in 200mLs of distilled water.  The 
following dilutions of PBS were made using distilled water; 0%, 25% 50% and 100%.  
The plate was incubated at 37
o
C for 7 days.  The samples were removed from the and 
left to dry at room temperature for 24 hours.  The samples were then examined using X-ray 
analysis and stained by Von Kossa stain for mineralisation. 
 
2.2.7.  Von Kossa stain as 2.1.18 
2.2.8.  X-ray analysis of glass and films 
 Elemental analysis of the surfaces was undertaken to determine if the coverslips taken 
from PBS solutions had mineralised.  Baseline data of the dry film was also measured to 
ensure that there was no background mineralisation occurring and that the minerals present 
were as a direct result of chemical interaction when the surfaces were exposed to PBS. 
The coverslips that were exposed to PBS and water were removed from the PBS 
solution and allowed to air dry for 24 hours.  
Dry modified films and glass coverslips were coated with carbon using a carbon 
coater (EMTECH, UK).  X-ray microanalysis was performed using a Leo 1550 SEM (Zeiss, 
UK) with an INCA system (Oxford Instruments).  Points of analysis were imaged at 5 
locations on the film.  From each of these fields 10 spectra were generated at random.  The 
resulting data were analyzed using ANOVA, to determine any statistically significant 
difference between the elements on the surfaces.  
Table 2.2.  Matrix of experiments conducted using varying concentrations of PBS 
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2.2.9.  Culture of Mesenchymal stem cells (MSC) as in 2.1.8 
 
2.2.10.  Application of Mesenchymal stem cell to modified Glass 
Passage 5 MSCs were allowed to reach confluence, trypsined as described in section 2.1.8 
and pelleted.  The individual pellets from each flask were re-suspended in 1mL of media each 
and pooled into one centrifuge tube.  These cells were then pelleted again, and re-suspended 
in 5mL of mesenchymal stem cell media (Lonza, UK) media.  200l of the cell suspension 
were removed and the cell number was counted using a haemocytometer (AGAR, UK) on an 
inverted light microscope (Zeiss Ltd, Germany).  Cells found in 5 areas were counted and 
averaged, this number corresponding with the cell number x10
4
 per mL of cell suspension.  A 
total cell number (in the 5mL cell suspension) was determined, and the cells were re-
suspended to make the seeding density 5x10
5
 cells in 100l media. 
 The pre-prepared materials were sterilised using 10 sec exposure to ultra violet (UV) 
light with ozone on both sides, and placed into a sterile 24 well tissue culture plate (SLS, 
UK).  A 100l aliquot of the cell suspension was then pipetted onto each material, and 
incubated at 37
o
C for 30 minutes.  Two mL of media was then added to each well.  Samples 
were then cultured for 7, 14 and 28 days at 37
o
C and 5% CO2. 
2.2.11.  Von Kossa staining of Coverslips 
Media was removed from wells and coverslips were washed using a 10% Dulbecco’s PBS 
solution.  PBS was removed and the cells on the coverslips were fixed using a 2% 
formaldehyde 4% sucrose solution (Sigma UK) for 15 minutes.  Fixative was then removed 
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and samples were washed with PBS.  After 3 submersions in distilled water the protocol 
outlined in section 2.1.18 was followed. 
2.2.12.  SEM 
The modified glass coverslips with primary human Mesenchymal stem cells were 
removed from culture, washed with PBS and fixed using 2.5% glutaraldehyde solution, for 15 
minutes.  The samples were then washed with PBS, and submerged in 70% ethanol for 15 
minutes, then 90% ethanol for 15 minutes followed by two changes of 100% ethanol for 15 
minutes.  The samples were then dried using a critical point dryer (Prion, UK).  Dry samples 
were then affixed to aluminium SEM stubs (Agar Scientific, UK) using double sided carbon 
sticky tabs (Agar Scientific, UK).  The samples were then coated with 20nm of chromium 
using a sputter coater (EMTECH, UK).  The coated samples were observed under a Leo 1550 
FESEM (Zeiss, UK).   
2.2.13.  Preparation of RNA using Trizol (Sigma, UK) 
Scaffolds or coverslips were removed from media at the appropriate time points, and 
placed into clean 24 well tissue culture plates (SLS Ltd, UK).  Samples were washed using 
sterile Dulbecco’s PBS (Sigma, UK) to remove any non-adherent cells.  Scaffolds were 
crushed manually and 500l of Trizol (Sigma, UK) added to each well and incubated at room 
temperature for 5 minutes.  Trizol reagent (Sigma, UK) then removed from the scaffolds and 
placed into DNA/RNA-free micro-centrifuge tube (SLS, UK) and frozen until required at -80 
o
C, at which point they were defrosted at room temperature. 
100l of chloroform (BDH, UK) was added to defrosted samples and vortexed.  Samples 
were spun at 18,000g for 5 minutes.  The upper layer of each preparation was then removed 
and placed into a new tube.  300l of isopropanol (Sigma, UK) was then added, and 
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centrifuged at 18,000g for 15 minutes.  The supernatant was removed, without disturbing the 
RNA pellet.  500l of 100% ethanol was added, and sample spun for 5 minutes at 18,000g.  
The supernatant was removed and replaced with 200l of 70% ethanol and spun for 2 
minutes at 18,000g.  The supernatant was removed and pellet was re-suspended 10l of 
DNA/RNA-free ultra pure water. (Sigma, UK)  Generic DNA contamination was eliminated 
using commercially available DNAse kits (Invitrogen UK).   
8l of RNA sample was inserted into a DNA/RNA free micro-centrifuge tube (SLS, 
UK).  1l of 10X DNase reaction buffer and 1l DNase I Amp grade was added (Invitrogen, 
UK).  Tubes were incubated at room temperature for 15 minutes and the DNase I was 
inactivated by the addition of 1l of 25mM EDTA solution (Invitrogen, UK) before heating 
to 65
o
C for 10 minutes. 
First strand cDNA was synthesised using kit (Invitrogen, UK) 10l of DNase treated 
RNA was added to a DNA/RNA micro-centrifuge tube.  1l of oligo(dT), 1l of 10mM 
dNTP mix and 1l of sterile distilled water was added per reaction.  Samples were heated to 
65
o
C for 5 minutes, then incubated on ice for 1 minute. 4l of 5X first strand buffer, 1l of 
0.1M DTT, 1l of RNaseOUT, and 1l SuperScript III RT was added to each tube, mixed 
and incubated at 50
o
C for 1 hour.  The reaction was inactived by heating to 70
o
C for 15 
minutes.  The resulting cDNA was used as a template for rt-PCR. 
2.2.14 rt-PCR  
qrt-PCR was conducted using primers for osteopontin, osteocalcin, osteonectin, 
collagen I, collagen II, and CBFA-1, with all results normalised against the housekeeping 
gene -Actin.  20l of forward and 20l of reverse primers were mixed with 160l of 
DNA/RNA-free water.  The following reagents were added in triplicate to the wells of a rt-
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PCR 96 well plate (BIO-RAD, UK): 2l cDNA template, 7.5l SyBR green (BIO-RAD, 
UK), 4.5l DNA/RNA-free water, and 1l diluted primer (as above).  rt-PCR was conducted 
using i-cycler (BIO-RAD,UK), using optimum temperatures for each primer (table 2.4). 
Target Accession 
 number 
Primer bases Temp in 
o
C 
B-Actin NM001101 GGACCTGACTGACTACCTCGCC
ATCTCTTGCTCGAAG 
53.9 
Collagen I NM000088 GCCACTCCAGGTCCTCAGCCAC
AGCACCAGCAACAC 
54.5 
Osteocalcin NM000711 AGCGAGGTAGTGAAGAGACGAA
AGCCGATGTGGTCAG 
55.2 
Osteopontin NM000582 GCGAGGAGTTGAATGGTGCTTG
TGGCTGTGGGTTTC 
53.9 
Osteonectin BC008011 GCTGGATGATGAGAACAACACA
AGAAGTGGCAGGAAGAG 
53.4 
Collagen II NM001844 GAGCAGCAAGAGCAAGGAGAA
GTGGACAGCAGGCGTAGGAAG 
54.3 
CBFA I AH005498 GGCAGTTCCCAAGCATTTCGCA
GGTAGGTGTGGTGTG 
54.5 
Sclerostin  CTGGTTAAGAAAGTTGGATAAG 
AAGGTTACACAGCAAGTTAG 
 
53.8 
 
 
 
All samples were run for 40 cycles using pre-programmed settings on i-cycler.  The threshold 
cycle (Ct) (the cycle at which the instrument detects the amplification generated fluorescence 
above the background fluorescence) was measured in triplicate in each case and averaged.  
The experiment was repeated 6 times.  The results were shown as the ct,1 and were 
normalised to the housekeeping gene, -actin. 
2.2.15.  Immunostaining for Confocal Microscopy 
 Cells on the silane-modified glass and PLGA were fixed using a 2% formaldehyde 
(Sigma, UK) and 4% sucrose (Sigma, UK) fixative.  The samples were washed in PBS.  The 
Table 2.4.  Primer bases for the corresponding gene of interest, and temperature 
at which reaction takes place. 
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samples were blocked/permabolised using a solution of 1% BSA PBS with 0.1% triton X100 
(Sigma, UK) with 10% normal horse serum (Vector, UK) added, for 45 minutes at 37
o
C.  The 
samples were then washed using 1% BSA PBS. 
The samples were stained using antibodies for osteocalcin (BD biosciences, UK), 
CBFA1(BD biosciences, UK),  collagen I and II(Abcam, UK) and stro-1(Abcam, UK).  The 
antibodies were diluted as below: 
Antibody Dilution in 1% BSA PBS 
Osteocalcin  1/500 
CBFA 1 1/500 
Stro-1 1/500 
Collagen I 1/1000 
Collagen II 1/500 
 
  
100l of primary antibody were added to the samples, and incubated at 4oC for 16 hours. 
Collagen I and II antibodies were added to the same sample to create a dual stain, the 
remaining antibodies were used as single stains.  The samples were washed using 1% BSA 
PBS.  The secondary antibodies (all from Life Technologies, UK) were added as below. 
Primary antibody Secondary antibody 
Osteocalcin Rhodamine 
CBFA-1 Texas red goat anti rat 
Stro-1 Alexa fluor 633 goat anti mouse 
Collagen I  594 HTC Chicken anti rabbit 
Collagen II 488 HTC anti mouse IgG 2a 
 
 100l of each the secondary antibodies were added to the samples and incubated at 
37
o
C in the dark for 1 hour.  Samples were then washed using PBS, and the osteocalcin, 
CBFA1 and Stro-1 samples stained using Oregon green (Life technologies, UK) to detect 
Table 2.5.  List of primary antibodies and the dilutions at which they were used for the 
antibody staining 
Table 2.6.  Table of primary antibodies with the corresponding secondary antibody. 
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actin cytoskeleton.  The samples were then washed with PBS and examined using a confocal 
microscope (Zeiss, UK) after being mounted using Vecta shield with Dapi (Vector UK). 
 
2.2.16.  Isolation of primary human osteoblast-like cells 
 The extent to which the surfaces can could induce MSC along an  osteogenic 
differentiation pathway was investigated at key temporal points.  MSCs are a good model for 
the initial cell response to surfaces, and the primary human osteoblast-like cells are a good 
model for later stage events in the osteogenic pathway.  
Human bone fragments taken from osteo-arthritis surgery were washed with a 
solution of PBS with streptomycin and penicillin (Sigma, UK).  The bone was then cut into 1-
2mm diameter pieces, and 6-8 of the bone pieces were placed in a 9cm diameter disposable 
Petri dish with 10mL of DMEM culture media enriched with foetal bovine serum (Sigma, 
UK).  5mL of media was removed and replaced every 2 weeks.  Cultures were left until cells 
migrated from the bone and populated the culture dish and reached confluence which was 6-8 
weeks. 
2.2.17.  Primary human osteoblast like cells on silane modified glass  
The silane modified glass coverslips were inserted into a 24 well tissue culture plastic 
plate. Primary human osteoblasts-like cells were washed with PBS then covered with 2 mL of 
Trypsin EDTA (Sigma, UK).  The cells were incubated at 37
o
C, and observed 
microscopically to check the progression of the trypsin digestion, when the cells started to lift 
off the plastic Petri dish 2mL of media was added to stop the reaction.  5x10
-4   
primary 
human osteoblasts were suspended in 100l of DMEM media (Sigma, UK) and seeded onto 
the glass surfaces and incubated at 37
o
C for 1 hour.  After the hour incubation 2mL of 
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DMEM media (Sigma, UK) was added to each well.  These samples were cultured for 7, 14 
and 28 days. 
2.2.18.  Primary human osteoblasts-like cells on silane modified PLGA films 
The silane modified PLGA films were inserted into a 24 well tissue culture plastic 
plate.  Then treated as protocol 2.2.17. 
 
2.2.19.  Von Kossa staining of human osteoblast samples 
 As in section 2.1.18 
 
2.2.20.  SEM of primary human osteoblast samples. 
As in 2.2.12 
2.2.21.  Nodule count and measurement 
Nodule size was measured using the SEM.  All nodules on each sample were 
measured across their widest diameter, using the micometer application on the annotation bar 
of the SEM.  Every nodule was measured and the mean was noted, to provide the mean 
nodule size for each sample. 
The numbers of nodules on each sample was counted using a light microscope (Zeiss, 
Germany) at low magnification so whole sample could be enumerated. 
2.2.22.  rt-PCR of osteoblast like cells  
 As in section 2.2.13 
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2.3.  Preparation and silane modification of PLGA films and spheres  
2.3.2.  PLGA (85:15mw) film production and modification 
 PLGA films were produced as an initial investigation into the viability of PLGA as a 
substrate for silane modification. 
Clean 12mm glass cover-slips were coated with chromium using an Emtech  575x 
sputter coater (Emtech, UK), to provide a surface for the PLGA film to form hydrogen bonds 
with.  100 l of 10 % 85:15 PLGA (Sigma, UK) in chloroform was spin-coated onto the 
chromium coated cover slips using a WS-400B-6NPP/LITE spin coater (Laurell 
Technologies Corporation, UK). Oxygen plasma was used to functionalize the polymer using 
a plasma coater (Emtech, UK), at the previously optimised settings of 30kW for 2 minutes 
(see appendix).  
The PLGA films were then modified with the following silanes: 
Modification abbreviation Silane used for modification 
CL3 (3-Aminopropyl)triethoxysilane (Sigma) 
CL4 4-(triethoxyslyl)butan-1-amine (fluorochem) 
CL6 3-(2-Aminoethylamino) 
propyldimethoxymethylsilane (Sigma) 
CL7 N-(6-Aminohexyl)amnomethyltriethoxysilane 
(fluorochem) 
CL11 11-Aminoundecyltriethoxysilane (fluorochem) 
 
The silanes were diluted to 0.1M solutions with isopropyl alcohol.  The PLGA films 
were then covered with these solutions for 30 minutes at room temperature.  The solutions 
were then washed using isopropyl alcohol, and distilled water.  Samples were left to dry at 
room temperature for 24 hours, followed by vacuum oven at room temperature for 24 hours. 
Table 2.8 Index of silanes used for modifications 
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2.3.3.  AFM microscopy 
 The modified coverslips (both Glass and PLGA coated) were stuck to a glass 
microscope slide using double sided adhesive tape.  The samples were examined using an 
AFM microscope (operated by Dr. Mark Murphey at Liverpool John Moores University).  3 
samples of each modification were examined and 4 areas on each of the samples were 
scanned in tapping mode on 500nm scan area.  The maximum feature height was measured, 
and their mean noted (using Argile light software).  The results were analysed using 
ANOVA. 
2.3.4.  Ninhydrin on films and glass 
The assay was conducted as in section 2.2.4 
 
 
2.3.5.  Preparation of Double Sided Materials for WCA 
Double sided materials were required for this technique as the water contact angle is 
measured when the material is dipped into water.  If the different sides were composed of 
different materials (ie, glass and polymer) the results would be unreliable. 
Materials were prepared by coating glass coverslips with 20nm of chromium using an 
EMTECH 575X sputter coater (EMTECH, UK).  This was repeated on both sides of 
coverslip.  1g of 85:15 PLGA was dissolved in 10 mL of Chloroform (Sigma, UK).  The 
PLGA solution was spin coated onto the chromium coated glass using a WS-400B-
6NPP/LITE spin coater (Laurell Technologies Corporation, UK), and dried overnight at room 
temperature before being inserted into a vacuum oven for 48 hour.  The process was then 
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repeated for the other side of the coverslip.  The materials were then modified with the 
silanes mentioned above in table 2.8, on both sides. 
 
 
2.3.6.  WCA measurements 
Conducted as in section 2.25 
2.3.7.  SEM of modified films  
 Conducted as in section 2.1.6 
2.3.8.  Application of Mesenchymal stem cell to modified PLGA films. 
Conducted as in section 2.2.10. 
2.3.9.  Von Kossa staining of Coverslips 
Conducted as in section 2.18 
 
 
2.3.10.  Sphere Manufacture for Silane Modifications 
85:15 PLGA (Sigma, UK) spheres were constructed using polyvinylalcohol (PVA) solution.  
1g of PLGA was dissolved in 10 mL of tetrachloromethane added to a solution of 30 mL 
PVA (Sigma, UK) in a drop by drop method and stirred continuously for 72 hours until all 
solvent has evaporated.  Spheres were then filtered and sieved so that only the particles 
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measuring 100-300m were used.  The spheres were then dried at room temperature for 48 
hours. 
 
 
2.3.11.  Silane modification of spheres 
PLGA spheres were oxygen plasma treated for 2 minutes at 30Kw, then submerged in 
10 mLs of 0.1M silane in isopropyl alcohol on a rocker plate for 20 minutes (see appendix for 
optimisation data).  The resultant solution was then filtered using a polypropylene funnel and 
flask (SLS, UK) to avoid silane retention by surface attachment to the glass flask.  The beads 
were washed with 10mLs of isopropyl alcohol.  The solution collected was then analysed 
using the ninhydrin technique to determine the amount of amine groups transferred to the 
spheres in this process (2.3.12).  The spheres were then dried in a vacuum oven for 24 hours, 
and stored under vacuum until used. 
2.3.12.  Ninhydrin assay of modified spheres 
The concentration of the –NH2 groups on the silane modified spheres were measured 
using the ninhydrin assay.  As it was difficult to measure accurately the concentration of –
NH2 tethered to the spheres directly, an indirect method was used.  The concentration of the 
silane coating solution was known (1M) and the concentration of the coating solution was 
measured after the coating of the spheres took place, to determine the concentration of silane 
that remained on the spheres.  A standard curve of each of the silanes concentrations was 
measured and plotted and the resulting equation from each curve was used to apply to the 
unknown concentrations (see appendix for standard curves/equations).  Assay was then 
conducted as in section 2.2.4. 
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2.3.13.  SEM of PLGA spheres 
The modified spheres were mounted onto aluminium SEM stubs (Agar, UK) using double 
sided carbon stickers (Agar UK).  The spheres were then coated with 40nm of chromium to 
illuminate charge, and observed under the SEM (Zeiss, UK) to determine if there were any 
macro-topographical differences between the modifications. 
2.3.14.  MSC on PLGA system 
Silane modified Spheres were incorporated into the 3D injectable system described in 
section 2.1. 
 
 
   
2.3.15.  Histology  
 The histological investigation of the 3D scaffolds was undertaken to examine the 
penetration of cells into the scaffold, and to ascertain the degree of cell differentiation. 
 
2.3.16.  Fixation 
Samples were removed from culture at 7, 14 and 28 day time points.  They were fixed 
with a 2.5% solution of glutaraldehyde (Sigma, UK) for 48 hours, and dehydrated by 
successive 2 hour submersions in 70, 90 and 100% ethanol solutions respectively.  
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2.3.17.  Embedding of Samples in Glycomethacrylate Resin 
Samples were embedded using Technovit 8100 (TAAB, UK).  100mL of base 
glycomethacrylate solution were mixed with 1 sachet of hardener 1.  To 90mL of this 
solution 3mL of hardener 2 was added.  Samples were then placed into moulds and covered 
with the embedding solution and placed in a vacuum on ice for 20 minutes.  Samples were 
then removed from the vacuum oven, mineral oil was placed on top of the embedding 
solution, and then they were then placed at -55
o
C for 4 days and 4
o
C for 6 hours prior to 
ejection from the moulds. 
 
2.3.18.  Sectioning 
As in section 2.1.15 
2.3.19.  H and E stain  
 As in section 2.1.16 
2.3.20.  Van Geison stain 
 As in section 2.2.17 
2.3.21.  Von Kossa stain 
 As in section 2.1.18 
2.3.22.  Alcian Blue stain 
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 As in section 2.1.19 
2.3.24.  Alizarin Red stain 
 As in section 2.1.20 
2.3.25.  Sample preparation for LDH Assay 
As in section 2.1.10 
2.3.26.  LDH Assay  
  As in section 2.1.11 
1. Benedetto, A., Abete, M.C., Squadrone, S. Towards a quantitative application of real-time 
PCR technique for fish DNA detection in feedstuffs Food Chemistry 126 1436–1442(2011)   
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Chapter 3: Results: Plasma Polymer Deposition 
Modifications to Injectable PLGA System 
 
3.1 Introduction 
 The injectable PLGA system was modified with four different surface modifications.  
These modifications include allylamine, allylalcohol, hexane and acrylic acid.  The active 
terminal groups that are deposited on the surfaces treated with these plasmas are listed in the 
table below: 
Chemical modification Terminal group deposited 
Allyl amine -NH2 
Allyl Alcohol -OH 
Hexane -CH3 
Acrylic Acid -COOH 
 
  
All of the above chemical modifications have been selected because they are terminal 
groups found in the extracellular matrix, and are thought to play a role in the osteogenic and 
chondrogenic differentiation pathways
1
.  The chemical groups have been shown to be the 
active regions on many osteogenic peptides, which have been used extensively in the past as 
an attempt to mimic the ECM, and have shown positive results
2,3
.  There are several reasons 
why the use of peptides to mimic ECM are limited, the most striking reason being the 
prohibitive expense of producing peptides on a large scale
4
, so applications for medical 
devices are limited.  The use of stable chemistries as an instigator of MSC differentiation 
could improve the efficiency of the injectable system by applying and refining the knowledge 
Table 3.1, Chemical modification. Themost abundant chemical group deposited from specific 
chemical modification.  
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gained from all of the studies involving peptides
5,6,
 and larger proteins intended to mimic 
some aspects of the ECM.  
 Applying these surface chemistries to an injectable system is novel, and this chapter 
of results aims to screen the four surface chemistries and asses their ability to cause the 
differentiation of MSCs in this in vitro model, which uses cured pieces of the injectable 
system, comprising of two components as demonstrated in figure 3.1. 
 
 
The red spheres are the components that carry the surface modifications and the blue 
amorphous shapes are the PEG-treated PLGA adhesive component, which cures at 37
o
C.  
The two components are mixed together in a modified syringe and the powders are seeded 
with MSCs whilst compacted into the syringe.  The system cures as the MSCs are adhering 
prior to the scaffold being ejected from the modified syringe mould.  The scaffolds are 
cultured in 6 well plates on a rocker plate to allow the flow of nutrients throughout the porous 
scaffold.  
The materials were characterised using water contact angle, SEM and XPS prior to 
the incorporation of the material into the in vitro model.  This in vitro system was analysed 
Figure 3.1, The two phase injectable scaffold.  Red spheres carry the chemical 
modification and the amorphous shapes represent the adhesive component. 
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using electron microscopy and LDH assay to determine cell number, histological staining 
techniques and analysis to determine the expression of differentiation markers throughout the 
scaffolds. 
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3.2 Water contact angle of modified materials. 
The water contact angle of the polymers changed after modification of the polymer.  
The allyl amine modified PLGA showed a statistically significant difference in water contact 
angle, (using ANOVA and Tukey statistical tests) when compared to an untreated control 
(p=<0.05) (figure 3.2).  The allyl amine modification introduced a more hydrophilic surface 
than the control.  The hexane showed some statistical significance and introduces a 
significantly more hydrophobic surface.  The acrylic acid showed a significantly more 
hydrophilic surface, than the untreated control and the other modifications.  The allyl alcohol 
modification also demonstrated a significant difference, showing the modification to be more 
hydrophilic than the control.  All these data are advancing angles only, and demonstrate that 
different surface energy and charge has been created on these surfaces.  The advancing angle 
is more significant than the retreating angle because it is this initial contact that is relevant to 
cellular contact with the biomaterial. 
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Figure 3.2 Water contact angle of modified PLGA to measure changes in surface energy. 
Modified spheres were compacted  into cakes (n=10). Starred bars indicate level of significance as 
determined by ANOVA and Tukey statistical tests * represent the level of significance (* p=<0.05, 
***p=<0.01) 
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3.3 SEM of modified spheres 
The SEM images of the treated spheres show no macro-topographical changes after 
the surface modifications have been applied when compared to the untreated spheres.  The 
spheres all appeared to be smooth and largely undamaged following modification.  The 
diameter of the spheres ranged from 30m up to 300m.  
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SEM of modified spheres 
 
  
a b 
c d 
e 
Figure 3.3.  SEM images of the plasma treated spheres. Spheres were treated with 
the plasma  polymer deposition system and images were taken of the spheres using a 
secondary electron detector 5kV accelerating voltage. The labelled images refer to the 
following modifications (a) Allyl amine, (b) Allyl alcohol, (c) Hexane, (d) Acrylic 
acid, and (e) untreated PLGA. 
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3.4 X-ray Photoelectron spectroscopy (XPS) 
Six separate batches of modified spheres were analyzed using X-ray photoelectron 
spectroscopy (XPS) to determine the elemental composition of the modified surfaces (n=6). 
The summary table highlights the average and standard deviations of the repeats (table 3.2).  
These XPS data demonstrated the increased concentration of carbon on the hexane modified 
surfaces (84.2% weight ±1.0).  As it is hypothesized that the hexane modified surface would 
be enriched with methyl groups, this confirms the success of the modification.  The XPS 
spectra for the allyl amine modification showed the presence of nitrogen on the 
surface(10.1% weight ±1.0).  This was indicative of the presence of amine groups, again 
demonstrating the successful transfer of surface chemistries to the substrate.  The increase in 
the surface oxygen seen on the acrylic acid modification (21.3% weight ±1.2) is indicative of 
the transfer of carboxyl groups.  The allyl alcohol modification did not show any major 
changes detectable by XPS from the control, but this is likely to be explained by the 
limitations of the XPS technique as hydrogen is undetectable by XPS, and it is likely that it 
would be hydroxyl groups deposited on the allyl alcohol surface.  
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a b 
c d 
e 
Figure 3.4. X-ray photoelectron spectroscopy (XPS) Spheres were treated with 
the plasma  polymer deposition system and spectra of the modified spheres and an 
untreated control were taken (n=6).  The labelled spectra are typical examples of 
the spectra taken and refer to the following modifications (a)Hexane, (b) allyl 
amine, (c) allyl alcohol, (d) acrylic acid, and (e) Unmodified spheres and show the 
presence of chemistry specific bonds (outlined on spectra). 
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Modifications Carbon Nitrogen Oxygen 
Untreated 78.9 ±1.9  21.1±1.9 
Allylamine 62.7±4.2 10.1±1.0 23.5±4.0 
Hexane 84.2±1.0  15.8±1.0 
Acrylic acid 55.7±1.5  43.0±0.6 
Allylalcohol 77.4±1.2  21.3±1.2 
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3.5 Cryo SEM of MSCs on plasma treated 3D scaffolds 
The cryo SEM images (Figure 3.5) show the morphology of the MSCs when cultured 
on the surfaces for 14 days.  The allylamine-modified scaffold lead to the cells presenting a 
flattened morphology, showing good infiltration into the scaffold and the presence of ECM.  
The allyl alcohol-modified scaffold had cells presenting a very rounded morphology.  The 
untreated and hexane-treated scaffold had cells presenting classical stem cell morphologies. 
This investigation demonstrated that the morphology of the cells on the different 
modified scaffolds was not the same, and that there was a significant quantity of ECM found 
on the allyl amine-modified scaffold.   
 
 
 
 
 
 
 
  
 
 
 
 
 Page 85 
 
 
 
 
  
 
 
 Figure 3.5:Cryo SEM images of Mesenchymal stem cell seeded onto the modified 
injectable system.  (a) Hexane, (b) Allyl alcohol, (c) Acrylic acid,(d)Allyl amine, 
and(e) Untreated scaffold. 
a b 
c d 
e 
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3.6 LDH assay to detect cell number on 3D scaffold 
 
 
 
 
 The LDH assay was conducted to determine cell number.  The data shown 
were the mean and standard deviation of 4 repeats.  They demonstrated an initial increase in 
cell number over a 14 day period (initial seeding density was 0.5 x10
6
), then proliferation 
between 14 and 28 days in the control, hexane and acrylic acid scaffolds but a plateau 
between 14 and 28 days for the allyl alcohol and allyl amine scaffolds.  There was a 
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Figure 3.6, LDH assay analysis of cell number on modified scaffolds.  Scaffolds were seeded with 
MSC for 14 and 28 days, and an LDH assay was conducted on the modified and untreated scaffolds 
after maceration at these timepoints.  (N=4)  * Indicates a statistically significant  difference of p=<0.05 
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statistically significant difference between the cells at 14 days on the hexane and the allyl 
alcohol scaffolds (p=0.05). 
 These results support the Cryo SEM (figure 3.5) examination because the 
plateau of the cell number could be indicative of stem cell differentiation.  As this plateau 
was observed only on the allyl alcohol and allyl amine scaffolds, it is likely that stem cell 
differentiation was limited to these two scaffolds.  
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3.7 Histological analysis of Plasma treated scaffolds 
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Table 3.3,Summary of Histological staining at 7 days MSC were cultured on 
scaffolds for 7 days and then processed and analysed using the histological 
stains mentioned above.  Microns refer to location of section when taken from 
scaffold.+ = positive staining, -= negative staining 
 
Table 3.4. ,Summary of Histological staining at 14 days MSC were cultured 
on scaffolds for 7 days and then processed and analysed using the histological 
stains mentioned above.  Microns refer to location of section when taken from 
scaffold.+ = positive staining, -= negative staining  
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Table 3.5 ,Summary of Histological staining at 28 days MSC were cultured 
on scaffolds for 7 days and then processed and analysed using the histological 
stains mentioned above.  Microns refer to location of section when taken from 
scaffold.+ = positive staining, -= negative staining  
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 The histological examination of the scaffolds was repeated 3 times.  The samples 
containing MSCs were sectioned at 7m and sections were stained at 200m intervals 
throughout the scaffold to determine if there was a homogeneous response throughout the 
scaffold.  The images presented are of the 28 day samples (experimental details 2.1.12-20). 
  The histological examination of the scaffolds (figures 3.7-3.11) reveal strong 
infiltration of cells throughout most of the scaffolds (as demonstrated by the H and E staining 
in figures 3.7d, 3.8d, 3.9d, 3.10d) and less observable infiltration in acrylic acid (figure 3.7e).  
The cells acted consistently throughout the scaffolds, with the notable production of GAG on 
the allyl alcohol scaffold at every measured physical point (ascertained by the positive alcian 
blue staining throughout, figure 3.10e) from 14 days onwards.  The allyl alcohol scaffold also 
showed positive Van Giesons stain (figure 3.10c) for collagen from day 7, but no positive 
staining for alizian red or Von Kossa which would denote calcification or a more generalized 
mineralization. 
 Conversely, the allyl amine-treated scaffold showed positive alizian red (figure 3.7b) 
and Von Kossa(figure 3.7a) at 28 days but not before, and no alcian blue staining.  There was 
however positive Van Gieson (figure 3.7c) staining at all time points. 
The hexane and acrylic acid treated scaffolds both showed positive staining for the 
Van Gieson staining (figure 3.9c), but no positive staining for GAG (figure 3.9e) or 
mineralization(figure 3.9 a and b).  The untreated control also showed a positive Van Geisons 
stain but no other positive staining for the other differentiation markers (figure 3.11 a-e). 
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Figure 3.7:Histological analysis of allyl amine-treated scaffolds. Scaffolds were cultured with MSCs 
for 28 days, histologically processed and stained with  (a) Von Kossa for mineralization, (b) Alizarin red 
for mineralization, (c) Van Geison for collagen, (d)H and E for cellular morphology and density and 
(e)Alcian blue for gylosaminoglycan.Blue arrows indicate areas of mineralisation and black arrow 
indicates area of dense cell population 
a b 
c d 
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Figure X: Allyl alcohol treated cultured with mesenchymal stem cells for 
 
 
 
Figure 3.8: Histological analysis of hexane-treated scaffolds. Scaffolds were cultured with MSCs for 
28 days, histologically processed and  stained with  (a) Von Kossa for mineralization, (b) Alizarin red 
for mineralization, (c) Van Geison for collagen, (d)H and E for cellular morphology and density and 
(e)Alcian blue for gylosaminoglycan.Black arrow indicated dense population of cells but no other 
staining present to show any differentiation 
a b 
c d 
e 
 
 
 
 Page 93 
 
 
 
  
 
 
 
Figure 3.9: Histological analysis of acrylic acid-treated scaffolds. Scaffolds were cultured with 
MSCs for 28 days, histologically processed and  stained with  (a) Von Kossa for mineralization, (b) 
Alizarin red for mineralization, (c) Van Geison for collagen, (d)H and E for cellular morphology and 
density and (e)Alcian blue for gylosaminoglycan. 
a b 
c d 
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Figure 3.10: Histological analysis of allyl alcohol-treated scaffolds. Scaffolds were cultured with 
MSCs for 28 days, histologically processed and  stained with  (a) Von Kossa for mineralization, (b) 
Alizarin red for mineralization, (c) Van Geison for collagen, (d)H and E for cellular morphology 
and density and (e)Alcian blue for gylosaminoglycan (GAG).  White arrow indicated positive GAG 
staining 
a b 
c d 
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Figure 3.11 Histological analysis of untreated scaffolds. Scaffolds were cultured with MSCs for 28 
days, histologically processed and  stained with  (a) Von Kossa for mineralization, (b) Alizarin red 
for mineralization, (c) Van Geison for collagen, (d)H and E for cellular morphology and density and 
(e)Alcian blue for gylosaminoglycan.Blue arrows indicate areas of cells stained with eosin.   
 
a b 
c d 
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3.8 Histological analysis of Dual and triple modifications.   
 Triple 
Modification 
Dual 
Modification 
Hexane Allyl Amine Allyl Alcohol Untreated 
Control 
Alizian red Banded + area Mixed 
response 
- + - - 
Alcian Blue Banded + area Mixed 
response 
- - + - 
 
  
 
 
The scaffold carrying three modifications showed positive staining for Alcian blue, in 
an isolated area at one end of the scaffold while simultaneously showing positive Alizian red 
staining at the opposite end of the scaffold.  The central portion of the scaffold showed 
positive mineralization staining but in a fine honeycomb type presentation, with the 3 distinct 
areas in defined bands.  The dual modification did not show banded separation like the 
triple modification, and there was a mixed cellular response.  The single modifications 
showed positive Alcian blue staining on the allyl alcohol scaffold, positive Alizian red and 
Von Kossa staining on the allyl amine scaffold, and positive van Gieson staining on all of the 
scaffolds. 
  
Table 3.6: Histological analysis of dual and triple modifications.  Allyl amine and 
allyl alcohol modified spheres were compacted in two layers of the same scaffold (dual 
modification) and allyl amine, hexane and allyl alcohol were compacted into three 
layers of the same scaffold (triple modification).  The scaffolds were processed and 
stained using alizian red and alcian blue. + indicates positive staining found, -indicates 
no staining.  
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Figure 3.12 Images from dual and triple scaffold modifications. Allyl amine and allyl alcohol modified 
spheres were compacted in two layers of the same scaffold (dual modification) and allyl amine, hexane and allyl 
alcohol were compacted into three layers of the same scaffold (triple modification).  The scaffolds were processed 
and stained using alizian red and alcian blue. (a)Alcian blue stain of triple modification scaffold, (b) Alizian red of 
triple modification scaffold, (c) Alcian blue of dual modification, (d) Alizarin red of dual modification, (e) 
Alizarin red stain of single allyl amine modified scaffold, (f) Alcian blue stain of single allyl amine modified 
scaffold, (g) Alizarin red of single allyl alcohol modified scaffold, and (h) Alcian blue single modification allyl 
alcohol scaffold 
a b 
c d 
e f 
g h 
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3.9 Discussion of Plasma modifications 
 The material characterization data demonstrated that the transfer of the chemistries to the 
surfaces was successful, as a change in surface energy was clearly demonstrated by the water contact 
angle measurements (figure 3.2).  This alone testifies that the surfaces have changed, but the XPS data 
(figure 3.4 and table 3.2) confirms the change in the surfaces chemical composition. Together, with 
the SEM images which show no macro-topographical changes to the surfaces (figure 3.3), the 
evidence supports the hypothesis that the chemistries have been introduced in such a manner that they 
have been responsible for the phenotypical changes in the human MSCs.  
The true evidence of differentiation is in the direct staining of the products of the cells and 
this is supported by the histological analysis conducted (tables 3.3-3.5, and figures 3.7-3.11).  The 
presence of a collagen matrix was confirmed by consistent Van Gieson staining through the scaffold 
(figures 3.7-3.11).  Van Gieson stains collagen but does not differentiate between the different types 
of collagen.  Further histological examination of the scaffolds revealed an osteogenic response 
throughout the amine treated scaffold (figure 3.7), where positive Von Kossa staining was 
concentrated in nodules and seen in every sample point throughout the scaffold.  The Von Kossa stain 
targets calcified ECM using silver nitrate to react to the phosphate which accompanies calcium in 
mineralized matrix in an acidic environment
7
, and as mineralization of the ECM is one of the key 
markers of osteogenic differentiation it is often seen as a definitive test.  It does not however indicate 
that there is bone formation, and caution should be taken before making this statement, as the staining 
does not indicate the calcium to phosphate ratio, which is crucial when determining the mineral 
formation of bone.
7  
The alizarin red stain, which also stains mineralized matrix, was consistent with 
the Von Kossa stain (figure 3.7), showing patches of mineralized matrix in nodules thoughout the 
amine-modified scaffold. 
 
 
 
 Page 99 
 
 
 
The LDH assay (figure 3.6)demonstrated that all the modifications support cell expansion, but 
there is a plateau of cell numbers on the amine modification between 14 and 28 days.  There are a few 
possible explanations for this result, there is evidence as explained above that the cells are starting to 
differentiate by 28 days, and this could indicate that the cells present in the scaffold are starting to 
enter a differentiation phase, and are in a non-proliferating state. 
Another possible explanation is the transfer of nutrients within the scaffold becomes slower as 
the pores become blocked with cells and ECM, causing either some cell death or that the cells have 
become non-proliferative.  There is the possibility that both of these processes are occurring to some 
extent.  There is evidence in the histology at day 28 that the amine modification induces an osteogenic 
response from the cells, but there is also evidence that some of the pores are starting to fill with 
cellular material, a phenomena that is demonstrated further by the H and E staining (figure 3.7).  It 
may be that the flattened morphology of the cells on this scaffold (demonstrated by the cryo SEM) 
(figure 3.5) leads to a reduction in the nutrient flow through the scaffold.  This suggests that a 
bioreactor may be necessary; to increase cell number at 28 days and also increased osteogenic 
differentiation. 
  The histological examination of the scaffolds showed that the hydroxyl modification was the 
only modification to support chondrogenic differentiation, as there were patches of positive Alcian 
blue staining within the serial sections.  Alcian blue stains GAGs which are markers of 
chondrogenesis (figure 3.10).  The positive Alcian blue staining was supported by the cryo SEM 
visualization of cellular morphology (figure 3.5).  The cells on the scaffold appeared to be a rounded 
which is entirely consistent with chondrocytic behavior in vitro.
8
  The Van Gieson stain was 
consistent throughout the scaffold, highlighting the collagen, which was present throughout the 
scaffold.  Combined with the Alcian blue stain, and the absence of any Von Kossa or Alizian red 
staining, the data indicates material-induced chondrogenic differentiation associated with the hydroxyl 
modification. 
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There was no evidence of differentiation on the hexane modification (figure 3.8), consistent 
with published data, showing that this surface chemistry is a useful tool in the maintenance of stem 
cell phenotype, as the LDH assay demonstrated that the MSCs do proliferate on this modification, the 
cell number increasing between 14 and 28 days.
1, 9
  There is a statistically significant difference 
between the hexane-modified scaffolds and the allyl alcohol-modified scaffolds at 14 days.  This 
shows that the cells do not proliferate as quickly on the –CH3 surfaces as on the allyl-alcohol surfaces.  
The hexane surface, as stated previously, seems to maintain stem cell phenotype, and it may be that 
the reduced cell number means that the cells are unable to create enough signaling growth factors to 
permit differentiation in these circumstances, at the correct time point. Conversely, the allyl alcohol-
modified surface is conducive to enough cells binding in the initial period to create sufficient growth 
factors to differentiate when enough time has elapsed.  This phenomenon may be investigated further 
by analyzing the intergrin binding molecule concentrations. 
The evidence discussed above directly supports the hypothesis that the surface chemistry 
influences the lineage of MSCs when deposited on a 3D substrate (in this case an injectable PLGA 
bone regeneration system).  
 
 
3.10 Dual and triple modifications 
The data obtained from the modifications in single cultures was an invaluable insight into 
what could be possible from these modifications.  The possibility of osteochondral defect treatment is 
something that would have wide reaching impact in regenerative medicine.The data suggest that 
controlling the surface chemistry of a scaffold can influence the fate of the cells migrating onto it, and 
fitting that into a wider context,potentially this could give rise to an injectable system consistent with 
the goals set out in the introduction.  It could theoretically be used on many different types of 
material, and may not just be limited to the single effects seen.  There are several specific areas in the 
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muscleroskeletal system which could benefit from a material which could increase the rate and quality 
of the repair, but are not homogeneous in their origin.  The junctions between tissues, where they 
meet are often areas that do not heal well, but are multilayered so that a “one si e fits all” approach 
would be wholly inappropriate. 
The example of the osteochondral junction is an area that has had much investigation and 
little success in terms of repair, and could be greatly advanced by a smart material approach.  
Differing modifications spanning in bands across the same scaffold may well be a way to influence 
cells to form different populations, localizing the cell signaling and restricting it to certain areas 
within a scaffold.  This could have wide reaching applications as an approach, and merited further 
investigation within this thesis.   
The results from the single modification study, reported earlier, showed that the allyl amine 
modified scaffold lead to an osteogenic effect.  The hydroxyl groups provided by the allyl alcohol 
modification were highlighted as a chemical modification that could achieve a chondrogenic effect, 
and during this dual and triple modification study, the modifications were put together in one scaffold 
to ascertain if it was possible to achieve the differentiation of MSCs into two different populations 
within opposite ends the same scaffold.  To carry this idea further the hexane modification was 
utilized as a buffer in the central portion of the scaffold, as this modification deposited methyl groups 
which had previously been thought to retain MSC phenotype.
10
 
As the identification of the phenotypic changes in these samples were localized, it was 
inappropriate to do any techniques that would homogenize the sample (such as rtPCR) so the option 
for identification purposes on these samples was restricted to the histological examination of 
scaffolds, which proved to be an ideal technique to examine the markers of differentiation within the 
scaffolds.  The results showed that the dual scaffold with allyl amine and allyl alcohol modifications 
with no hexane layer showed no separation in the layers, and a mixed response from the MSCs (figure 
3.12).  There were no defined layers of staining when the Alcian blue and alizarin red stains were 
used.  However, when the scaffold contained a layer of methyl rich hexane modification, there were 
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clearly defined bands of positive Alcian blue and alizarin red staining (figure 3.12).  The area in-
between the allyl alcohol and the allyl amine groups showed a positive alizarin red staining, which 
showed a honeycomb type structure, which could have been indicative of the early stages of 
mineralization within the methyl-rich layer.  When comparing the scaffold to the natural 
osteochondral junction, the calcified cartilage layer is the layer that occurs between the bone and 
cartilage.  The migration of calcification through the methyl-rich layer in the scaffold could be 
occurring because the signals between the two separate populations on stem cells have produced a 
gradient conducive to the production of a calcified cartilage layer. 
While this is a very interesting result in terms of what is possible from a scaffold, and the 
parameters of localized surface chemistries, the plasma modifications are limited in their application, 
as it is difficult to achieve information about the concentration of the chemistries, and so difficult to 
characterize the surface enough to apply these modifications in a clinical setting.  To actually transfer 
these findings to a clinically applicable model, the chemistry of the surfaces would have to be 
considerably more defined, and for this reason the pursuit of a chemical modification that can be 
easily measured and applied is still a priority.  Wet chemical techniques are easier to monitor for 
consistency than using plasma, as the volume and concentration of the coating solution can be 
monitored accurately, where plasma is very difficult to monitor with any degree of accuracy. 
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Chapter 4: Silane Modifications on Glass Substrate 
Introduction 
The aim of this chapter and chapter five is to use different application techniques to 
modify the surface chemistry of PLGA, and translate the baseline 2D effects into a 3D 
system, to enhance the differentiation of MSCs within a 3D platform. 
The ultimate aim of the following result chapters is to enhance the efficiency of an 
injectable osteogenic regeneration system.  For this reason the focus has been on molecules 
that have been seen in previous work to instigate an osteogenic response from MSCs.  The 
literature, while supporting the osteogenic nature of the molecules used, does show that there 
is some conflict in the results reported by different studies
1,2
.  It is therefore necessary to 
determine and optimise the material variables that induce osteogenesis. 
  By highlighting a core set of chemical groups (CH3, COOH, NH2 and OH) which 
were applied to a 3D system by a plasma polymer deposition technique, then focusing on one 
group (NH2), which showed the most successful results for the purposes of osteogenic 
differentiation, we are refining the variables that will ultimately allow the application of the 
surface chemistries.  Using the –NH2 terminal group with a different application technique 
that allows greater control of the presentation of the terminal group allows us to explore 
variation in chain length.  The potential of presenting the amine terminal group in a different 
way, will lead on from the initial plasma treated data and will attempt to elucidate the 
mechanism of the response seen, thereby enhancing the consistency of the response. 
 Initially, the starting point of this work studied a polymer plasma deposition system 
that was able to deposit chemical groups onto a surface in a random fashion.  It was possible 
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with this technique to confirm the presence of different surface chemistries, but very difficult 
to determine the concentration of those terminal groups on the surface other than varying 
times of exposure, and power levels which were really dictated by what the underlying 
substrate could withstand before damage was incurred.  The main positive feature about this 
technique was the application of this plasma could be performed on a 3D substrate, but it was 
impossible to define the exact concentration of the amine groups on the surface.  Because of 
this, it would be very difficult to apply these chemistries to a bone regenerating material with 
the level of consistency required for the production of medical devices.  For this purpose they 
need to be applied in a quantifiable and defined way, which can be measured in situ as the 
surface is being modified. 
Silanes have been shown to be very versatile in this area
3
, and because the preparation 
technique is by wet chemistry rather than an ionized gas technique, there is more potential for 
developing an assay to measure the deposition of chemical groups onto the surface during the 
manufacturing process.  The technique that has been developed in this thesis is novel, using 
ninhydrin.  The use of ninhydrin to detect free amine is well established.
4
,
5
.  Ninhydrin 
solution binds to available amine sites and instigates a colour change, from yellow to dark 
purple, which is measurable spectroscopically.  The novelty in this application is to provide 
both qualitative and quantitative information from the same sample.  It was possible, at the 
endpoint of the manufacturing process, to react all the amine in the defined coating solution 
with ninhydrin to determine what concentration of the coating solution had been deposited 
onto the surface.  The amine on the surface was also stained purple (the qualitative 
confirmation of the deposition of the surface chemistries), but the concentration of the amines 
deposited was calculated by a simple deduction method: 
SC=OC-PCC 
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 Where the surface concentration (SC) is equal to the original concentration of the 
coating solution (OC) minus the post coating concentration of the coating solution (PCC).  
All these concentrations were determined by creating a standard curve of the specific amine 
linked silanes reacted with a ninhydrin solution and measured spectroscopically at 590nM.  
See appendix for details of standard curves, the derived equation and r
2
 values which support 
the validity of the assay. 
 The ability to obtain an absolute concentration on these samples, on 2D films or 3D 
spheres is a clear step forward in the characterization of the materials, which is not possible 
with the plasma polymer deposition technique.  This is one clear reason why this technique, 
providing all other things are equal, would be a superior technique to the plasma 
modification.  Another reason why this technique could be considered to be superior to 
plasma is the simplicity of the equipment required to coat the samples.  As this is a wet 
chemical technique, it is a simple technique to perform requiring less specialized equipment 
to conduct.  This would be a consideration if this technique was ever to be scaled up, and as a 
wet chemical technique, would have the potential to coat a whole porous scaffold (depending 
on the interconnectivity of the pores). 
 While the plasma modifications can provide a good screening method for applying 
chemistries to a surface and very good proof of principle techniques, a technique that is more 
defined, simpler to manufacture, reproduce and monitor would be required if this was to go 
any further, and the silane modifications could meet the parameters required for that to occur. 
 In this chapter a range of different silanes with the same terminal groups were used to 
modify a glass substrate.  This initial investigation was conducted to determine if there was 
any discernable difference between the modifications on a flat easily defined environment 
(i.e. glass), prior to the modification of a more complex degradable polymer which would 
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bring more variables into the experimentation.  The following investigation determines by 
what degree the length of the hydrocarbon chain presenting the terminal group affects the 
efficiency by which the silane coats the surface, surface topography and osteogenicity.  
MSCs and primary osteoblast-like cells were used to determine the osteogenicity of the 
surfaces. 
 
4.1 Surface characterization of silane modified 
glassusing AFM microscopy: 
 AFM Microscopy of the silane modified glass revealed differences in the maximum feature 
height of the surfaces.  The features of CL3 and CL4 (fig 4.1.2  and 4.1.3) were similar and showed a 
significant difference to untreated glass, they displayed a rough microstructure, which was quite 
uniform.  CL6 and CL7(fig 4.1.4 and 4.1.5) displayed a roughness with defined clumping of features, 
less uniform surface with less of the micro-structure roughness seen in CL3 and CL4.  CL11 (fig 
4.1.6) showed a macro-topographical landscape with similar micro-structural topographical roughness 
to CL3 and CL4.     
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Figure 4.1.1 AFM micrograph of untreated borosilicate glass. 12mm diameter glass 
coverslips were cleaned as stated in protocol.  AFM images taken from 5 areas per sample, 
representative image shown 
Figure 4.1.2 AFM image of borosilicate glass treated with 
CL3.  12mm diameter glass coverslips were cleaned as stated in 
protocol, and modified using oxygen plasma, then the CL3 silane.  
AFM images taken from 5 areas per sample, representative image 
shown 
 
 
 
 
 Page 109 
 
 
 
 
Figure 4.1.3 AFM micrograph or borosilicate glass treated with CL4. 
12mm diameter glass coverslips were cleaned as stated in protocol, and 
modified using oxygen plasma, then the CL4 silane.  AFM images taken 
from 5 areas per sample, representative image shown 
Figure 4.1.4 AFM micrograph of borosilicate glass treated with 
CL6.  12mm diameter glass coverslips were cleaned as stated in 
protocol, and modified using oxygen plasma, then the CL6 silane.  
AFM images taken from 5 areas per sample, representative image 
shown 
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Figure 4.1.5 borosilicate glass treated with CL7.  12mm diameter glass 
coverslips were cleaned as stated in protocol, and modified using oxygen 
plasma, then the CL7 silane.  AFM images taken from 5 areas per sample, 
representative image shown 
Figure 4.1.6 borosilicate glass treated with CL11.  12mm diameter glass 
coverslips were cleaned as stated in protocol, and modified using 
oxygen plasma, then the CL7 silane.  AFM images taken from 5 areas 
per sample, representative image shown 
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4.2 Ninhydrin assay of silane modified borosilicate glass: 
 
 
 
Ninhydrin assay demonstrated that there was no statistical difference between the 
concentration of the amine groups on CL3, CL4, CL6 or CL11, but there was a significant 
difference between these modifications and CL7 which was significantly lower than the other 
modifications.  (As defined by ANOVA to a 95% confidence interval) 
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Figure 4.2 Amine concentration determined by ninhydrin assay.Ninhydrin assay 
conducted to determine the concentration of amine groups on the surfaces.  Stars 
indicate statistically significant difference from other modifications (p<0.05) 
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4.3 Dynamic water contact angle of silane modified 
borosilicate glass (advancing angle): 
 
 
 
Water contact angle of the modified glass showed that there was a statistical 
difference between the control and the CL3, 4, 7 and 11, but there was no statistically 
significant difference between the control and CL6.  There was no statistically significant 
difference between CL3, 4 and 11, but there was a difference between these modifications 
and CL6 and 7. (As defined by ANOVA to a 95% confidence interval) 
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Figure 4.3: Advancing water contact angle of modified glass surfaces. Water 
contact angle was measured to determine changes in surface energy between the 
modifications  *p<0.05,  
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4.4 Interaction of silane modified surfaces with phosphate 
buffered saline solutions. 
 
The biomimetic characteristics of the silane modified surfaces were investigated, due to some 
reported interactions between calcium carbonate and phosphate solutions and certain self-assembled 
monolayer interactions. 
6
  The results indicated there was some biomimetic properties demonstrated 
by the surface treated with CL11 when it was left in contact with a phosphate buffered saline solution 
for 7 days.  Von Kossa stain was performed as an initial qualitative test to determine if there was any 
mineralisation on the surface.  This was evident so further more detailed investigation was warranted.  
X-ray microanalysis of the surfaces was conducted. 
Time point 7 day 14 day 28 day 
Concentration 
of PBS (%) 
0 25 50 100 0 25 50 100 0 25 50 100 
CL3 - - - - - - - - - - - - 
CL4 - - - - - - - - - - - - 
CL6 - - - - - - - - - - - - 
CL7 - - - - - - - - - - - - 
CL11 - + + + - + + + - + + + 
Untreated - - - - - - - - - - - - 
Table 4.1:  PBS interactions with modified glass. + indicated positive Von Kossa 
staining for mineralisation 
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Figure  4.4  Mineral deposition study, Images show surfaces exposed to differing concentrations of PBS for 7 days, then stained using von Kossa’s stain for mineralisation, positive 
staining (brown) shown on CL11. 
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X-ray microanalysis of surfaces after PBS exposure for 7 
days. 
The mineral deposition study demonstrated that the CL11 surface is capable of 
attracting deposits of phosphorous from PBS solutions, where as the other surfaces do not.  
The concentration of the PBS in the solution is not relevant at the concentrations tested as the 
phosphorous deposited did not vary significantly.  There was a significant difference between 
the untreated control and all three PBS concentrations at 7 days on the CL11 surface. 
There is also a significantly increased concentration of carbon on the CL11 treated 
surface when compared to the other treated surfaces.  This is likely to be theincreased 
hydrocarbon chain length of CL11.  The differences between the other carbon levels are not 
detectable with this technique. 
The probability of finding phosphorous on the CL11 modification when exposed to 
any concentration of PBS is very high.  This was calculated using the total number of spectra 
taken, divided by the number of positive spectra found on the samples(table 4.2).  50 spectra 
from each sample were used, taken from randomly selected areas, and 3 repeats were 
conducted. This way of interpreting the data shows the incidence of the presence of the 
phosphorous which is more meaningful than just using the averages of the spectra, when only 
a few spectra are positive for the element on the CL6 and CL7 modifications.   
When both analysis techniques are taken into account the presence of phosphorus on 
CL11 is shown to be significantly more concentrated than the other modifications, but also, 
and perhaps more meaningful, its presence is significantly more frequent. 
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Figure 4.9: X-ray analysis of elemental composition of Silane treated glass exposed to  
water for 7 days 
Figure 4.5: X-ray analysis of elemental composition of Silane treated glass in 25% 
PBS. Silane modified glasses were exposed to PBS for 7 days and then analysed using 
Xray analysis..  *p<0.05. 
 
Figure 4.6: X-ray analysis of elemental composition of Silane treated glass in 50% 
PBS. Silane modified glasses were exposed to PBS for 7 days and then analysed using 
Xray analysis..  *p<0.05. 
* 
* 
* 
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Figure 4.7: X-ray analysis of elemental composition of Silane treated glass in 
100% PBS. Silane modified glasses were exposed to PBS for 7 days and then 
analysed using Xray analysis.  *p<0.05. 
Figure 4.8: Concentration of phosphorous on silane modified surfaces.  Surfaces 
were exposed to varying concentrations of PBS for 7 days.  *=p<0.05.  C is an untreated 
glass control. 
* 
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Insidence of Phosphorous on surfaces: 
  C CL3 CL4 CL6 CL7 CL11 
Water 0 0 0 0 0 0 
25% 
PBS 0 0 0 0 0 0.43 
50% 
PBS 0 0 0 0 0.05 1 
100% 
PBS 0 0 0 0.45 0 0.9 
  Table 4.2: Probability of phosphorous occurring on the surfaces.  
Probability of phosphorous occurring on the glass surfaces after 7 days 
exposure to PBS was calculated  0 = no probability and 1= high probability. 
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The Von Kossa staining of the control untreated glass cultured with MSCs showed no 
positive staining at 7, 14 or 28 days.  The CL3, 4, 6, 7 all showed a small amount of 
mineralisation, but the CL11 showed an extensive degree of mineralisation at 7 days which 
was sustained through to 28 days..    
4.6 Human mesenchymal stem cell interactions with 
silane modified glass after 7, 14 and 28 days 
incubation, stained with Von Kossa’s stain for 
mineralisation. 
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Figure 4.9:  MSC on modified glass after 7 days incubation MSCs on modified glass after 7 days 
incubation and stained with Von Kossas stain for mineralisation, (a) unmodified glass, (b) CL3, (c) 
CL4, (d) CL6. (e) CL7 and (f) CL11. Blue arrow indicates strong mineralisation of surface 
a b 
c d 
e f 
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4.7: SEM investigation of Human mesenchymal stem cell 
interactions with silane modified glass after 7, 14 and 28 
days incubation. 
The SEM examination of  the hMSCs on the silane modified glass revealed that CL3 
and 4 demonstrated very flat cellular morphology, that formed a monolayer from 7 days that 
was maintained until 28 days. 
CL6 had many rounded cells, that appeared to reducein number by 28 days.  CL7 
showed a monolayer formation by 7 days that was maintained throughout the 28 days period. 
CL11 showed a monolayer formation at 7 days that was starting to produce a dense 
matrix by 14 days.  By 28 days the cells were completely covered by this dense matrix that 
appeared to have a pitted texture when examined at high magnification.  
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Figure 4.10: SEM images of human MSCs cultured on modified glass for 7 days.  MSC were cultured 
on the modified glasses for 7 days, fixed with glutaraldehyde, critical point dried, and coated with 
chromium.  Representative images were then taken using a field emission scanning electron microscope.  
(a) CL3, (b) CL4, (c) CL6, (d) CL7, (e) CL11* and (f) untreated control*Shown at higher magnification to highlight 
ECM detail.  
a b 
c d 
e f 
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Figure 4.11: SEM images of human MSCs cultured on modified glass for 14 days.  MSC were cultured 
on the modified glasses for 14 days, fixed with glutaraldehyde, critical point dried, and coated with 
chromium.  Representative images were then taken using a field emission scanning electron microscope.  (a) 
CL3, (b) CL4, (c) CL6, (d) CL7, (e) CL11 and (f) untreated control.  All images shown at varying 
magnifications to highlight details. 
 
a b 
c d 
e f 
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Figure 4.12: SEM images of human MSCs cultured on the modified glass for 28 days.  MSC 
were cultured on the modified glasses for 28 days, fixed with glutaraldehyde, critical point 
dried, and coated with chromium.  Representative images were then taken using a field 
emission scanning electron microscope.  (a) CL3, (b) CL4, (c) CL6, (d) CL7, (e) CL11 and (f) 
untreated control 
 
a b 
c d 
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4.8: Real time Polymerase Chain Reaction (rt PCR) 
investigation into human mesenchymal stem cell 
interactions with silane modified glass after 7, 14 and 28 
days incubation. 
MSC scultured on CL3 modified glass demonstrated a minor upregulation of 
ostepontin at 7 days but no other significant upregulations.   
MSCs cultured on CL4 showed upregulation of osteopontin at 7, 14 and 28 days 
along with an up-regulation of osteonectin at 7 days and expression of CBFA 1 at 14 and 28 
days.   
CL7 showed an upregulation of osteopontin, collagen 1, osteonectin at 7 days and 
sclerostin at 14 days.  The MSCs exposed toCL11 showed  upregulation of osteopontin, 
collagen I, Osteonectin and osteocalcin at 7 days and sclerostin and osteocalcin at 14 days, 
with osteocalcin being upregulated to a lesser degree at 28 days.  
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Expression of collagen I in hMSC after 7, 14 and 28 days incubation with the 
modifcations 
7 14 28
* 
Figure 4.14: Expression of osteopontin by human MSCs on modified glass at 7, 14 
and 28 days.  Scaffolds were processed for rt-PCR, and   N=6 and data normalised to b-
actin housekeeping gene.  Data was analysed using the ct method of analysis 
Figure 4.15: Expression of collagen I by human MSCs on modified glass at 7, 14 
and 28 days.  Scaffolds were processed for rt-PCR, and   N=6 and data normalised to 
b-actin housekeeping gene.  Data was analysed using the ct method of analysis 
* 
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Expression of CBFA 1 in hMSC after 7, 14 and 28 days incubation with the 
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Expression of Osteonectin in hMSC after 7, 14 and 28 days incubation with the 
modifcations 
 
7 14 28
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* 
Figure 4.16Expression of CBFA 1 by human MSCs on modified glass at 7, 14 and 
28 days.  Scaffolds were processed for rt-PCR, and   N=6 and data normalised to b-
actin housekeeping gene.  Data was analysed using the ct method of analysis 
Figure 4.17: Expression of osteonectin by human MSCs on modified glass at 7, 14 
and 28 days.  Scaffolds were processed for rt-PCR, and   N=6 and data normalised to 
b-actin housekeeping gene.  Data was analysed using the ct method of analysis 
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Expression of sclerostin in hMSC after 7, 14 and 28 days incubation with the 
modifcations 
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Figure 4.19: : Expression of sclerostin by human MSCs on modified glass at 7, 
14 and 28 days.  Scaffolds were processed for rt-PCR, and   N=6 and data 
normalised to b-actin housekeeping gene.  Data was analysed using the ct 
method of analysis 
 
Figure 4.18: Expression of osteocalcin by human MSCs on modified glass at 7, 14 
and 28 days.  Scaffolds were pr cessed for rt-PCR, and   N=6 and d ta ormalised to 
b-actin housekeeping gene.  Data was analysed using the ct method of analysis 
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The MSC marker Stro-1 showed that the mesenchymal stem cells on the control 
untreated sample were still demonstrating a MSC phenotype after 28 days.  This combined 
with no expression of CBFA 1 and Osteocalcin confirms that the MSCs have not 
spontaneously differentiated.   
 CL3 demonstratedpositive collagen I and Stro-1 staining at 7 days, combined with 
negative CBFA1 and Osteocalcin.  By 14 days the CBFA 1 and Osteocalcin were mildly 
positive. 
 CL4 showed positive Collagen I staining at 7 days, no Stro-1 staining, and no CBFA 
1 or osteocalcin staining until 28 days. 
 CL6 only showed positive collagen staining throughout the 28 day period. 
 CL7 started to show positive CBFA 1 and Osteocalcin by 28 days but nothing at the 
earlier time points. 
 CL11 demonstrated a thick matrix that stained for osteocalcin and collagen I by 7 
days, showing an extensive and thick pitted matrix by 14 days with was maintained through 
to 28 days. 
  
4.9: Confocal microscopy investigation into human 
mesenchymal stem cell interactions with silane 
modified glass after 7, 14 and 28 days incubation. 
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Figure 4.20: Immunostaining of MSCs cultured on modified glass at 7 days.   MSC were 
cultured  on  silane modified glass for 7 days and stained with Stro-1, DAPI and Oregeon green.  
Blue staining shows nuclei, green staining shows actin filaments and red staining shows presence of 
stro-1 (a)untreated control, (b) CL3 (c) CL4, (d) CL6, (e) CL7 and (f) CL11 
a b 
c d 
e f 
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Figure 4.21: Immunostaining of MSCs cultured on modified glass at 7 days.   MSC were 
cultured  on  silane modified glass for 7 days and stained with collagen I, DAPI and Oregeon 
green.  Blue staining shows nuclei, green staining shows actin filaments and red staining 
shows presence of collagen I (a)untreated control, (b) CL3 (c) CL4, (d) CL6, (e) CL7 and (f) 
CL11I 
a b 
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Figure 4.22: Immunostaining of MSCs cultured on modified glass at 7 days.   MSC were 
cultured  on  silane modified glass for 7 days and stained with osteocalcin, DAPI and Oregeon 
green.  Blue staining shows nuclei, green staining shows actin filaments and red staining shows 
presence of osteocalcin (a)untreated control, (b) CL3 (c) CL4, (d) CL6, (e) CL7 and (f) CL11 
a b 
c d 
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The Von Kossa stain on the osteoblasts cultured on the silane modified surfaces 
revealed several effects of note.  There was a response seen on the CL3 and CL4 treated 
surfaces which lead to the formation of mineralised nodules by 7 days.  This response was 
maintained throughout the culture period of 28 days and restricted to the CL3 and CL4 
modifications.  A statistically insignificant number of nodules was seen on the other 
modifications which supported cell expansion throughout the culture period but with no 
observed change in phenotype during this time. 
 
  
4.10: The interaction of primary human osteoblast-
like cells with silane modified glass for 7, 14 and 28 
days, stained with Von Kossa’s stain for 
mineralisation 
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Figure 4.23 Osteoblast-like cells cultured on silane modified glass for 7 days.  Osteoblast like 
cells were cultured on the silane modified glass (and an untreated control) for 7 days, then stained 
with Von Kossa’s stain for mineralisation (a) untreated glass control, (b) CL3, (c) CL4, (d) CL6, (e) 
CL7 and (f) CL11. 
a b 
c d 
e f 
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Figure 4.24, Osteoblast-like cells cultured on silane modified glass for 14 
days.  Osteoblast like cells were cultured on the silane modified glass (and an 
untreated control) for 14 days, then stained with Von Kossa’s stain for 
mineralisation (a) untreated glass control, (b) CL3, (c) CL4, (d) CL6, (e) CL7 
and (f) CL11.. 
 
a b 
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Figure 4.25 Osteoblast-like cells cultured on silane modified glass for 28 days.  Osteoblast 
like cells were cultured on the silane modified glass (and an untreated control) for 28 days, 
then stained with Von Kossa’s stain for mineralisation (a) untreated glass control, (b) CL3, (c) 
CL4, (d) CL6, (e) CL7 and (f) CL11. 
 
a b 
c d 
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4.11:  Investigation of the number of nodules formed by 
primary human osteoblast like cells after 7, 14 and 28 days 
incubation with silane modified glass 
The number of nodules were counted visually, and the resulting data displayed in figure4.26.  
The nodule number is significantly reduced at 28 days on both CL3 and CL4, when compared 
to 14 day figures for the same modification analysed by Ttest, the results showed significant 
differences to the 95% confidence interval.  There is a significant increase between CL4 at 7 
days and CL4 at 14 days (to a 95% confidence interval), whereas there is a plateau between 7 
and 14 days on CL3.  
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Figure 4.26: Quantity of nodules formed on the modified surfaces. The 
nodules were  counted using a light microscope. (N=16) Seris 1,2 and 3 
correspond to 7, 14 and 28 days, results show avage and error bars show 
standards deviation from the mean 
* 
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4.12:  Investigation of the size of nodules formed by 
primary human osteoblast-like cells after 7, 14 and 28 
days incubation with silane modified glass. 
 
 
 The size of the nodules also changed significantly (to a 95% confidence interval as 
determined by T test) between 14 and 28 days (figure 4.27).  These results could indicate that 
the size of the nodule could reach a critical mass before being released by the surface, and 
that this occurs between 14 and 28 days. 
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Figure 4.27: Size of nodules on the modified surfaces  Nodules on surfaces 
treated with CL3 and CL4 were measured after after 7,14 and 28 days results 
show avage and error bars show standards deviation from the mean. 
* 
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4.13:  SEM investigation of primary human osteoblast like 
cells after 7, 14 and 28 days incubation with silane 
modified glass 
The SEM images above clearly demonstrate the nodule formation.  The nodules on 
CL3 and CL4 appear to be covered in extracellular matrix, which appears to mature as the 
incubation time progresses.  The higher magnification image (figure 4.31) shows a more 
detailed image of the extracellular matrix produced with what appears to be smoother 
mineralised areas.  This mineralisation is also demonstrated by the positive von Kossa 
staining from early in the culture period. (figure 4.23) 
The extracellular matrix is also produced in abundance on the CL11 surface, but in 
the absence of nodule formation to any significant degree (figure 4.32). 
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 Figure 4.28, SEM micrographs of Osteoblast-like cells cultured on silane 
modified glass after 7 days incubation. Osteoblast –like cells were isolated from 
human trabecular bone and seeded onto the silane modified surfaces. (a) untreated 
glass, (b) CL3, (c) CL4, (d) CL6 , (e) CL7 and (f) CL11. White arrows indicate 
nodules, green arrow indicates production of ECM on CL11 and red arrow shows 
very rounded cells on CL6 modification 
a b 
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Figure 4.29, SEM micrographs of Osteoblast-like cells cultured on silane 
modified glass after 14 days incubation. Osteoblast –like cells were isolated from 
human trabecular bone and seeded onto the silane modified surfaces. (a) untreated 
glass, (b) CL3, (c) CL4, (d) CL6 , (e) CL7 and (f) CL11. White arrows indicate 
nodules, green arrow indicates production of ECM  
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Figure 4.30 SEM micrographs of Osteoblast-like cells cultured on silane modified 
glass after 28 days incubation. Osteoblast –like cells were isolated from human 
trabecular bone and seeded onto the silane modified surfaces. (a) untreated glass, (b) 
CL3, (c) CL4, (d) CL6 , (e) CL7 and (f) CL11. White arrows indicate nodules,  
a b 
c d 
e f 
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Figure 4.31:  SEM micrographs of Osteoblast-like cells cultured on silane 
modified glass after 7 days incubation. Osteoblast –like cells were isolated from 
human trabecular bone and seeded onto the silane modified surfaces Image taken from 
surface of nodule formed at 7 days incubation on CL3.  White arrows highlight the 
fiberous nature of the matrix, and green arrows show areas of smooth mineralisation 
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Figure 4.32: SEM micrographs of Osteoblast-like cells cultured on silane 
modified glass after 7 days incubation. Osteoblast –like cells were isolated from 
human trabecular bone and seeded onto the silane modified surfaces. High 
magnification image of cells after 7 days incubation on CL11.  Highlighting the 
output of matrix by the cells, while cells remain in monolayer. 
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4.14:  Real time Polymerase Chain Reaction (rtPCR) 
investigation of primary human osteoblast like cells after 
7, 14 and 28 days incubation with silane modified glass. 
There is a significant upregulation of sclerositin in the osteoblasts exposed to the CL3 
and CL4 modifications after 14 and 28 days.  The expression is less after 28 days and peaks 
at 14 day.  Osteopontin is expressed in cells exposed to CL7 at 14 days but not after.  
Osteocalcin was expressed in early time points forcells exposed to  CL3, CL4 , CL6 and CL7 
and was expressed later at 28 days for CL11.There was no significant expression of Collagen 
I by these cells, and there was no significant expression of CBFA1, but this may be expected 
as it is an early differentiation marker and a transcription factor with is usually only 
expressed during early in a cells differentiation.  Sclerostin, a maker of the osteocytic 
pathway is switched on in the cells exposed to CL3 and CL4-modified glass, which correlates 
with the samples having significant nodule formation.  
  Page 146 
 
 
 
 
 
-5000000
0
5000000
10000000
15000000
20000000
CL3 CL4 CL6 CL7 CL11
Fo
ld
 c
h
an
ge
 in
 d
e
lt
a 
ct
 n
o
rm
al
is
e
d
 t
o
 
b
e
ta
 a
ct
in
 
Expression of osteopontin in osteoblast like cells after 7, 14 and 28 days 
incubation with the modifcations 
 
7 14 28
-500
0
500
1000
1500
2000
2500
3000
3500
CL3 CL4 CL6 CL7 CL11
Fo
ld
 c
h
an
ge
 in
 d
e
lt
a 
ct
 n
o
rm
al
is
e
d
 t
o
 b
e
ta
 a
ct
in
 
 Expression of osteocalcin in osteoblast like cells after 7, 14 and 28 days 
incubation with the modifcations 
 
7 14 28
* 
Figure 4.33, Expression of osteopontin in human osteoblast like cells 
after 7, 14 and 28 day incubation with silane modified glass.  Osteoblast 
like cells were isolated from human trabecular bone and processed for rtPCR.  
Expression of osteopontin was measured and normalised to expression of -
Actin and unmodified scaffold.  Data shown is average expression and 
standard deviation from mean. *=p<0.10, **=p<0.05, ***=p=<0.01 
Figure 4.34, Expression of osteocalcin in human osteoblast like cells after 7, 
14 and 28 day incubation with silane modified glass.  Osteoblast like cells 
were isolated from human trabecular bone and processed for rtPCR.  Expression 
of osteopontin was measured and normalised to expression of -Actin and 
unmodified scaffold.  Data shown is average expression and standard deviation 
from mean.  *=p<0.10, **=p<0.05, ***=p=<0.01 
*** 
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Expression of osteonectin in osteoblast like cells after 7, 14 and 28 days 
incubation with the modifcations 
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Figure 4.35, Expression of osteonectin in human osteoblast like cells after 7, 14 
and 28 day incubation with silane modified glass.  Osteoblast like cells were 
isolated from human trabecular bone and processed for rtPCR.  Expression of 
osteopontin was measured and normalised to expression of -Actin and unmodified 
scaffold.  Data shown is average expression and standard deviation from mean.  
*=p<0.10, **=p<0.05, ***=p=<0.01 
 
Figure 4.37, Expresion of CBFA1 in 
human osteoblast like cells after 7, 14 
and 28 day incubation with silane 
modified glass.  Osteoblast like cells 
were isolated from human trabecular 
bone and processed for rtPCR.  
Expression of osteopontin was 
measured and normalised to expression 
of -Actin and unmodified scaffold.  
Data shown is average expression and 
standard deviation from mean.  
*=p<0.10, **=p<0.05, ***=p=<0.01 
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 Expression of collagen I in osteoblast like cells after 7, 14 and 28 days 
incubation with the modifcations 
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* 
Figure 4.36, Expression of collagen I in human osteoblast like cells after 7, 14 and 
28 day incubation with silane modified glass.  Osteoblast like cells were isolated 
from human trabecular bone and processed for rtPCR.  Expression of osteopontin was 
measured and normalised to expression of -Actin and unmodified scaffold.  Data 
shown is average expression and standard deviation from mean.  *=p<0.10, 
**=p<0.05, ***=p=<0.01
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4.15:Discussion of silane modifications on glass. 
To determine if the hypothesis that presentation of a key terminal group was an important 
factor in influencing osteogenicity, baseline data was produced on a model substrate, in this case 
glass.  To examine the potential of chemical modifications the response was measured using both 
human MSCs and primary human osteoblast-like cells.  These cells make a suitable model to examine 
the initial phase of osteogenic differentiation as discussed in the literature review and described in 
detail in several studies
3, 1, 7,8,9, 10.
  The osteoblast model represents a more mature environment, further 
along the differentiation pathway
11
,
12
.
13
. 
The various chemistries influence the surface properties of glass when applied.  The material 
properties of the surfaces were changed significantly when the silanes were applied.  When the 
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Expression of Sclerostin in osteoblast like cells after 7, 14 and 28 days 
incubation with the modifcations 
7 14 28
* 
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Figure 4.38, , Expression of sclerostin in human osteoblast like cells after 7, 14 
and 28 day incubation with silane modified glass.  Osteoblast like cells were 
isolated from human trabecular bone and processed for rtPCR.  Expression of 
osteopontin was measured and normalised to expression of -Actin and unmodified 
scaffold.  Data shown is average expression and standard deviation from mean.  
*=p<0.10, **=p<0.05, ***=p=<0.01 
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variance of mean was examined using ANOVA (p=≥0.05) CL3, CL4 and CL11 showed a 
significantly different water contact angle when compared to the control, and to CL6 and CL7.  CL6 
and CL7 did not differ significantly from the control (figure 4.3). 
The ninhydrin assay for amine concentration (figure 4.2) demonstrated that its concentration 
on CL7 was significantly less than any of the other modifications when analysed using ANOVA 
(p=≥0.05).  This indicates that it may be the concentration of amine that is responsible for the change 
seen in the water contact angle. 
The difference seen on CL7 could be due to the amine chains clumping and not forming a 
complete self-assembled monolayer(SAM), which is less stable, and less likely to withstand the 
vigorous washing procedure.
14
 
The AFM images of the CL7 modification (figure 4.1.1-4.1.6)show the formation of clumps 
of matter which formrelatively (from a nanotopography standpoint) large ridges.  This pattern was 
also seen on the CL6 surface, but the concentration of the amine on CL6 was significantly higher than 
CL7.  The inconsistency of the results would be explained by a multiple layer clumping effect, where 
the silanes do not form full SAMs, and where some of the clumps are washed away by the vigorous 
washing procedure but some remain in situ, the clumps that remain in situ on CL6, would easily 
explain the raised concentration on the CL6, as equally the removal of the clumps via washing could 
explain the reduced concentration seen on CL7.  The SEM images on the modified glass showed no 
differences on the modified glass, which highlights that this topographical phenomenon is seen only at 
the nanoscale.  
The AFM highlights the differences in nanotopography, and maximum feature height of the 
surfaces (figure 4.1.7).  There is a statistically significant difference in the maximum feature height 
between the modified surfaces.  This could give some indication of the thickness of the silane 
coatings.  While the scale of the AFM images are unlikely to indicate directly that there is a difference 
between the silanes on an atomic scale, the marked difference in the maximum feature height of the 
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silanes does indicate that the longer chain silanes produce a thicker coating than the shorter chain 
lengths.  
Taken together the three characterization techniques (AFM, Ninhydrin and WCA) 
demonstrates clearly that the range of silanes used in this study successfully altered the glass 
substrate.  They created different surface topographies when examined on the nanoscale, in addition 
to the change in surface chemistry.  There was an increased concentration of amine groups after 
modification. Amine groups have been demonstrated in previous studies to show osteogenic 
capacity.
6,15
  There has been a large amount of research focused around the influence of surface 
nanotopography on stem cells and it has been demonstrated that there is an optimum surface 
topography for osteogenic differentiation.
16
  The key points from the studies that were successful in 
creating an osteogenic topography were that they created a surface that had an optimal surface 
roughness, but only when it was not ordered.  The experiment that highlighted this particularly well 
used a titanium surface with mechanically punched pits.  The pits were osteogenic when punched in 
an irregular grid formation, but showed no osteogenic potential when they were in a regular grid 
formation If this topography could be achieved successfully, and consistently using a silane coating, it 
would be a step forward in the area of bone regeneration.  
Mineral deposition on silane treated glass 
 The mineralization process is one of the key progressions of the bone regeneration process.  
The development of biomimetic surfaces attempts to fulfill this important step in the regeneration 
process by chemical interactions where a material can self-mineralize.  The ability of some SAMs to 
cause the nucleation of minerals on surfaces offers a route to accelerate the osteogenic process, and 
cause early mineralisation
6
.  This phenomenon was described by Towoefe et al where the SAM in 
question, while not produced from the same chemical used in this study, demonstrated an extended 
carbohydrate chain similar in length to the long chain amines used in this work. To demonstrate the 
ability of the surfaces produced for this study to self-mineralize, the surfaces were exposed to 
different concentrations of PBS for 7 days.  The resulting surfaces were then examined using a Von 
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Kossa stain for mineralization (figure 4.4), and X-ray microanalysis (figures 4.5-4.8) to show the 
elemental composition of the surfaces.  After 7 days the CL11 modification showed positive 
mineralization of the surfaces, demonstrated by positive Von Kossa staining at 7 days, and the 
abundant presence of phosphate detected with X ray analysis (figures 4.5-4.8).  The presence of 
phosphate in hydrogel has previously been shown to induce an osteogenic response
17
 so the ability of 
the surface of CL11 to attract and bind phosphorous could be indicative of this type of event.  The 
probability of the surface modification on CL11 being the cause of the phosphate detected using X-
ray microanalysis was calculated in table 4.2, which suggested that the collelation was statistically 
significant(p≥0.95)  None of the other chain lengths showed this effect. 
Mesenchymal stem cell response to silane modified glass 
 The cellular response to the silane-modified glass was examined using rtPCR to determine the 
expression of genes at defined time points (figures 4.14-4.19).  The cells were examined for the 
expression of several markers of stem cell differentiation that are key to the osteogenic pathway.  
CBFA1 was the first gene to be examined, as it is considered to be the corner pin of the osteogenic 
differentiation process
18,19
.
  
It is only present in the early phases of differentiation and for a relatively 
short period of time
19
.  There was no positive expression of CBFA1 on CL3, CL7 or CL11 at any of 
the time points tested, but there was up regulation on CL4 and 6 at 28 days.  There was an expression 
of osteonectin which is a key protein in the osteogenesis process 
,20, 21,22  
at 7 days by the cells on CL4, 
CL6 CL7 and CL11, the most prominent response seen with CL7 and CL11 which were statistically 
significant when analysed by ANOVA (p≤0.05).  There was a statistically significant difference in the 
expression of osteopontin, which also plays a role in osteogenesis 
20
, on CL7 and CL11 at 7 days, and 
osteocalcin (a vital mineralization protein)
23,24,
was expressed at 7 and 14 days on CL11, which was 
greatly reduced at 28 days.  Sclerostin, a marker of embedded osteocytes and so a clear indicator of 
osteogenic maturity
,25,26,27
 was expressed by CL11 at 14 days.  Taken together, these results suggest 
that osteogenic markers are present consistently on the CL11 sample.  The absence of CBFA1 on 
CL11 may be due to the initial time point (7 days) being too late to pick up an initial burst of 
expression following initial contact.  It is a gene that may only be expressed for a short period of time. 
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The expression of osteonectin, osteopontin and osteocalcin all indicate that the cells are capable of 
producing these proteins, which are heavily linked to osteoblastic activity.  The results show that the 
expression of these genes drops out after 7-14 days, and there is then a positive expression of the 
osteocyte marker sclerostin on CL11 at 14 days.  This shows that the cells on CL11 have the capacity 
to differentiate into osteocytes, which is the next phase of osteogenic differentiation after the cells 
have passed through the osteoblast phase.  For the cells to achieve this status, they must become 
embedded in a thick ECM, composed of osteocalcin, and collagen amongst other proteins.
25,26
 
 Examining the cells using SEM to determine their morphology and matrix production was 
performed to provide more evidence of differentiation.(Figures 4.10-4.13). The 7 day time point 
revealed that CL3, CL4 and CL7 all had very flat adhered cells.  Cells were very rounded in 
morphology on CL6 but flat and adhered and producing many proteinacious extrusions on CL11.  By 
14 days the cell numbers on CL6 were reduced, CL3 and CL4 and CL7 were all demonstrating a very 
flat monolayer of cells, and CL11 was showing a dense formation of matrix over a monolayer of very 
flat adhered cells.  By 28 days, there were even fewer cells on CL6, but CL3, CL4 and CL7 were 
demonstrating flat cells with some protein production.  The CL11 sample was covered in a dense 
matrix that seemed to be becoming pitted in its appearance, with the cells that were completely 
obscured by ECM.  This is verified by the PCR data, showing the upregulation of matrix genes on 
CL11, and then the expression of sclerostin which could only be produced if the cells were embedded 
in a thick ECM, which completely encased the cells. 
 The presence of the ECM was confirmed by the SEM images of the samples. Identification of 
the presence of osteogenic markers by confocal microscopy confirms the composition of the ECM 
which was produced by the cells.  One of the many advantages of confocal microscopy is that cells 
and proteins can be stained fluorescently when in multiple layers.  3D matrix can be scanned in layers 
and an image of the whole sample can be produced, rather than the SEM which is restricted to just the 
top.   
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Confocal microscopy was also used to detect a marker of MSC plasticity, Stro-1 (figures 
4.20-4.22).  This marker is a way of identifying undifferentiated cells, and its absence in these 
samples only occurs if the cells have already begun differentiation
28
,
29
.  If Stro-1 is absent and other 
positive markers of osteogenic differentiation such as CBFA1 and Osteocalcin are present, then it is 
likely that the cells are committed to an osteogenic fate. 
The MSCs on the untreated control expressed Stro-1 at 7, 14 and 28 days.  This, in 
conjunction with the absence of any of the osteogenic markers, confirms that the MSCs have not 
spontaneously differentiated.  The confocal staining of the modified glass showed that Stro 1 was 
expressed at 7 days, but not at 14 days and there was positive staining for Osteocalcin and CBFA1.   
CL4 modified samples showed positive collagen 1 staining at 7 days but not Stro-1, although no 
differentiation markers were expressed until 28 days.  CL6 showed positive Collagen I staining 
throughout the 28 day period, but was not positive for any of the osteogenic markers.  CL7 showed 
some positive CBFA1 staining at 28 days, but nothing before that time point, so this could not be 
described as a truly osteogenic response.  The most interesting result, however, came from the CL11 
surface.  The CL11 sample showed matrix by 7 days which was positive for osteocalcin and collagen, 
and by 14 days was showing a thick, pitted morphology.  This response was maintained through to the 
28 day time point, and is a good osteogenic response from the cells. 
The Von Kossa stain for mineralization was used to determine the extent of mineralization in 
the samples.  This process is well established and has been used in many studies to determine the 
extent of mineralisation
11
,
22
.  It should however not be used as a definitive test for the production of 
bone, and if possible there should be other confirmatory tests if there is a positive result.
30
 The 
samples showed some positive staining on all of the modifications, however it was more marked on 
the CL11 sample.  The control untreated glass showed no positive staining. 
The results all support the hypothesis that CL11-modified surfaces modification is a powerful 
stimulant to MSCs, and is able to induce an osteogenic response from them in the absence of any 
exogenous growth factors.  There are a few different possibilities that could explain the root cause of 
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that osteogenic differentiation.  This surface has several osteogenic properties, including topography 
which possesses the parameters that induce an osteogenic response, as confirmed by AFM 
microscopy including the correct size of feature, which appears to have a very powerful effect on stem 
cells.
31,16,32,33
 
The abundant availability of CL11 amine groups, which as discussed in the introduction is 
inductive of osteogenesis
3
.  The ability of the CL11 surface to harness phosphorous
6
, in a biomimetic 
way may well be contributing to the availability of minerals to the cells.  It could be that in their 
productive osteoblastic state the cells require greater quantities of the minerals that are available more 
readily on the CL11 surfaces.   
It may be that the ability of CL11 surfaces to procure minerals and make them available 
accelerates the process of osteogenic differentiation and eventually allows the it to progress to the 
next phase, osteocytic differentiation.  This is demonstrated quite clearly by the expression of 
sclerostin at 14 days, with thick matrix production, and it could be that the pits formed in this matrix 
is the start of rudimentary re-modeling.  For future work, it would be very interesting to study the 
MMPs as markers of re-modeling and to extend the study further in time, to 2 months.   
Primary human osteoblastlike-cells on silane modified glass 
 The primary human osteoblast-like cell model used represents an advanced stage in the 
osteogenic pathway.  Examining how these cells interact with the modified surfaces are an attempt to 
demonste how mature cells will react to the surface modifications, giving an impression of what the 
longer term effects may be.  There was an interesting response observed at the first time point, Von 
Kossa staining (figures 4.23-4.25) showed mineralized nodules formation on the CL3 and CL4 
surfaces.  This reaction was not seen on the other surfaces, where the cells remained in monolayer 
throughout the 28 day period.  The nodule formation on CL3 and CL4 could be explained by the 
progression of the osteogenic differentiation of the cells.  Primary human osteoblasts have been 
shown to form nodules
12
 when in 3D culture on bioactive glass, but only in the presence of exogenous 
growth factors.  This stimulus in this incidence could have come purely from the material.   
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 The formation of nodules on the CL3 and CL4 surfaces was confirmed by SEM, and Von 
Kossa stain.  As the cells used in this model were already capable of producing ECM, all of the 
samples including the untreated glass control stained positive for mineralization (Von Kossa) at 7 
days, however the cells on the untreated control were less densely mineralized by 28 days than the 
silane treated samples.  The cells on CL6, CL7 and CL11 all retained the ability to produce matrix 
which became mineralized.   
 The SEM of surfaces with osteoblasts revealed that there was an extensive production of 
ECM on the CL3 and CL4 samples when the cells were clumped together in the nodule (figure 4.28-
4.32).  The ECM appears to mature throughout the 28 day period and goes from an obvious fibrous 
formation of proteins at 7 days to a more dense, mineral-covered matrix at 14 days and by 28 days the 
cells appeared to be embedded in this matrix. 
 The size of the nodules (figure 4.27) was shown to increase over a 14 day period and then 
significantly decrease.  This occurrence when combined with the statistically significant drop in total 
number of nodules (figure 4.26) at 28 days could be indicative of the nodules reaching a critical size 
and then detaching from the surface.  This would warrant further investigation as a material that could 
product and then release these boney nodules might have interesting applications for filling bone 
defects. 
 The PCR figures (4.33-4.38) of these samples revealed an interesting response.  All data were 
normalized to the untreated glass control so the expression shown was above the baseline of normal 
osteoblast activity on glass.  The osteogenic markers are only above the baseline activity at 7 days and 
not statistically significant after this time point.  Interestingly on CL3 and CL4 the expression of 
sclerostin was notable at 14 and 28 days.  As this is a marker specifically for osteocytic activity, this 
along with the reduction of normal osteoblastic markers after 7 days is indicative of the further 
differentiation of the cells along the osteogenic pathway.  All the results are consistent with this 
hypothesis. 
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 Interestingly CL11 does not seem to have the same powerfully osteogenic effect on the 
osteoblasts as it does on human MSCs.  CL11 does however, seem to maintain the osteoblasts and 
allows them to form a mineralized matrix; the cells were shown by SEM to produce large quantities of 
ECM.  The Von Kossa staining shows that mineralization is occurring, on this sample, but there are 
no nodules present.  It has been documented earlier that the CL11-modified glass surfaces have the 
ability to attract phosphorous (see PBS interaction figure 4.4, and hMSC data figures 4.5-4.8).  In this 
experiment, because the cells are mature osteoblasts, they are covered in minerals such as 
phosphorous and calcium.  It could be that the cells are “captured” by the surface, and that the 
minerals on the surface of the cells are used to adhere the cell to the surface in an irreversible way.  
This would explain why the CL11 samples are not forming nodules, as the cells are unable to migrate.  
CL6 and CL7 have not shown any significant osteogenic potential in any of the tests, and were not 
shown to produce any significant matrix.  The cells on CL6 were very rounded until between 7 and 14 
days at which point they started to form a monolayer.  This delayed adhesion could be responsible for 
the lack of osteogenic markers seen from this modification. 
 The differences observed between the chain lengths and their osteogenic effects could be 
attributed to several things.  The procurement of minerals by CL11, the topography that is induced at 
the nanoscale and the mimicry of the ECM by the chemical modification could be key factors in these 
results. 
 The results indicate that CL11 could be a powerful inducer of osteogenic differentiation, and 
would accelerate the differentiation of MSCs, in the absence of exogenous growth factors.  In 
osteoblasts, while CL11 maintains the production of matrix, it does not allow the already mature cells 
to continue down the osteogenic pathway to the osteocytic phenotype, but if the initial interaction 
with the surface is at the MSC stage, differentiation can be induced right along the osteoblastic 
lineage to osteocytic fate.  This could be explained by the hypothesis mentioned earlier where the 
mineralized surfaces of the cells can be chemically bound to the CL11 surface.  To define this with a 
time line of events, it appears that mineralization of the surface happens initially and quite rapidly 
6
, 
before the cells adhere to the mineralized surface.  If the cells have minerals on the surface (as in the 
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osteoblast-like cell model) this time line initially is disrupted and the cells captured in the initial 
mineralization phase, hindering migration (and their ability to form nodules). To extend this study 
further, this hypothesis could be tested by looking at the movement of the cells across the surface.  
Time lapse imagery of the cells over a 7 day period may answer this question, but ideally an intergrin 
binding profile could be examined in more detail to determine the factors in play at the initial 
adherence. 
 In the instance of the CL3 and CL4 nodule formation, it is likely that it is the amine rich 
surfaces and the topography that instigates the formation of nodules.  The surfaces do not have the 
same self-mineralizing properties and so the phenomenon can’t be related directly to mineral 
deposition on the surfaces.  It is either the topography or chemistry which instigates this process, not 
the presence of phosphorous alone. 
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Chapter 5: Mesenchymal Stem Cell Response to Silane 
Modification of PLGA Films and Injectable 3D System 
 Transferring the silane-coating technology from a flat glass surface onto a 2D 
polymer surface is an important step for the successful translation of surface modifications to 
a clinical setting.  Ultimately, the goal is to achieve the same the optimised behaviour 
established on the glass surfaces on a PLGA sphere, and thin in the 3D system described in 
the plasma modification chapter.  While this is our objective, it is by no means a certain 
proposition, as the surface energy of PLGA is very different to that of glass and this step 
requires more investigation before it can be taken to the 3D platform.  Therefore initial tests 
will be conducted on flat PLGA films.  There is a precedent applying the chemistries in a 2D 
system before attempting any 3D modifications, and most successful studies take this route of 
investigation.
1
 
 This chapter will detail the translation of modifications onto PLGA films, steps taken 
to optimise the deposition of chemical groups and the associated cell responses.  This will be 
done using an in vitro MSC model.  Once the parameters are defined and explored, the 
surface modifications will be applied to PLGA spheres and incorporated into the 3D system. 
 PLGA has different material properties to glass and is technically challenging to 
process, so for this reason some techniques used on the glass surfaces in chapter 4, are 
unsuitable for the samples generated in this chapter.  It is not possible, for example to use 
SEM on the cells on the PLGA film, as the film becomes too disrupted in the process 
required to process the cells, therefore different techniques are sometimes deployed.  The 
base line data seen in the silane-modified glass chapter, demonstrated significantly modified 
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cell responses when. The challenge now is to see if the modifications are applicable to the 
very different PLGA surfaces. 
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5.1: AFM microscopy of flat PLGA films 
 
 
 
 
The maximum feature height was calculated using the maximum peak on 50 nm area at 5 
separate areas on a sample.  This was repeated 3 times.  The data was analysed using 
ANOVA to determine significant differences in the variance of mean (p=<0.95).  CL11 had a 
significantly greater maximum peak height than all the other modifications, indicating that 
the coverage of the silanes was significantly increased on CL11, and implying that the 
topography of CL11 is significantly different. 
The examination of the PLGA films with AFM showed a topographical difference between 
the different modifications.  CL3 and CL4 had a similar morphology of surface features to 
each other, being a similar height, and pattern.  There was a well dispersed and relatively 
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Figure 5.1: Maximum feature height of silane modified surfaces. Measured using 
AFM.  5 areas were measured on each sample (n=3) Error bars indicate the standard 
deviation and * indicates statistical significance (p<0.05) 
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uniform nanotopography that appeared to stay uniform in its coverage across the entirety of 
the samples.  CL6 and CL7 demonstrated a more clumped macrotopography, where the 
coverage was less uniform and more nodular in its presentation.  CL11 was interesting 
because it combined the two morphologies, showing a macrotopography that was covered in 
a nanotopography similar to that of  seen in the CL3 and CL4 modifications.  
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Figure 5.2: AFM micrograph of untreated PLGA film. 12mm diameter 
glass coverslips were cleaned as stated in protocol and spin coated with 
PLGA.  AFM images taken from 5 areas per sample, representative image 
shown 
 
Figure 5.3: AFM micrograph of CL3 treated PLGA film. 12mm diameter 
glass coverslips were cleaned as stated in protocol and spin coated with PLGA, 
then modified with CL3.  AFM images taken from 5 areas per sample, 
representative image shown. 
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Figure 5.4: AFM micrograph of CL4 treated PLGA film. 12mm diameter glass 
coverslips were cleaned as stated in protocol and spin coated with PLGA, then 
modified with CL4.  AFM images taken from 5 areas per sample, representative image 
shown. 
Figure 5.5: AFM micrograph of CL6 treated PLGA film. 12mm diameter glass 
coverslips were cleaned as stated in protocol and spin coated with PLGA, then modified 
with CL6.  AFM images taken from 5 areas per sample, representative image shown. 
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Figure 5.6: AFM micrograph of CL7 treated PLGA film. 12mm diameter glass 
coverslips were cleaned as stated in protocol and spin coated with PLGA, then 
modified with CL7.  AFM images taken from 5 areas per sample, representative image 
shown. 
 
Figure 5.7: AFM micrograph of CL11 treated PLGA film. 12mm diameter glass 
coverslips were cleaned as stated in protocol and spin coated with PLGA, then modified 
with CL11.  AFM images taken from 5 areas per sample, representative image shown. 
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5.2: Ninhydrin Assay of flat PLGA films 
 
 
 
 
The concentration of amine on the surfaces was measured using the ninhydrin assay.  CL11 
demonstrated a significantly higher concentration of amines when compared to the other 
modifications (p=>0.05).  CL3, CL4, C6 and CL7 showed no statistically significant 
differences in the variance of their means.  
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5.3: Dynamic Water Contact Angle of flat PLGA films 
The advancing angle of the dynamic water contact angle was used as a representation 
of the actual surface energy that cells are exposed to when they are seeded on a surface.  This 
is more relevant to the experiment than the receding angle, which is not shown in this chart. 
The statistical analysis showed that there were significant differences between all of 
the modifications and the control (the stars indicate degree of difference) and significant 
differences between CL3 and CL6, and CL6 and CL11 (p=>0.05). 
There is an inverse linear correlation between the chain length/number of carbon 
atoms in the chain of the silane molecule and the advancing water contact angle (r
2
=0.9645) 
which is above the 95% confidence interval and so statistically significant.    
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The advancing angle of the dynamic water contact angle was used as a  
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Figure 5.9:  Dynamic water contact angle The average advancing angle across the mid point 
of the surface was measured (n=6)  Stars indicate degree of difference between untreated 
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Figure 5.10: Correlation between dynamic water contact angle and number of carbon 
atoms in hydrocarbon chain of silane molecule.  Results were plotted as a correlation and 
R
2
 value showed a significant correlation. 
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5.4: SEM microscopy of flat PLGA films 
The SEM images of the PLGA films show a lack of features on the macroscale, apart 
from on the CL11 sample, which shows a disordered cracked structure on part of the sample.   
  
a b 
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Figure 5.11: SEM of modified PLGA films.  Films were  modified with (a) Untreated 
PLGA(b),CL3 (c),CL4 (d),CL6 (e) CL7and (f) CL11.  White arrows indicate macroscopic 
topographical structures on CL11 
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5.5: Light microscopy of flat PLGA films seeded with Mesenchymal stem 
cells and stained with Von Kossa’s stain for mineralisation. 
 
   
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.12: hMSC on modified PLGA films. Films were modified with the following 
modifiections;(a)untreated PLGA (b) CL3 (c) CL4, (d) CL6, (e) CL7, and (f) CL11. After 7 days 
incubation with hMSC they were fixed and stained with Von Kossa stain for mineralization. (f) 
White arrows show positive mineralization staining on CL11 modification. 
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The modified PLGA films were seeded with MSC and cultured for 7, 14 and 28 days.  
They were then stained using Von Kossa’s stain for mineralisation.  Positive staining 
occurred after 7 days on the CL11 treated surface.  The images in fig. 5.12 depict the 
widespread mineralisation by brown staining.  Dark blue/purple staining shows the cell nuclei 
present.  The cells were shown to be in monolayer formation by 7 days on CL3, CL4 and the 
untreated sample, but were more disrupted on the CL6 and CL7 treated surface.  CL11 
showed that there were a good coverage of cells (which appeared to have formed a good 
monolayer) under a mineralised topography.  In areas where there was no mineralisation 
staining there was still a full coverage of cells.  
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Figure 5.13 hMSC on modified PLGA films. Films were modified with the following 
modifiections;(a)untreated PLGA (b) CL3 (c) CL4, (d) CL6, (e) CL7, and (f) CL11. After 14 days 
incubation with hMSC they were fixed and stained with Von Kossa stain for mineralization. (f) 
Shows positive mineralization staining on CL11 modification. 
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The 14 day incubation time point revealed that there was a reduced number of cells on 
CL3, CL4, CL6 , CL7, and CL11 but there was still a mineralised response from CL11, and a 
good coverage of cells on this surface.  The untreated control had a full monolayer at 14 days 
incubation. 
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Figure 5.14: hMSC on modified PLGA films. Films were modified with the following 
modifiections;(a)untreated PLGA (b) CL3 (c) CL4, (d) CL6, (e) CL7, and (f) CL11. After 28 
days incubation with hMSC they were fixed and stained with Von Kossa stain for 
mineralization. (f) Shows positive mineralization staining on CL11 modification. 
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After 28 days, there were cells still present on all the surfaces, and they appeared to 
have remained at the same percentage coverage as 14 days, with no further decrease in cell 
number.  The most notable change was on CL11, which demonstrated a dense coverage of 
mineralisation, which stained dark brown with Von Kossa’s stain for mineralisation..  The 
layer appeared to have formed pits, which could be the beginning of the remodelling process.   
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5.6:  Ninhydrin assay to determine the concentration of amine groups 
deposited onto spheres during silanisation. 
 
 
 
T 
 
The concentration of amine groups on the surfaces of the spheres was measured using 
the ninhydrin assay developed in this thesis. Four separate repeats were tested at the point of 
application of the silanes to the surfaces.  The concentrations of the amines were variable, 
and considerably higher than on the flat PLGA surface (p=<0.05).  
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Figure 5.15: Mean concentration of amine groups on treated PLGA spheres.  The 
concentration of amine groups was measured by nynhydrin assay. Error bars show 
standard deviation from the mean (n=4).  Star indicates statistically significant 
reduction in coverage when compared to CL3, CL6 and CL11 (p=<0.05).   
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5.7: Histological examination of silane-treated spheres incorporated into 
the PLGA system. 
 
 
 
The histological analysis of the scaffolds revealed the presence of cells throughout the 
scaffolds at 7, 14 and 28 days, but the cells had not proliferated greatly and there was no positive 
staining from any of the differentiation marker stains (Von Kossa, Alizarin red, Van Gieson, and 
Alcian blue).  There was no evidence of collagen production (Van Gieson), and no evidence of any 
mineralization (Von Kossa, Alizarin red).  Very few cells were evident on the control untreated 
scaffold after 28 days and these results correlate with the LDH assay results showing a lack of cells 
after 28 days on this scaffold. 
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H & E + + + + 
+ 
+ + + + + + + + + + + + + 
Van 
Geison  
- - - - 
- 
- - - - - - - - - - - - - 
Alcian 
Blue  
- - - - - - - - - - - - - - - - - - 
Alizian 
Red 
- - - - - - - - - - - - - - - - - - 
Von 
Kossa 
- - - - - - - - - - - - - - - - - - 
Table 5.1:  Summary of histological staining 3D scaffolds were cultured with MSCs and 
incubated for 7, 14 and 28 days.  Scaffolds were then processed for histological analysis and 
sectioned. + = presence of positive staining, - = no staining. 
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Figure 5.16: hMSC on modified PLGA scaffolds.  Scaffolds were  modified with with (a) CL3 (b) 
CL4, (c) CL6, (d) CL7, (e) CL11 and (f) untreated PLGA and cultured for 28 days. After incubation 
the samples were processed, sectioned and stained with H and E.  Blue arrows show presence of cells 
stained by eosin 
 
 
a b 
c d 
e f 
  Page 181 
 
 
 
  
 
 
 
Figure 5.17 hMSC on modified PLGA scaffolds.  Scaffolds were  modified with with (a) CL3 
(b) CL4, (c) CL6, (d) CL7, (e) CL11 and (f) untreated PLGA and cultured for 28 days. After 
incubation the samples were processed, sectioned and stained with Von Kossa’s stain for 
mineralisation.No positive staining found. 
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Figure 5.18 hMSC on modified PLGA scaffolds.  Scaffolds were  modified with 
with (a) CL3 (b) CL4, (c) CL6, (d) CL7, (e) CL11 and (f) untreated PLGA and 
cultured for 28 days. After incubation the samples were processed, sectioned and 
stained with Alizarin red for mineralisation. No positive staining found. 
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Figure 5.19 hMSC on modified PLGA scaffolds.  Scaffolds were  modified with with (a) CL3 (b) 
CL4, (c) CL6, (d) CL7, (e) CL11 and (f) untreated PLGA and cultured for 28 days. After incubation 
the samples were processed, sectioned and stained with  Alcian blue stain for Glycosaminoglycan 
(GAG), no positive staining found. 
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Figure 5.20 hMSC on modified PLGA scaffolds.  Scaffolds were  modified with with (a) 
CL3 (b) CL4, (c) CL6, (d) CL7, (e) CL11 and (f) untreated PLGA and cultured for 28 days. 
After incubation the samples were processed, sectioned and stained with. Van Giesons stain 
for collagen. No significant positive staining found 
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There was evidence of cells on the scaffolds, confirmed by the H and E staining and 
the LDH assay, but no differentiation was detected by the other histological staining 
procedures. As the cells were seeded with 1 million cells initially, there is no evidence of 
proliferation beyond this point on the scaffolds, when you take into account the standard 
deviations.  There is no statistically significant increase in cell number over time with the 
exception of CL4 which showed a statistically significant difference in cell number after 28 
days than the initial 7 day count (p=<0.05).  There was evidence of cells after 28 days, but 
there was no evidence of stem cell differentiation within any of the scaffolds, as 
demonstrated by the histological staining undertaken previously.  The control untreated 
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Figure 5.21 LDH assay for cell number.  hMSC were seeded into silane 
modified scaffolds and cultured for 7, 14 and 28 days.  Error bars indicate 
standard deviation from mean. *shows a statically significant difference 
(p<0.05), than the same modification at 7 days. 
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scaffold showed a statistically significant drop in cell number between 14 and 28 days.  This 
was not seen on any of the treated samples. 
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5.9: Discussion of the transfer of silane modifications onto PLGA films and 
spheres and the subsequent cellular responses. 
 The transfer of the surface chemistries to flat PLGA films was successful, and instigated an 
interesting response in terms of the dynamic water contact angle.  The water contact angle had an 
inverse relationship to the chain length of the modification (figure 5.9).  This is an unusual result, 
because when the molecule is considered the longer chain molecule will introduce more CH2 groups 
to the surface, which in turn should theoretically increase surface hydrophobicity.  This was not 
observed.  This could be because the substrate, PLGA, is already very hydrophobic, the addition of 
silane groups with hydrophilic end groups (-NH2) leading to an increase in hydrophillicity despite the 
hydrophobic chain molecules.  The hydrophobic chains only act as a spacer physically keeping the 
hydrophilic NH2 groups away from the very hydrophobic substrate, creating a layer which would be 
in contact with cells, that is hydrophilic, and conducive to cell growth. 
 The Atomic force microscopy (AFM) investigation (Figure 5.2-5.7) of the surfaces was quite 
revealing, the images showing quite variable coverage from the different modifications on the PLGA 
films.  The maximum peak height exemplifies the hypothesis that the CL11 modification is 
considerably different from the other modifications.  The CL11 modification appears to have two 
layers of microstructure, that being the macro-topography and also the nano-topography.  It is likely 
that it is the unique combination of the two, combined with the surface energy demonstrated by the 
advancing dynamic water contact angle that seems to create the active surface demonstrated in this 
thesis. 
 The application of the silanes to 3D polymer system was unsuccessful in this instance from 
the standpoint of cell response.  There was no evidence of differentiation on any of the modifications 
when examined using histological techniques.  There was evidence of cells on the system but they 
  Page 188 
 
were not producing matrix.  The stains used would have identified the key proteins necessary for 
differentiation throughout the scaffold and they were all negative. 
 One possible reason for this is that the concentration of the silanes on the surface of the 
spheres was not the same as the concentration on the films which were successful (in the instance of 
CL11).  It is likely that it would be possible to optimize the techniques further by taking a close look 
at the coating methods in more detail.  The coating technique involves a flow of silane to stop the 
spheres from clumping, and the wash steps can’t be as vigorous as that on a film or glass surface.  
This leads to the concentration of silanes being significantly higher (10 fold) on the spheres than 
films.  It is likely that the coating technique and washing procedures would need to be heavily 
modified to allow the sufficient coating and washing of the spheres while avoiding the clumping that 
is detrimental to the materials effectiveness.  Further work would involve the examination and 
identification of a suitable solvent that could wash the system appropriately without causing damage 
to the PLGA, or leave any cytotoxic residues, as demonstrated in pharmaceutical release studies that 
the role of the solvent used to make the spheres, and also modify them, may play more of a role than 
merely dissolving the polymers and then evaporating
2
. Further optimization of this may be a crucial 
next step in this work. 
 Another possible reason why the application of the surface chemistries onto a 3D system did 
not cause stem cell differentiation could be that the modification protocol caused the chemical groups 
to be too closely packed together, creating steric hindrance, and not allowing the surface chemistry to 
be accessible by large protein molecules involved in  stem cell differentiation 
3
,
4
.  Obtaining a similar 
concentration of the surface groups will be key to the success of further work in this area, that 
combined with the development of suitable techniques to investigate the surface chemistry and 
topography on spherical samples, to allow better optimization of the technique. 
 Full exploration and optimization of the reactions involved in the coating of PLGA spheres 
and the investigation of the subsequent effects on cell interactions would be an ideal progression for 
this work, and is likely to lead to the creation of the biomimetic 3D system which would be applicable 
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for the purposes of bone regeneration and would be a good step forward in the clinical treatment on 
non-union bone fracture, and may lead to further applications in osteochondral repair.  To obtain this 
goal, much more work on the transfer of the chemistries to the 3D system will have to be conducted. 
1. Koegler, W.S. Griffith, L.G. Osteoblast response to PLGA tissue engineering scaffolds 
with PEO modified surface chemistries and demonstration of patterned cell response. 
Biomaterials 25, 2819-30 (2004). 
2. Ito, F. Fujimori, H. Honnami, H. Kawakami, H. Study of types and mixture ratio of 
organic solvent used to dissolve polymers for preparation of drug-containing PLGA 
microspheres. European Polymer Journal 45, 658-667 (2009). 
3. Cavalcanti-Adam, E. A., Micoulet,A., Blümmel, J.. Lateral spacing of integrin ligands 
influences cell spreading and focal adhesion assembly. European journal of cell 
biology 85, 219-24 (2006). 
4. Selhuber-Unkel, C. Erdmann,T., Lopez-Garcia, M. Cell adhesion strength is controlled 
by intermolecular spacing of adhesion receptors. Biophysical journal 98, 543-51 
(2010).  
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Chapter 6: Discussion of Results and Further Work 
 There is significant evidence in the review of current work (chapter 1) to show a clear, 
unequivocal need for bone regeneration system that could be applied in non-union fracture 
that occurs in circumstances such as trauma and bone cancer surgery.  Autologous bone 
transplantation is the first line treatment for non-union bone fracture and has success, 
depending on the type of bone harvested, with cancellous bone containing numerous 
osteogenic factors but without much mechanical strength, and cortical bone having good 
mechanical strength but fewer easily available factors
1,2
.  The use of autologous bone as a 
treatment has many obstacles.  Only limited donor sites are suitable for an autologous bone 
graft and this is a limitation that increases with the age of the patient.
2
  Donor site morbidity 
is also a very serious problem, with pain lasting in some cases for longer than the repair takes 
to heal
3
.  Minor complications from this procedure included superficial infections and 
hematomas. More serious complications included herniation through large bone graft donor 
sites, vascular injuries, serious infections, neurological injuries, and further fractures.
4
 
 The other current treatments for non-union fractures include several specialised 
surgical techniques, such as compression plating and supracondylar femoral nailing
5
, and 
many surgeons use techniques like this to treat non-unions.  There are problems associated 
with invasive surgeries such as soft tissue stripping and damage, localised infection and nerve 
damage.  Compression plating has a 1 in 10 incidence of nerve damage when used in non-
union humeral shaft fractures
5
 and for this reason the supracondylar nailing can be seen as a 
better option, this is often true, but also has its drawbacks, and its success is dependent on the 
stability of the fit between the nail and the internal cavity, as instability will cause further 
complications.
5
  These surgical techniques are only suitable for certain non-union fractures, 
and not when large pieces of bone are required. 
  Page 191 
 
 Allografts, another relatively common treatment, are usually human cadaver bones, 
that are processed to remove any of the osteogenic cells, and leave an osteoconductive 
scaffold for the patient own cells to infiltrate and colonise.  The problems associated with 
using this type of material is the risk of infection and immunogenicity/patient rejection.  
Generally the donor bone is cleaned and stripped of any of the cellular/osteogenic 
components, and is screened for infectious diseases such as HIV, but there is always a small 
risk with this sort of tissue.  The cleaning of the allograft denatures not only any potential 
hazardous viruses, but also the factors that would be useful to the in-growth of native cells, so 
in these cases it is likely that exogenous growth factor would be necessary. 
 Alternative material solutions are available, and currently used.  Ceramic scaffolds 
containing BMPs are used to treat non union fractures and there has been success with these 
materials, is one study the use of BMP-7 was shown to cause healing in non-union fractures 
after 4 months, where previous surgical techniques including grafts had failed, with a success 
rate of 92% (of 28 patients).
6
  While this is very impressive, the cases may not reflect the 
general population of non-union fractures. 
 Non-union bone fracture has a very serious impact on the patient, and with up to 10% 
of all fractures becoming non-union
4
 (this figure depends upon the location of the fracture, 
but will rise to 50% of all open tibia fractures) it is also a considerable economic problem. In 
the US it is estimated that the treatment of non-union fractures was around 14.6 billion US 
dollars per annum
4
.  There is a very great need for a more cost effective solution than 
autologous transplant or the use of BMP treated material grafts.  Both of these treatments cost 
in the region of £15,000 per patient, if the non-union fracture is in the long bones
7
.  This is 
prohibitively expensive and would not be an option in developing countries.  Cheaper 
treatments would be a real possibility if a biomaterial with an osteo-inductive surface 
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chemistry was developed, particularly if the active surface was composed of a synthetic 
chemical rather than a peptide or growth factor. 
If this treatment had the advantage of being injectable, like the one outlined in this 
thesis, it would not only be cheaper to produce than peptide treated materials and other 
alternatives, but it would also be less invasive for the patient, and ultimately require less 
hours of surgery (which is the major cost associated with a non-union fracture, with the more 
complicated non-unions requiring several separate surgical procedures).   
 There are many benefits to a regenerative technique using PLGA that possesses an 
osteogenic surface, which include the controllable degradation rate
8
, and the conducive 
osteogenic environment it provides to stem cell and osteoblast-like cells.  This technique 
would bypass the majority of the negative, problematic side effects observed in the 
autologous bone graft.  It would, as an advanced active material method, be capable of 
containing a powerful biological stimulus, that instigates the migration of the patients own 
stem cells, providing an in situ tissue engineering solution. 
 A scaffold that creates an environment which causes recruitment of native bone 
marrow-derived MSCs and which could also stimulate them following their infiltration in 
vivo, may be an achievable goal. The work conducted in this thesis demonstrated potential in 
this field.  The individual results have been discussed in isolation in previous chapters but 
their significance will now be discussed when considering the context of the complete study. 
 The initial experimentation was undertaken using a range of surface chemistries on a 
3D PLGA system (chapter 3).  It was important to characterise these surfaces sufficiently to 
ascertain that they had been deposited on the surfaces.  While there were limitations to the 
characterisation of the surfaces, the techniques employed assessed a full spectrum of the 
surfaces properties.  XPS (figure 3.4) identified the presence of chemical elements and 
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energies associated with the species deposited, and SEM identified the surfaces were 
undamaged by the plasma chemical deposition process (figure 3.3).  It was important at this 
stage to identify that the different surface chemistries were not inducing topographical 
changes that were vastly different from each other.  This was to determine that it was in fact 
the chemistry that was responsible for the response seen.  The water contact angle was 
measured to show any changes in surface energy.  At this point the nanotopography was not 
taken into consideration as the measurement of the surfaces nanotopography is technically 
very challenging when the substrate is polymer spheres. 
  This analysis all confirmed that the surfaces had been modified in such a way that 
the surface chemistry had altered, while the macrotopography had remained similar to that of 
the untreated control.  
Markers of differentiation were highlighted in the direct staining of the cells and their 
ECM via the histological analysis (tables 3.3-3.5, and figures 3.7-3.11).  Consistent Van 
Gieson staining through the scaffold (figures 3.7-3.11) stained collagen, but does not 
differentiate between the different types of collagen.  Further histological examination of the 
scaffolds revealed an osteogenic response throughout the amine treated scaffold (figure 3.7), 
where Von Kossa staining was concentrated in nodules and seen in every sample point 
throughout the scaffold.  The Von Kossa reagent stains calcified ECM using silver nitrate to 
react to the phosphate which accompanies calcium in mineralized matrix in an acidic 
environment
9
, and as mineralization of the ECM is one of the key markers of osteogenic 
differentiation it is often seen as a definitive test.  It does not however indicate that there is 
bone formation, and caution should be taken before making this statement, as the staining 
does not indicate the calcium to phosphate ratio, which is crucial when determining the 
mineral formation of bone.
9  
The alizarin red stain, which also stains mineralized matrix, was 
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consistent with the Von Kossa stain (figure 3.7), showing areas of mineralized matrix in 
nodules throughout the amine-modified scaffold. 
The LDH assay (figure 3.6) demonstrated that all the modifications support cell 
expansion, but there is a plateau of cell numbers on the amine modification between 14 and 
28 days.  There are a number of possible explanations for this result: there is evidence as 
explained above that the cells are starting to differentiate by 28 days, and this could indicate 
that the cells present in the scaffold are starting to enter a differentiation phase, and are in a 
non-proliferating state.  
Alternatively, another explanation is that the transfer of nutrients within the scaffold 
slows as the pores become blocked with cells and ECM, causing either some cell death or 
that the cells have become non-proliferative.  Both of these processes could be occurring.  
There is evidence in the histology at day 28 that the amine modification induces an 
osteogenic response from the cells, but there is also evidence that some of the pores are 
starting to fill with cellular material, a phenomenon that is demonstrated further by the H and 
E staining (figure 3.7).  It may be that the flattened morphology of the cells on this scaffold 
(demonstrated by the cryo SEM) (figure 3.5) leads to a reduction in the nutrient flow through 
the scaffold.  This suggests that a bioreactor may be necessary, to increase cell number at 28 
days and also increased osteogenic differentiation. 
The histological examination of the scaffolds showed that the hydroxyl modification 
was the only modification to support chondrogenic differentiation, as there were patches of 
positive Alcian blue staining within the serial sections.  Alcian blue stains GAGs which are 
markers of chondrogenesis (figure 3.10).  The positive Alcian blue staining was supported by 
the cryo SEM visualization of cellular morphology (figure 3.5).  The cells on the scaffold 
appeared to be a rounded which is entirely consistent with chondrocytic behavior in vitro.
10
 
  Page 195 
 
The Van Gieson stain was consistent throughout the scaffold, highlighting the collagen, 
which was present throughout the scaffold.  Combined with the Alcian blue stain, and the 
absence of any Von Kossa or Alizian red staining, the data indicates material-induced 
chondrogenic differentiation associated with the hydroxyl modification. 
There was no evidence of differentiation on the hexane modification (figure 3.8), 
consistent with published data, showing that this surface chemistry is a useful tool in the 
maintenance of stem cell phenotype, as the LDH assay demonstrated that the MSCs do 
proliferate on this modification, the cell number increasing between 14 and 28 days.
11, 10
  
There is a statistically significant difference between the hexane-modified scaffolds and the 
allyl alcohol-modified scaffolds at 14 days.  This shows that the cells do not proliferate as 
quickly on the –CH3 surfaces as on the allyl-alcohol surfaces.  The hexane surface, as stated 
previously, seems to maintain stem cell phenotype, and it may be that the reduced cell 
number means that the cells are unable to create enough signaling growth factors to permit 
differentiation in these circumstances, at the correct time point. Conversely, the allyl alcohol-
modified surface is conducive to enough cells binding in the initial period to create sufficient 
growth factors to differentiate when enough time has elapsed.  This phenomenon may be 
investigated further by analyzing the intergrin binding molecule concentrations. 
To summarise: when the MSCs were introduced to the 3D system, there was several 
positive effects seen, including a positive osteogenic response in the allyl amine treated 
scaffold and a positive chondrocytic effect seen in the allyl alcohol treated scaffolds.  These 
results fuelled the further investigation of the surface chemistries and lead to the initial 
osteochondral investigation, using a single scaffold to differentiate two separate populations 
of stem cells within one scaffold.  These initial positive results had further potential that will 
be discussed later in this chapter, and as stand-alone results they were very promising, but the 
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investigation of this work took the positive effect seen in the osteogenic amine modification 
and pursued it in a more definable way. 
 The osteogenic effect seen using amine was reported in other studies that showed both 
amine promoting an osteogenic effect and the opposite, where the amine groups did not 
support osteogenesis
11
,
12
.  This lead to the assumption that more factors were involved other 
than just the presence of an amine terminal group, and that the presentation of this terminal 
group could be an important factor.  The area merited a closer look, and due to the inflexible 
nature of the plasma coating with regards to the presentation of the moiety, a logical 
progression was to investigate a modification that could be altered subtly to change 
presentation, and so suitable amine terminated silanes were investigated, which had varying 
chain length. 
To determine if the presentation of a key terminal group was an important factor in 
influencing osteogenicity, baseline data was produced on a model substrate (in this case 
glass).  To examine the potential of chemical modifications the response was measured using 
both human MSCs and primary human osteoblast-like cells.  These cells make a suitable 
model to examine the initial phase of osteogenic differentiation as discussed in the literature 
review and described in detail in several studies
11,12, 13,14,15, 16.
 The osteoblast model represents 
a more mature environment, further along the differentiation pathway
17
,
18
.
19
. 
The chemistries influence the surface properties of glass when applied.  The material 
properties of the surfaces were changed significantly when the silanes were applied.  When 
the variance of mean was examined using ANOVA (p=≥0.05) CL3, CL4 and CL11 showed a 
significantly different water contact angle when compared to the control, and to CL6 and 
CL7.  CL6 and CL7 did not differ significantly from the control (figure 4.3). 
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The ninhydrin assay for amine concentration (figure 4.2) demonstrated that its 
concentration on CL7 was significantly less than any of the other modifications when 
analysed using ANOVA (p=≥0.05).  This indicates that it may be the concentration of amine 
that is responsible for the change seen in the water contact angle. 
The difference seen on CL7 could be due to the amine chains clumping and not 
forming a complete self-assembled monolayer (SAM), which is less stable, and less likely to 
withstand the vigorous washing procedure.
20
 
The AFM images of the CL7 modification (figure 4.1.1-4.1.6) demonstrate the 
formation of clumps of matter which form relatively (from a nanotopographical standpoint) 
large ridges.  This pattern was also seen on the CL6 surface, but the concentration of the 
amine on CL6 was significantly higher than CL7.  The inconsistency of the results would be 
explained by a multiple layer clumping effect, where the silanes do not form full SAMs, and 
where some of the clumps are washed away by the vigorous washing procedure but some 
remain in situ, the clumps that remain in situ on CL6, would easily explain the raised 
concentration on the CL6, as equally the removal of the clumps via washing could explain the 
reduced concentration seen on CL7.  The SEM images on the modified glass showed no 
differences on the modified glass, which highlights that this topographical phenomenon is 
seen only at the nanoscale. 
The AFM highlights the differences in nanotopography, and maximum feature height 
of the surfaces (figure 4.1.7).  There is a statistically significant difference in the maximum 
feature height between the modified surfaces.  This could give some indication of the 
thickness of the silane coatings.  The marked difference in the maximum feature height of the 
silanes does indicate that the longer chain silanes produce a thicker coating than the shorter 
chain lengths.   
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Taken together the three characterization techniques (AFM, Ninhydrin and WCA) 
demonstrate that the range of silanes used in this study successfully altered the glass 
substrate. They created different surface topographies when examined on the nanoscale, in 
addition to the change in surface chemistry.  There was an increased concentration of amine 
groups after modification. Amine groups have been demonstrated in previous studies to show 
osteogenic capacity.
21,22
  Surface nanotopography on stem cells has been extensively 
researched and it has been demonstrated that there is an optimum surface topography for 
osteogenic differentiation.
23
  The key points from the studies that were successful in creating 
an osteogenic topography were that they created a surface that had an optimal surface 
roughness, but only when it was not ordered.  The experiment that highlighted this 
particularly well used a titanium surface with mechanically punched pits.  The pits were 
osteogenic when punched in an irregular grid formation, but showed no osteogenic potential 
when they were in a regular grid formation
24
.  If this topography could be achieved 
successfully, and consistently using a silane coating, it would be a step forward in the area of 
bone regeneration.  
The material coating in this study showed another potentially osteoinductive property 
that was investigated using an experiment to observe the mineralization potential of the 
surfaces in the absence of any osteogenic cells. 
 Mineralization is a key progression of the bone regeneration process. The 
development of biomimetic surfaces attempts to fulfill this important step in the regeneration 
process by chemical interactions where a material can self-mineralize.  The ability of some 
SAMs to cause the nucleation of minerals on surfaces offers a route to accelerate the 
osteogenic process, and cause early mineralisation
21
.  This phenomenon was described by 
Towoefe et al where the SAM in question, while not produced from the same chemical used 
in this study, demonstrated an extended carbohydrate chain similar in length to the long chain 
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amines used in this work. To demonstrate the ability of the surfaces produced for this study to 
self-mineralize, the surfaces were exposed to different concentrations of PBS for 7 days.  The 
resulting surfaces were then examined using a Von Kossa stain for mineralization (figure 
4.4), and X-ray microanalysis (figures 4.5-4.8) to show the elemental composition of the 
surfaces.  After 7 days the CL11 modification showed positive mineralization of the surfaces, 
demonstrated by positive Von Kossa staining at 7 days, and the abundant presence of 
phosphate detected with X ray analysis (figures 4.5-4.8).  The presence of phosphate in 
hydrogel has previously been shown to induce an osteogenic response
25
 so the ability of the 
surface of CL11 to attract and bind phosphorous could be indicative of this type of event.  
The probability of the surface modification on CL11 being the cause of the phosphate 
detected using X-ray microanalysis was calculated in table 4.2, which suggested that the 
correlation was statistically significant(p≥0.95)  None of the other chain lengths showed this 
effect. 
 The next phase of the investigation was to use an MSC model to investigate how 
these cells interact with the silanes, on a model surface, in this instance, glass. 
 The cellular response to the silane-modified glass was examined using rtPCR to 
determine the expression of genes at defined time points (figures 4.14-4.19).  The cells were 
examined for the expression of several markers of stem cell differentiation that are key to the 
osteogenic pathway.  CBFA1 was the first gene to be examined, as it is considered to be the 
corner pin of the osteogenic differentiation process
26,27, 
.  It is only present in the early phases 
of differentiation and for a relatively short period of time.
27
  There was no positive expression 
of CBFA1 on CL3, CL7 or CL11 at any of the time points tested, but there was up regulation 
on CL4 and 6 at 28 days.  There was an expression of osteonectin which is a key protein in 
the osteogenesis process 
,28, 29,30
at 7 days by the cells on CL4, CL6 CL7 and CL11, the most 
prominent response seen with CL7 and CL11 which were statistically significant when 
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analysed by ANOVA (p≤0.05).  There was a statistically significant difference in the 
expression of osteopontin, which also plays a role in osteogenesis
28
, on CL7 and CL11 at 7 
days, and osteocalcin (a vital mineralization protein)
31,32,
was expressed at 7 and 14 days on 
CL11, which was greatly reduced at 28 days.  Sclerostin, a marker of embedded osteocytes 
and so a clear indicator of osteogenic maturity
,33,34,35
 was expressed by CL11 at 14 days.  
Taken together, these results suggest that osteogenic markers are present consistently on the 
CL11 sample.  The absence of CBFA1 on CL11 may be due to the initial time point (7 days) 
being too late to pick up an initial burst of expression following initial contact.
36
  It is a gene 
that may only be expressed for a short period of time.  The expression of osteonectin, 
osteopontin and osteocalcin all indicate that the cells are capable of producing these proteins, 
which are heavily linked to osteoblastic activity.  The results show that the expression of 
these genes drops out after 7-14 days, and there is then a positive expression of the osteocyte 
marker sclerostin on CL11 at 14 days.  This shows that the cells on CL11 have the capacity to 
differentiate into osteocytes, which is the next phase of osteogenic differentiation after the 
cells have passed through the osteoblast phase.  For the cells to achieve this status, they must 
become embedded in a thick ECM, composed of osteocalcin, and collagen amongst other 
proteins.
33,34
 
 Examining the cells using SEM to determine their morphology and matrix production 
was performed to provide more evidence of differentiation(Figures 4.10-4.13).  The 7 day 
time point revealed that CL3, CL4 and CL7 all had very flat adhered cells.  Cells were very 
rounded in morphology on CL6 but flat and adhered and producing many proteinacious 
extrusions on CL11.  By 14 days the cell numbers on CL6 were reduced, CL3 and CL4 and 
CL7 were all demonstrating a very flat monolayer of cells, and CL11 was showing a dense 
formation of matrix over a monolayer of very flat adhered cells.  By 28 days, there were even 
fewer cells on CL6, but CL3, CL4 and CL7 were demonstrating flat cells with some protein 
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production.  The CL11 sample was covered in a dense matrix that seemed to be becoming 
pitted in its appearance, with the cells that were completely obscured by ECM.  This is 
verified by the PCR data, showing the up-regulation of matrix genes on CL11, and then the 
expression of sclerostin which could only be produced if the cells were embedded in a thick 
ECM, which completely encased the cells.
35
 
 The presence of the ECM was confirmed by the SEM images of the samples. 
Identification of the presence of osteogenic markers by confocal microscopy confirms the 
composition of the ECM which was produced by the cells.  One of the many advantages of 
confocal microscopy is that cells and proteins can be stained fluorescently when in multiple 
layers.  3D matrix can be scanned in layers and an image of the whole sample can be 
produced, rather than the SEM which is restricted to just the top. 
Confocal microscopy was also used to detect a marker of MSC plasticity, Stro-
1(figures 4.20-4.22).  This marker is a way of identifying undifferentiated cells, and its 
absence in these samples only occurs if the cells have already begun differentiation
37
,
38
.  If 
Stro-1 is absent and other positive markers of osteogenic differentiation such as CBFA1 and 
Osteocalcin are present, then it is likely that the cells are committed to an osteogenic fate. 
The MSCs on the untreated control expressed Stro-1 at 7, 14 and 28 days.  This, in 
conjunction with the absence of any of the osteogenic markers, confirms that the MSCs have 
not spontaneously differentiated.  The confocal staining of the modified glass showed that 
Stro 1 was expressed at 7 days, but not at 14 days and there was positive staining for 
Osteocalcin and CBFA1.  CL4 modified samples showed positive collagen 1 staining at 7 
days but not Stro-1, although no differentiation markers were expressed until 28 days.  CL6 
showed positive Collagen I staining throughout the 28 day period, but was not positive for 
any of the osteogenic markers.  CL7 showed some positive CBFA1 staining at 28 days, but 
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nothing before that time point, so this could not be described as a truly osteogenic response.  
The most interesting result, however, came from the CL11 surface.  The CL11 sample 
showed matrix by 7 days which was positive for osteocalcin and collagen, and by 14 days 
was showing a thick, pitted morphology.  This response was maintained through to the 28 
day time point, and is a good osteogenic response from the cells.   
The Von Kossa stain for mineralization was used to determine the extent of 
mineralization in the samples.  This process is well established and has been used in many 
studies to determine the extent of mineralisation
17
,
30
.  It should however not be used as a 
definitive test for the production of bone, and if possible there should be other confirmatory 
tests if there is a positive result.
9
  The samples showed some positive staining on all of the 
modifications, however is was more marked on the CL11 sample.  The control untreated 
glass showed no positive staining. 
The results all support the hypothesis that CL11-modified surfaces modification is a 
powerful stimulant to MSCs, and is able to induce an osteogenic response from them in the 
absence of any exogenous growth factors.  There are a few different possibilities that could 
explain the root cause of that osteogenic differentiation.  This surface has several osteogenic 
properties, including topography which possesses the parameters that induce an osteogenic 
response, as confirmed by AFM microscopy including the correct size of feature, which 
appears to have a very powerful effect on stem cells.
39,23,40,41
 
The abundant availability of CL11 amine groups, which as discussed in the 
introduction is inductive of osteogenesis
11
.  The ability of the CL11 surface to harness 
phosphorous
21
, in a biomimetic way may well be contributing to the availability of minerals 
to the cells.  It could be that in their productive osteoblastic state the cells require greater 
quantities of the minerals that are available more readily on the CL11 surfaces.   
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It may be that the ability of CL11 surfaces to procure minerals and make them 
available accelerates the process of osteogenic differentiation and eventually allows the it to 
progress to the next phase, osteocytic differentiation.  This is demonstrated quite clearly by 
the expression of sclerostin at 14 days, with thick matrix production, and it could be that the 
pits formed in this matrix is the start of rudimentary re-modeling.  For future work, it would 
be very interesting to study the MMPs as markers of re-modeling and to extend the study 
further in time, to 2 months.  
After the investigation using MSC, another model was used with shows a response 
from a more mature cell, and gives an insight into the later phases of the osteogenic pathway.  
A primary human osteoblast-like cell model was used.  Examining how these cells interact 
with the modified surfaces are an attempt  to demonste how mature cells will react to the 
surface modifications, giving an impression of what the longer term effects may be.  There 
was an interesting response observed at the first time point, Von Kossa staining (figures 4.23-
4.25) showed mineralized nodules formation on the CL3 and CL4 surfaces.  This reaction 
was not seen on the other surfaces, where the cells remained in monolayer throughout the 28 
day period.  The nodule formation on CL3 and CL4 could be explained by the progression of 
the osteogenic differentiation of the cells.  Primary human osteoblasts have been shown to 
form nodules
18
 when in 3D culture on bioactive glass, but only in the presence of exogenous 
growth factors.  This stimulus in this incidence could have come purely from the material.   
 The formation of nodules on the CL3 and CL4 surfaces was confirmed by SEM, and 
Von Kossa stain.  As the cells used in this model were already capable of producing ECM, all 
of the samples including the untreated glass control stained positive for mineralization (Von 
Kossa) at 7 days, however the cells on the untreated control were less densely mineralized by 
28 days than the silane treated samples.  The cells on CL6, CL7 and CL11 all retained the 
ability to produce matrix which became mineralized.   
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 The SEM of surfaces with osteoblasts revealed that there was an extensive production 
ofECM on the CL3 and CL4 samples when the cells were clumped together in the nodule 
(figure 4.28-4.32).  The ECM appears to mature throughout the 28 day period and goes from 
an obvious fibrous formation of proteins at 7 days to a dense mineral-covered matrix at 14 
days and by 28 days the cells appeared to be embedded in this matrix. 
 The size of the nodules (figure 4.27) was shown to increase over a 14 day period and 
then significantly decrease.  This occurrence when combined with the statistically significant 
drop in total number of nodules (figure 4.26) at 28 days could be indicative of the nodules 
reaching a critical size and then detaching from the surface.  This would warrant further 
investigation as a material that could product and then release these boney nodules might 
have interesting applications for filling bone defects. 
 The PCR figures (4.33-4.38) of these samples revealed an interesting response.  All 
data were normalized to the untreated glass control so the expression shown was above the 
baseline of normal osteoblast activity on glass.  The osteogenic markers are only above the 
baseline activity at 7 days and not statistically significant after this time point.  Interestingly 
on CL3 and CL4 the expression of sclerostin was notable at 14 and 28 days.  As this is a 
marker specifically for osteocytic activity, this along with the reduction of normal 
osteoblastic markers after 7 days is indicative of the further differentiation of the cells along 
the osteogenic pathway.  All the results are consistent with this hypothesis. 
 CL11 does not have the same powerfully osteogenic effect on the osteoblasts as it 
does on human MSCs.  CL11 does however, seem to maintain the osteoblasts and allows 
them to form a mineralized matrix; the cells were shown by SEM to produce large quantities 
of ECM.  The Von Kossa staining shows that mineralization is occurring, on this sample, but 
there are no nodules present.  It has been documented earlier that the CL11-modified glass 
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surfaces have the ability to attract phosphorous (see PBS interaction figure 4.4, and hMSC 
data figures 4.5-4.8).  In this experiment, because the cells are closer down the differentiation 
pathway to mature osteoblasts, they are covered in minerals such as phosphorous and 
calcium.  It could be that the cells are “captured” by the surface, and that the minerals on the 
surface of the cells are used to adhere the cell to the surface in an irreversible way.  This 
would explain why the CL11 samples are not forming nodules, as the cells are unable to 
migrate.  CL6 and CL7 have not shown any significant osteogenic potential in any of the 
tests, and were not shown to produce any significant matrix.  The cells on CL6 were very 
rounded until between 7 and 14 days at which point they started to form a monolayer.  This 
delayed adhesion could be responsible for the lack of osteogenic markers seen from this 
modification. 
 The differences observed between the chain lengths and their osteogenic effects could 
be attributed to several things.  The procurement of minerals by CL11, the topography that is 
induced at the nanoscale and the mimicry of the ECM by the chemical modification could be 
key factors in these results. 
 The results indicate that CL11 could be a powerful inducer of osteogenic 
differentiation, and would accelerate the differentiation of MSCs, in the absence of 
exogenous growth factors.  In osteoblasts, while CL11 maintains the production of matrix, it 
does not allow the already mature cells to continue down the osteogenic pathway to the 
osteocytic phenotype, but if the initial interaction with the surface is at the MSC stage, 
differentiation can be induced right along the osteoblastic lineage to osteocytic fate.  This 
could be explained by the hypothesis  mentioned earlier where the mineralized surfaces of the 
cells can be chemically bound to the CL11 surface. To define this with a time line of events, 
it appears that mineralization of the surface happens initially and quite rapidly 
21
, before the 
cells adhere to the mineralized surface.  If the cells have minerals on the surface (as in the 
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osteoblast-like cell model) this time line initially is disrupted and the cells captured in the 
initial mineralization phase, hindering migration (and their ability to form nodules).  To 
extend this study further, this hypothesis could be tested by looking at the movement of the 
cells across the surface.  Time lapse imagery of the cells over a 7 day period may answer this 
question, but ideally an intergrin binding profile could be examined in more detail to 
determine the factors in play at the initial adherence. 
 In the instance of the CL3 and CL4 nodule formation, it is likely that it is the amine 
rich surfaces and the topography that instigates the formation of nodules.  The surfaces do not 
have the same self-mineralizing properties and so the phenomenon can not be related directly 
to mineral deposition on the surfaces.  It is either the topography or chemistry which 
instigates this process, not the presence of phosphorous alone. 
 To summarise, because it was necessary to characterise these surfaces in a more 
accurate way, it  was likely that the silanes examined would show only very small 
differences, the work was undertaken using a model substrate  (in this case glass in chapter 
4).  The base line data was discussed in detail in chapter 4, but the over-reaching hypothesis 
of this work was that the presentation of the chemistry was of similar importance to the 
terminal group.  It was demonstrated that the presentation of the amine terminal groups 
influenced nanotopography, this was demonstrated very clearly with the use of a AFM 
(figures 4.1.1-4.1.6).  The data collected by the AFM brought the possibility that the surfaces 
nanotopography was a very important factor in the induction of osteogenicity from 
mesenchymal stem cells, and that while the chemistry does have an effect (as demonstrated 
by the plasma modifications) the topography can indeed have a very strong effect.
40
 
 Other work done around the silane and SAM methods of surface modification pointed 
towards another factor that was becoming apparent.  The self-mineralising properties of the 
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silane with the longest chain length was evident in the more in depth surface analysis, and the 
experimental work involving exposing the surfaces to a Phosphate buffered saline (PBS) 
solution
21
.  This self-mineralising effect could be responsible for some of the phenotypical 
changes in the cells exposed to these surfaces, and could be responsible for the nucleation of 
minerals that stimulate osteogenic events. 
 The wet chemical technique for the application of silanes had advantages over the 
plasma modification.  Whilst the main reason for choosing the chemistries was the alterable 
nature of the way they present their terminal group, the concentration of amine could also be 
measured more accurately using a ninhydrin solution which was a technique developed in 
this thesis.  Ninhydrin is a long established detector of free amine groups, but the use of it to 
detect tethered amine groups is a novel application of it. 
 The main focus of this thesis was the PLGA bone regeneration system, and for all the 
baseline data to progress the surface chemistries had to be conducted on PLGA before it was 
to be useful in the bone regeneration system.  The decision was made to make incremental 
steps when doing this.  The first step was the modification of flat films.  
 The transfer of the surface chemistries to flat PLGA films was successful, and 
instigated an interesting response in terms of the dynamic water contact angle.  The water 
contact angle had an inverse relationship to the chain length of the modification (figure 5.9).  
This is an unusual result, because when the molecule is considered the longer chain molecule 
will introduce more CH2 groups to the surface, which in turn should theoretically increase 
surface hydrophobicity.  This was not observed.  This could be because the substrate, PLGA, 
is already very hydrophobic, the addition of silane groups with hydrophilic end groups (-
NH2) leading to an increase in hydrophillicity despite the hydrophobic chain molecules.  The 
hydrophobic chains only act as a spacer physically keeping the hydrophilic NH2 groups away 
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from the very hydrophobic substrate, creating a layer which would be in contact with cells, 
that is hydrophilic, and conducive to cell growth. 
 The AFM investigation (Figure 5.2-5.7) of the surfaces showed variable coverage 
from the different modifications on the PLGA films.  The maximum peak height exemplifies 
the hypothesis that the CL11 modification is considerably different from the other 
modifications.  The CL11 modification appears to have two layers of microstructure, that 
being the macrotopography and also the nanotopography.  It is likely that it is the unique 
combination of the two, combined with the surface energy demonstrated by the advancing 
dynamic water contact angle that seems to create the active surface demonstrated in this 
thesis. 
 The application of the silanes to 3D polymer system was unsuccessful in this instance 
from the standpoint of cell response.  There was no evidence of differentiation on any of the 
modifications when examined using histological techniques.  There was evidence of cells on 
the system but they were not producing matrix.  The stains used would have identified the 
key proteins necessary for differentiation throughout the scaffold and they were all negative. 
 One possible reason for this is that the concentration of the silanes on the surface of 
the spheres was not the same as the concentration on the films which were successful (in the 
instance of CL11).  It is likely that it would be possible to optimize the techniques further by 
taking a close look at the coating methods in more detail.  The coating technique involves a 
flow of silane to stop the spheres from clumping, and the wash steps can not be as vigorous 
as that on a film or glass surface.  This leads to the concentration of silanes being 
significantly higher (10 fold) on the spheres than films.  It is likely that the coating technique 
and washing procedures would need to be heavily modified to allow the sufficient coating 
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and washing of the spheres while avoiding the clumping that is detrimental to the materials 
effectiveness. 
 Another possible reason why the application of the surface chemistries onto a 3D 
system did not cause stem cell differentiation could be that the modification protocol caused 
the chemical groups to be too closely packed together, creating steric hindrance, and not 
allowing the surface chemistry to be accessible by large protein molecules involved in stem 
cell differentiation 
42
,
43
.  Obtaining a similar concentration of the surface groups will be key 
to the success of further work in this area that, combined with the development of suitable 
techniques, investigate the surface chemistry and topography on spherical samples to allow 
better optimization of the technique. 
   The transfer of these chemistries into a 3D sphere will require further optimisation to 
determine if it is possible to obtain the concentration that is conducive to osteogenesis onto 
the surface of a sphere, and if the geometry of the surface of the spheres within this size range 
is conducive to the SAM formation.  If the concentration is too high there is a possibility of 
steric hindrance, and if it is too low, there may be an imperfect siloxane layer which would 
make the sample less stable.There are studies to suggest that the surface roughness effects the 
formation of the SAM layer, and that the thickness of the layer is proportionate to the 
roughness of a surface, so the surface roughness of the underlying sphere could be 
investigated, to determine if the spheres roughness could be a factor in causing an elevation 
in the concentration of amines
44
.  If this were to be the situation, steps could be taken to try to 
reduce the surface roughness of the polymer.  Other studies have demonstrated that for 3D 
coating of porous scaffolds, a dynamic coating environment it likely to be required, whereas 
on a 2D surface the static coating environment was sufficient
45
.  Further work would also 
involve the examination and identification of a suitable solvent that could wash the system 
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appropriately without causing damage to the PLGA, or leave any cytotoxic residues, as 
demonstrated in pharmaceutical release studies that the role of the solvent used to make the 
spheres, and also modify them, may play more of a role than merely dissolving the polymers 
and then evaporating
46
.  Further optimization of this may be a crucial next step in this work. 
 The potential of these surface chemistries is however highlighted in chapter 4, when 
we were able to obtain a very powerful response from both MSC, and primary osteoblast-like 
cells.  The surfaces can push cells down an osteogenic lineage and promote the rapid 
mineralisation at early time points.  This is a significant advance when considering this is the 
use of a synthetic chemical, and not a growth factor or a peptide.  The steps we have taken 
give a good foundation for further work, and while more optimisation is necessary to take this 
technology further, the first steps have been made. 
 This injectable system could also be used as a carrier for the patient’s own MSCs.  It 
is the product of long debate as to if using the patient’s MSCs is a genuine practical option 
when treating non-union bone fracture as it is a problematic area in itself, many culture 
methods would have to be refined before this became a viable option
47,48
, and it may be that 
the source of cells and the number of cells required for a sizable repair would be too many to 
cultivate in a timely manner for a patient treatment.  This would also be very expensive, and 
would not offer the benefits like cost effectiveness, long term stability of an off the shelf 
product that could be used universally.  
The plasma results (Chapter 3) gave an insight into the further potential of surface 
chemistry on 3D systems, and the next steps that could be taken.  There are two potential 
pathways this work may take in the future, if it were to be revisited.  One would be to channel 
energies into defining the characterisation of the surfaces and finding new more accurate 
techniques to do so, and the other would be to experiment with the potential of putting 
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various other modifications onto the surfaces with plasma, to see if there would be more 
extensive wider reaching applications in other areas of regenerative medicine, focusing on 
soft tissues more. 
In its present state the more accurate characterisation of the surfaces involved would 
need to be investigated before the applications of chemistries using plasma would be a 
clinically relevant technique.  The unpredictable nature of plasma modification is where the 
technique falls down, and until the surface chemistry concentration is definable with this 
technique it will be a theoretical exercise.  There are some spectroscopy techniques that may 
clear this picture up in the future.In particular, destructive techniques such as time of flight 
mass spectroscopy may be able to define the surface concentrations to the level that would be 
required.  
To assess fully the potential of the materials osteogenic capability, it will be necessary 
to conduct some animal model work.  There are several relevant animal experiments that 
could be conducted.  Initially a subcutaneous rodent model 
49
,
50
 could be conducted to 
investigate the ability of stem cells delivered with the material to differentiate.  This would 
require a full histological analysis using markers mentioned earlier in this thesis to determine 
the level of differentiation.  This would be a good first line in vivo experiment, and could be 
used to investigate some of the biocompatibility (ie, the inflammatory response) and the 
cellular migration throughout the scaffold.  If the correct techniques are deployed it will be 
possible to differentiate between host cells migrating into the scaffold and the implanted 
cells.  The use of fluorescent trackers 
51
,
52
 or chromosomal differences are used increasingly 
more commonly to do this type of work. 
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The next logical step would be the investigation of critical bone defect models
53
, but 
as the amine rich allyl amine modification was the only result to show sufficient osteogenic 
potential, it is likely that only this modification should be pursued for this application. 
The potential of using several well defined chemical modifications together in a 
scaffold to direct cells down different lineages would have impact in the wider field of 
regenerative medicine, and would potentially be useful for any of the junctions in tissue 
where one tissue becomes another, the most striking potential being within the osteochondral 
junction, on which some preliminary work was done in chapter 3. There have been several 
studies conducted that used biomaterials to tackle this problem, 
54
, 
55
,
56
, but most of this work 
used biphasic materials, with different degradation rates.  The benefit of using this injectable 
system is it is only the surface chemistry which is different across the body of the 
biomaterial, the underlying scaffold is the same material, and so would degrade at the same 
rate.  There is far more work to conduct on this, and taking the dual and triple modifications 
from an in vitro model to an in vivo model would be a good step forward with this.  There is 
a massive potential for this work to take place, and a knee model could show some of the 
potential that the in vitro work pointed towards.  If a delivery system could be designed that 
would allow the application of a multi-layered scaffold delivery, initially in the absence of 
cells but perhaps later moving towards a stem cell delivery model, a great deal of information 
could be gained from the application of this scaffold into an osteochondral defect. 
Initially it would be important to gain a response from the materials in the absence of 
any additional cells, to see what sort of native migration is demonstrated.  The material 
should be injected into an osteochondral defect that penetrates the medual cavity, so that the 
infiltration of stem cells and osteoblast like cells into the scaffold can be measured.  The 
subsequent dissection and histological examination of the knee would be likely to reveal the 
extent of regeneration from the native cells and demonstrate the osteoconductive nature of the 
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material.  Ideally this would be sufficient and make the treatment meet the requirements 
outlined earlier.  
The next experiment would see the incorporation of pre-cultured cells into the 
material prior to the injection into the aforementioned cavity.  This would be a more 
complicated procedure that would require timing and precision in the growth of enough cells 
to transplant.  This set of experiments would go some way to show how the materials would 
behave in vivo and give some insights into how this material might behave and degrade over 
time, depending on how long the experiment is conducted. 
The potential of the silane modifications has not been reached within this work 
(chapter 5), as further optimisation is required to successfully apply the silanes to a 3D 
system.  The successful application and characterisation of these surface chemistries to glass 
and a flat film (Chapter 4 and 5) was an insight into the possibilities that will be accessible 
with this technology in the future.  The chain length (and therefore the presentation of the 
terminal group) has proved to be very important on the expression of markers from 
mesenchymal stem cells and mature primary bone cells (Chapter 4).  The preference of the 
cells to the different chain lengths, with mesenchymal stem cells taking stimulus from the 
longer CL11 chain length and the mature osteoblasts gaining stimulus to differentiate from 
osteoblasts to osteocytes on the shorter chain lengths warrants further investigation. 
This delicate and subtle dynamic demonstrated numerous times throughout the thesis 
is changed significantly when applied to a 3D sphere (Chapter 5).  There are many areas 
where this application needs to be optimised.  The physical environment in which the self-
assembled monolayer of the silane forms needs to be optimised, to achieve a full layer on a 
spherical substrate.  It is likely that this will need to occur in a dynamic environment, which 
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adds a further level of complication. The flat surface is coated in a static application, which 
has proven to be much simpler
57
. 
To transfer the chemistry successfully, the precise environment will need to be 
optimised.  Work on this was started, and first attempts were shown to be unsuccessful in 
terms of differentiation stem cells (chapter 5), but the characterisation techniques are now in 
place, and further work into optimising the dose of amine groups transferred to the PLGA 
spheres would be possible now, as the ninhydrin test would be suitable to measure the 
quantity of amines bound to the surface of the spheres accurately and  the next step towards 
optimisation would be to try to obtain the same concentration of amine groups using similar 
chain lengths on the 3D system that is successful of the flat films (Chapter 4 and 5). 
The first step in this process would be to optimise the amount of oxygen groups that 
are successfully transferred to the PLGA spheres.  After that the concentration of silanes and 
the precise flow/dynamic incubation required to achieve controllable coverage would be 
optimised.  Clear characterisation of the surfaces would be essential at this point, and then the 
spheres could go into the complex dynamic culture with cells. 
Further work could also be done on the potential of the surfaces to harness osteogenic 
minerals, some of which are found on the surfaces of osteogenic cells.  CL11 showed a 
potential for phosphate deposition, which creates a biomimetic surface, and could potentially 
be used to increase mineralisation in the absence of cells
21
.  This could have applications in 
regenerative medicine where mineralisation is necessary, even in the absence of a cellular 
component.  If the material can start the mineralisation process before the infiltration of cells, 
this is likely to accelerate the healing process by way of giving the cellular component less 
work to do, or giving the native cells a more powerful osteogenic signal, to which they can 
respond. 
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The mineralisation capacity of these materials could be explored for the applications 
of other mineralised tissues, calcified cartilage, and dental treatments are just a few of the 
further reaching applications that become apparent.  Coatings of dental fillings or where there 
has been loss of mineralisation due to tooth decay could be an interesting application, and a 
more detailed investigation into this application could take place. 
There may also be applications of this work for cell selection, if indeed the minerals 
are present on the cell surfaces of differentiated cells, it may be a way to separate the cells 
with osteogenic potential from a fraction of bone marrow, or speed of which the osteoblast 
like cells can migrate from a bone chip into a coated petri dish.  Currently osteoblast like cells 
are isolated using standard plastic petri dishes, and the isolation process takes several weeks 
of culture to isolate a few million cells.  It would be an advantage to speed up the isolation 
process as this would also be an indication of the potential osteoconductive nature of these 
modifications. 
The work with the primary human osteoblast like cells showed several areas for 
potential further research (Chapter 4).  The CL3 and CL4 modifications showed an ability to 
stimulate the cells into forming nodules, which appeared, after staining and SEM 
investigation, to be mineralised.  When they reached a critical size the nodules appeared to 
detach from the material, and further investigation into the viability of these nodules should 
be investigated.  I would suggest a full histological investigation into the nodules, that are 
released from the surfaces to check the viability of the centre of the nodules and if any 
mineralisation occurs sub surface. 
While this was an unexpected result from this work, it certainly has some potential for 
growth.  A surface that could produce nodules of bone, that are viable, would certainly have 
applications in transplantation, perhaps not as part of the injectable system but delivered on 
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their own without a carrier.  It could be hypothesised that mineralised nodules of bone would 
have a greater chance of remaining in the area they are required to be in than previous 
attempts to transplant either mature osteogenic cells or stem cells. 
However, if the nodules could be seeded across the area of non-union fracture they 
may increase the capacity to heal, and would be osteoinductive and osteogenic, and there 
would be a potential for the application of the nodules as part of aosteoconductive scaffold, 
with a mineralising silane coating (like CL11 has demonstrated).  This combination of pre-
treated osteoblast and/osteocyte like cells along with a mineralising silane environment may 
harmonise quite well.  If the cells are already being pushed in to an osteocytic state and the 
silane induces a mineralisation process then cells may start to go down a regulatory pathway 
and help maintain the osteogenic response long term.  This is an area for further development 
and looking at applying the silanes to an osteoconductive porous scaffold such as a classical 
ceramic or metallic material would be an interesting avenue of investigation. 
This thesis has identified a few potential pathways of research, and shows that the 
coatings/modifications developed need not be limited to the constraints of an injectable bone 
regeneration system.  The wider potential of chemical modifications has also become 
apparent
11
.  The potential seen in some of the surface modifications to repress the 
differentiation of mesenchymal stem cells or osteoblasts (chapter 4) is also interesting and 
should be pursued, as the spontaneous differentiation of mesenchymal stem cells in tissue 
culture is one of the potential pitfalls in stem cell cultures, which is an area that needs far 
more research before cellular medicine is a true reality
37
.  If a simple synthetic chemical 
modification, (that controls surface energy and deposits its own topography), can achieve the 
maintenance of the stem cell phenotype for longer periods of time (particularly for adult stem 
cells that do lose some of the ability to differentiate after multiple passages in culture), the 
  Page 217 
 
vast cell numbers that are necessary for even the smallest transplant will become a more 
realistic goal. 
If materials have the potential to stimulate differentiation in a reproducible and 
relatively inexpensive way, there will be no need for the expensive and potentially 
compromising xenological components of tissue culture media, such as growth factors.  If the 
growth factors are produced by the cultured cells themselves, there will be less risk of 
interspecies incompatibility and it will be a step towards the widespread clinical use of stem 
cells. 
There would also potentially be a way to produce growth factors that does not require 
animals or animal products, so it could potentially have a commercial benefit, if it were 
possible to isolate the growth factors from the culture media where they are released.  This is 
just a possibility, but highlights the potential of these surfaces to the greater scientific 
community, and not just for the applications of regenerative medicine or stem cell biology.  
To carry this out however would require significant investment and a thorough and expensive 
investigation into the metablomic potential of the cells on these surfaces. 
As stated above there are numerous opportunities for further research that have been 
opened up from this initial investigation, and they are certainly not restricted to the field of 
injectable systems, bone regeneration, stem cell research or even regenerative medicine, but 
could have a more wider reaching cell culture and dental applications, give us an insight into 
cell cycles and material chemistry, that has not been demonstrated previously.  
In conclusion, this work has developed into a novel study that could develop further 
into wider reaching research that has clinical applications for osteochondral tissue repair and 
bone regeneration.  The advancement in osteochondral repair could impact the treatment of 
osteochondral disease, such as osteoarthritis.  The bone regeneration however was the main 
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focus of this thesis, and it is the osteogenicity of amine-rich modifications that has become 
apparent.  By exploring the presentation of the amine groups, it has become apparent that the 
small differences in chain length influence surface nanotopography, and that this in itself can 
be a driving factor of osteogenicity.  Some of the conflicting reports about surface chemistry 
could be due to changes made on the nanoscale that perhaps were not highlighted by the 
surface characterisation conducted
12
,
11
.  The terminal group is an important factor that 
influences the osteogenic potential of a surface, however the presentation of the terminal 
group, and the nanotopography that brings about, may also be key factors. 
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Chapter 7: Conclusions 
7.1  Conclusions for Plasma modifications on PLGA system 
The transfer of surface chemistries using the novel plasma polymer deposition technique 
was successful. 
1) Plasma modifications influence the mesenchymal stem cell fate; hydroxyl 
modifications push mesenchymal stem cells down a chondrocytic pathway and the 
amine modifications send mesenchymal stem cells down an osteogenic pathway, the 
methyl modifications seem to deter any differentiation, while the carboxyl groups also 
so no significant differentiation. 
2) Mesenchymal stem cells are influenced by the surface chemistries even in the 
presence of conflicting signals, and two separate populations of cells can be created 
by differing surface modifications alone. 
 
7.2  Conclusions silane modifications on glass 
1) The silane modifications were transferred successfully using a wet chemical technique 
onto glass  
2) The nanotopography of the materials revealed significant differences between the 
longest and shortest chain lengths. 
3) The water contact angle showed significant differences. 
4) The longer chain lengths increased the expression of osteogenic markers from the 
mesenchymal stem cells. 
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5) The shorter chain lengths allowed the formation of calcified nodules by primary 
human osteoblasts, pushing osteoblasts further down the osteogenic lineage towards 
embedded osteocytes. 
 
7.3 Conclusions for silanes on PLGA films 
1) The surface modification induces a nanotopography on PLGA film that is detectable 
by AFM microscopy 
2) The concentration of amine is higher on the CL11 than the other modifications 
(p=<0.95) demonstrating the efficiency of this modification. 
3) The dynamic water contact angle measurements showed a significant difference 
between some of the modifications, this highlighted a correlation between the chain 
length and the dynamic water contact angle. 
4) Human mesenchymal stem cells showed evidence of significant differentiation when 
incubated on CL11 modified PLGA surface. 
7.4 Conclusions for silanes on PLGA injectable system 
1) The amine group concentration on the spheres was significantly higher than the 
concentration of amine groups on the flat PLGA surfaces.  This is likely to be 
responsible for the absence of differentiation seen in the scaffolds. 
2) There was no significant differentiation seen on any of the scaffolds, but the further 
optimisation of this technique will lead to this. 
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Appendix 1 Ninhydrin assay standard curves 
 
 
 
 
 
 
  
y = 0.0173x + 0.239 
R² = 0.9198 
0
0.5
1
1.5
2
2.5
0 50 100 150
O
p
ti
c
a
l 
d
e
n
s
it
y 
a
t 
6
0
0
n
m
 
Concentration of CL3 silane in M 
y = 0.0141x + 0.0796 
R² = 0.979 
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
0 50 100 150
Concentration of CL4 silane (M) 
y = 0.0046x 
R² = 1 
0
0.05
0.1
0.15
0.2
0.25
0.3
0.35
0.4
0.45
0.5
0 50 100 150
O
p
ti
c
a
l 
d
e
n
s
it
y
 
Concentration of CL6 silane (M) 
y = 0.0141x + 0.0042 
R² = 0.9996 
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
0 50 100 150
Concentration of CL7 silane (M) 
y = 0.0136x - 0.0853 
R² = 0.8418 
-0.2
0
0.2
0.4
0.6
0.8
1
1.2
1.4
0 50 100 150
Concentration of CL11 Silane  (M) 
Appendix 1:Standard curves for individual silanes.  Standard curves used to calculate unknown 
concentrations of silanes,  showing linear regression lines, calculations and r values for each of the 
silanes used. (a) CL3, (b)CL4, (c) CL6, (d) CL7, and (e)CL11. 
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Appendix 2 LDH assay standard curves 
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Appendix 2: LDH assay standard curve.  Optical density plotted against a known number of 
cells. 
